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Abstract
I
n order to adjust to changes in the environment, cells can communicate via signalling
cascades. A common pathway for intercellular communication is the G-protein-coupled-
receptor (GPCR) signal transduction cascade which is triggered by a (chemical or physical)
extracellular signal, such as light or small molecules. This external interaction induces confor-
mational changes that can lead either to GPCR activation or deactivation. In the active form,
GPCRs can induce the activation of trimeric G proteins, which results in the dissociation of the
Gα from the βγ subunits. Subsequently, active Gα can interact with other cytosolic proteins,
such as adenylyl cyclase (AC), which converts adenosine triphosphate to cyclic adenosine
monophosphate (cAMP) upon stimulation. AC activation can be induced via stimulatory Gα
subunit (Gαs) interactions, while inhibition is related to inhibitory Gα (Gαi ) association.
X-ray crystallography is crucial for the computational study of the GPCR signal transduction
pathway. However, sometimes important molecules or moieties can become lost or cannot
be incorporated during crystallisation procedures, which can have a signiﬁcant effect on a
protein’s conformation and function. In this thesis, three steps in the GPCR signal transduction
cascade have been studied, rhodopsin activation (i), the conformation of active Gαi (ii) and
the interaction between Gαi and AC (iii). In all three cases some groups or molecules that are
absent in the X-ray structures play a vital role in the function of the proteins.
In the ﬁrst project, rhodopsin’s early intermediates after photon exposure are investigated
together with a deprotonation reaction that takes place in the later stages of the activation
pathway. The classical molecular dynamics (MD) and mixed quantum mechanics/molecular
mechanics MD results suggest that photon exposure induces active site rearrangements which
increase the stability of rhodopsin’s deprotonated Schiff base state. A bridging water molecule
in the active site that is absent in the X-ray structure appears to play an important role during
the deprotonation mechanism, which demonstrates the dependence of the protein’s function
on its environment.
The second study investigates the conformation of the active soluble form of Gαi , which
has not yet been fully resolved via experimental studies due to crystallisation difﬁculties of
the lipidated N-terminus. To investigate the effect of lipidation via classical MD simulations,
a model of soluble lipid-bound Gαi was constructed. The simulations show that Gαi can
form a hydrophobic pocket for the lipid on the protein surface. Other regions of the protein,
important for protein-protein interaction, are adjusted as well. Hence, the post-translational
iii
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modiﬁcation appears to have a signiﬁcant impact on Gαi ’s active conformation and function,
which was not captured via the unlipidated X-ray structures.
The last project is devoted to a complex of active soluble Gαi and AC (Gαi :AC). While the
interaction site for Gαs on AC is known, the interaction site for Gαi has not yet been identiﬁed.
Classical MD simulations were performed on a docked Gαi :AC complex to understand the
inhibition mechanisms as well as the differentiation between AC stimulation/inhibition. The
results show that Gαi binding not only leads to AC inhibition via impeding ATP binding but
also by preventing re-activation via Gαs through closure of the subunit’s interaction site on
AC.
Keywords: GPCR signal transduction pathway, G-protein-coupled recepter, rhodopsin, G
protein, complex formation, cis-trans isomerisation, adenylyl cyclase
iv
Riassunto
P
er adattarsi ai cambiamenti dell’ambiente, le cellule possono comunicare attraverso
segnali a cascata. Un meccanismo tipico di comunicazione è la cascata di trasduzione
del segnale dei recettori accoppiati a proteine G (GPCR), innescata da un segnale extra-
cellulare chimico (piccole molecole) o ﬁsico (fotoni). Lo stimolo esterno induce cambiamenti
conformazionali che possono portare all’attivazione o alla disattivazione dei GPCR. GPCR
attivi possono indurre l’attivazione delle proteine G trimeriche, che porta alla dissociazione
delle sub-unità Gα da quelle βγ. In seguito, le Gα attive possono interagire con altre proteine
citosoliche, come la adelinilico ciclasi (AC), che converte l’adenosina trifosfato in adenosina
monofosfato ciclica (cAMP), dopo la stimolazione. L’attivazione delle AC può essere indotta
da interazioni con Gα stimolatrici (Gαs ); l’inibizione è legata all’associazione di Gα inibitorie
(Gαi ).
La cristallograﬁa a raggi X è fondamentale nello studio deimeccanismi di trasduzione. Tuttavia,
alcune molecole o parti di esse, possono non venire incorporate durante la cristallizzazione,
con un impatto anche notevole sulla conformazione o sulla funzione della proteina. In questa
tesi sono stati studiati tre aspetti della cascata di trasduzione del segnale dei GPCR: l’attivazione
della rodopsina (i), la conformazione della Gαi attiva (ii) e l’interazione tra Gαi e AC (iii). In
tutti i casi, alcuni gruppi funzionali o molecole non presenti nelle strutture cristallograﬁche
sono cruciali per la funzione delle proteine.
Nel primo progetto sono stati studiati sia gli intermedi iniziali della rodopsina, seguenti l’espo-
sizione a fotoni, che la reazione di deprotonazione che avviene in una fase posteriore. I risultati
di simulazioni di dinamica molecolare (MD) classica e mista quantomeccanica/meccanica
molecolare (QM/MM) suggeriscono che la foto-eccitazione induce una riorganizzazione del
sito attivo che aumenta la stabilità dello stato deprotonato della base di Schiff della rodopsina.
Una molecola d’acqua “pont” nello stato attivo, assente nelle strutture da raggi X, sembra esse-
re importante nel meccanismo di deprotonazione: ciò dimostra la dipendenza della funzione
della proteina dall’ambiente ad essa circostante.
Il secondo studio riguarda la conformazione della forma attiva solubile della Gαi , non ancora
completamente determinata sperimentalmente per via di difﬁcoltà di cristallizzazione del
dominio N-terminale lipidato. Per indagare l’effetto della lipidazione è stato costruito un
modello di Gαi solubile legata a un lipide. Simulazioni MD classiche mostrano che la Gαi
può formare una tasca idrofobica per il lipide sulla superﬁcie della proteina. Anche altre
v
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importanti regioni della proteina risultano modiﬁcate: la modiﬁcazione post-traduzionale
sembra avere un ruolo signiﬁcativo sulla conformazione e sulla funzione della Gαi , ruolo non
colto attraverso strutture non-lipidate.
L’ultimoprogetto è dedicato a un complesso dell’unità attiva solubile Gαi e dell’AC, (Gαi :AC). Il
sito di interazione della Gαi sulla AC non è stato ancora identiﬁcato. Simulazioni MD classiche
di un complesso accoppiato (Gαi :AC), effettuate per capire i meccanismi di inibizione e le
differenziazioni tra stimolazione e inibizione dell’AC, mostrano che il legame con la Gαi porta
all’inibizione dell’AC non solo impedendo il legame ATP ma anche prevenendo la riattivazione
via Gαs , mediante chiusura del sito di interazione della sub-unità sulla AC.
Parole chiave: meccanismo di trasduzione del segnale nelle GPCR, recettori accoppiati a
proteine G, adelinilico ciclasi, formazione di complessi, isomerizzazione cis-trans.
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(PDB code 1AS3) zoomed in on ARF1’s myristoyl binding site (orange diamond)
in the inactive conformation. (b) Alignment of the Cα atoms of the ARF1:GDP
complex in pink (PDB code 2K5U) and the Gαnoni1 :GTP conformation in blue
(PDB code 1GIA) zoomed in on ARF1’s myristoyl binding site. The myristoyl
moiety of ARF1 is depicted in green and is interacting with a hydrophobic pocket,
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4.2 Proposed activation mechanism of Gmyri1 in which an activated GPCR induces
GDP/GTP exchange that leads to dissociation of the Gαi1 and Gβγi1 inter-
face. A represents the activation of Gαmyri1 in which the N-terminal palmitoyl
group is still present. B shows the conversion to activated depalmitoylated
Gαmyri1 which results in an equilibrium (C) between a solvated Gα
myr
i1 :GTP and
a membrane-bound Gαmyri1 :GTP complex. D represents the palmitoylation of
active membrane-bound Gαmyri1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.3 Structural overview of Gαmyri1 :GTP and comparison with X-ray structures. (a)
Representation of the initial homology model that was used to start the classical
MD simulation. The template for the cyan region was PDB entry 4PAQ, for the
orange area the PDB structure 1AS3 was used and the blue part was modelled
after PDB entry 2K5U. The myristoyl moiety is depicted in yellow. (b, c, d) Three
different views of the ﬁnal Gαmyri1 structure in which the myristoyl moiety, GTP
and Mg2+ are also shown. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
4.4 (a) Zoom on the proposed myristoyl binding site of aligned Gαi1 subunits in-
teracting with GTP, a GTP analog or GDP. The mauve coloured structure is a
Gαnoni1 :GTPγS complex (PDB code 1GIA) and the model, Gα
myr
i1 :GTP, after about
∼ 1.8 μs is shown in cyan. The Gnoni1 :GDP conformation (PDB code 1GP2) is
coloured blue. By the orange diamond it is shown where the myristoyl group
is connected to the Gαi1 subunit of the model. The yellow arrow speciﬁes the
outward movement of the β2-β3 domain upon myristoyl binding. Additionally,
Phe336’s orientation is shown for all three structures in the previously described
structure colours. (b) Theβ2-β3 shift between theGnoni1 :GDP and theGα
myr
i1 :GTP
complexes is shown by the red arrow and the myristoyl binding site is depicted
as an orange diamond. The color scheme for the structures is the same as in the
a image. (c) Alignment of Gαi1 subunits in which the difference in the switch
II region is shown. The red pentagon is showing the location of the guanine
nucleotide binding site. The colour scheme of the Gαi1 structures is the same as
in the a image, except for the fact that the tan structure is the X-ray conformation
of the Gαs :GTPγS complex (PDB code 1AZT) [Sunahara et al., 1997b]. . . . . . . 51
4.5 Alignment of several Gα sequences and ARF1 from saccharomyces cerevisiae. . 51
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4.6 Detailed representation of Gαmyri1 ’s myristoyl binding site and N-terminus. (a)
Zoom on Gαmyri1 ’s hydrophobic binding pocket in which the myristoyl group
(pink) is binding. Non-polar residues are colored in white, polar residues are
shown in green. (b) Myristoyl binding pocket of the simulated Gαmyri1 :GTP com-
plex in which the myristoyl moiety (pink) and several residues are shown: Met53
(blue), His57 (orange), Phe189 (green), Phe191 (gray) and Phe336 (purple). In
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2.1 μs, is shown for all described moieties. (c) Alignment of Gαmyri1 :GTP in the
equilibrated conformation (cyan) at ∼ 1.8 μs of classical MD and ARF1:GDP
(pink), PDB code 2K5U. Besides the protein, also the location of the myristoyl
group, GTP , GDP and Mg2+ are shown for both conformations. (d) Location
of the N-terminus with respect to the rest of the Gαmyri1 subunit. The myristoyl
moiety is shown in pink. Negatively (red) and positively (blue) charged residues
are shown on and around the N-terminus that keep the N-terminal tail into place
on the Gα subunit. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
4.7 Comparison of the switch II region of Gαmyri1 :GTP and Gα
non
i1 :GTPγS together
with the change conformation of the AH domain. (a) Detailed description of the
switch II region of the 1GIA PDB structure. Non-polar residues are depicted in
white, polar residues in green, positively charged residues in blue and negatively
charged residues in red. The nucleotide binding site is shown via the red pen-
tagon. (b) Detailed description of the switch II region of the solvated Gαmyri1 :GTP
structure. The color scheme for the residues and nucleotide interacting site is
the same as in the a image. (c) Conformational changes in the AH domain when
comparing the initial conformation (yellow) to a conformation of the protein
after ∼ 1.8 μs (blue). The red regions on the helices depict the location of Glu115
and Glu116. The red pentagon represents the location of the GTP binding site. 57
xv
List of Figures
4.8 Comparison of the Gαnoni1 :GTPγS complex and Gα
myr
i1 :GTP. Front (a) and top (e)
view of the Gαnoni1 X-ray structure (PDB code 1GIA) in complex with GTPγS, a
GTP analog. The pentagon indicates the location of the GTPγS molecule and the
orange dotted rectangles represent the regions at which AC5 binds to Gαs in the
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surface map of the front (d) and top (h) view of the Gαmyri1 structure after about
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1 Introduction
I
n everyday life, medication is used as a remedy for a vast amount of diseases. Drugs can
help to relieve symptoms such as pain but are also used in the ﬁght against Parkinson’s
and heart disease, for example. Close to 40% of drugs on the market target the G-protein-
coupled-receptor (GPCR) signal transduction pathway as this pathway is widely used for
intercellular signalling within the human body. Most GPCR based signalling pathways are
triggered by ligands that are too large to directly travel across the membrane and interact
therefore with membrane-embedded GPCRs to transfer the signal to the intracellular region.
Besides drugs, examples of natural ligands are hormones, neurotransmitters, small proteins
but also chemical or physical exogenous signals such as caffeine or photons. Ligands can
function as agonists, antagonists or inverse agonists, depending on their speciﬁc interaction
with a GPCR. Once the signal has arrived in the cytosol via a GPCR, activated by an agonist,
several proteins have to be employed in order to achieve the ﬁnal biological result, which
can range from cell growth to apoptosis. In order to get a better understanding of the way
an extracellular signal impacts the conformation of a GPCR as well as the transmission of
the extracellular signal into the cytosol, three steps in the GPCR signal transduction pathway
have been investigated in this thesis, namely rhodopsin activation, the conformation of active
inhibitory G proteins and their interaction with the enzyme adenylyl cyclase. The proteins
that play an important role in these steps (rhodopsin, G proteins and adenylyl cyclase) are
described in more detail in Section 1.1. The last sections of the introduction contain the
problem statement and the outline of this thesis.
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1.1 Context and Motivation
1.1.1 Rhodopsin, a Prototypical G-Protein-Coupled Receptor
The G-protein-coupled receptor family includes around 800 GPCRs [Lagerström and Schiöth,
2008], which are present in, for instance, the pulmonary system, the central nervous system,
the immune system, the eye and muscles [Borea et al., 2015]. GPCRs have a large impact on
the function of the human body because they are located in the membrane of cells which
enables them to relay communication between the intracellular and extracellular side of a cell.
Active GPCRs are able to stimulate or inhibit several proteins, which include protein kinase
A (PKA) and C (PKC) as well as RhoA (Fig. 1.1a). The activation of these proteins can have a
range of effects in the cell. PKA, for example, when activated in fat cells, can stimulate the
breakdown of fat [Patrick, 2013].
GPCRs are divided into six classes, from class A to class F, that share similarities in sequence
and function. The largest class, class A, includes around 700 GPCRs that are composed of seven
trans-membrane domains, three intracellular loops, three extracellular loops, a C-terminus
and an N-terminal domain (Fig. 1.1b). One of class A’s GPCRs rhodopsin is located in the
outer-segment of rod cells in the eye (Fig. 1.2b). Besides the structural elements described
in ﬁgure 1.1, rhodopsin also includes an 11-cis-retinal moiety that is covalently linked to the
a b
Figure 1.1: Description of the G-protein-coupled-receptor (GPCR) signal transduction cascade and a
class A GPCR template structure. (a) Activation of intracellular pathways via different G-protein families,
induced via GPCR stimulation, leads to the activation or inhibition of adenylyl cyclase, phospholipase
Cβ or RhoGEF, which ultimately result in the activation or inhibition of protein kinase A, RhoA, protein
kinase C, or a concentration increase in Ca2+. Taken from Ritter and Hall [2009]. (b) Template class A
GPCR structure showing the G-protein binding site and the general ligand binding site together with the
trans-membrane domains and the N-terminal and C-terminal tail. Taken from Foreman et al. [2010].
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receptor in the active site (Fig. 1.2a, c) [Smith, 2010]. Before rhodopsin photoactivation, retinal
acts as an inverse agonist in the active site, however, after light exposure, the chromophore
is converted to the GPCR’s agonist [Struts et al., 2011]. This change from inverse agonist to
agonist is induced by the ultrafast photoisomerisation of an 11-cis to an all-trans conﬁguration
of the chromophore (Fig. 1.2a) which triggers a series of events that start near the retinal
moiety in the active site and ultimately spreads over the entire protein (Fig. 1.2d).
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Figure 1.2: Rhodopsin’s activation mechanism. (a) 11-cis to all-trans photoisomerisation and later
deprotonation of covalently bound retinal in rhodopsin due to exposure to light. (b) Schematic repre-
sentation of the human eye and the composition of the retina, showing the rods, in which rhodopsin
is located, and the cone cells. Taken from Saey [2015]. (c) X-ray structure of inactive rhodopsin (PDB
code 1U19). The black lines indicate the location of the cell membrane. (d) Alignment of the active and
inactive conformation of rhodopsin, viewed from the intracellular side. Corresponding PDB codes are
listed in the same colour as the colour of the protein structure. The main structural changes due to
activation are indicated by yellow arrows. (e) X-ray structure of inactive rhodopsin (PDB code 1U19) in
which speciﬁc regions that are especially affected by retinal’s cis-trans isomerisation are highlighted.
The retinal moiety is shown in orange.
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After the chromophore’s change in conﬁguration, also its orientation in the active site is gradu-
ally altered. The subsequent relaxation induces deprotonation of the protonated Schiff base
(PSB) of Lys296, covalently linked to the retinal group, and protonation of the counter ion
Glu113 (Fig. 1.2a, e). This deprotonation mechanism is highly inﬂuenced by rhodopsin’s
environment since, for example, deprotonation takes place earlier in the activation pathway
at room temperature than when rhodopsin is exposed to photons at low temperatures [Sand-
berg et al., 2014; Thorgeirsson et al., 1993]. The pathway leading to the active conformation
of rhodopsin also includes more intermediate states at room temperature than when low
temperatures are applied to the system, as, for instance, during X-ray crystallisation. Besides
PSB deprotonation, a change in the position of Trp265 takes place in the photoisomerised all-
trans retinal conﬁguration as well as a rearrangement of the hydrogen-bond network around
Glu122 and His211 (Fig. 1.2e). Further away from the active site in the intracellular region, the
isomerisation ultimately affects the "closed" interaction site for G proteins that includes the
conserved residues Glu134, Arg135 and Glu247, called the ionic lock (Fig. 1.2e). As part of the
activation process, the salt bridges Glu134-Arg135 and Arg135-Glu247 are broken and Glu134
is protonated, leading to an "open" conformation of the intracellular region, the signalling
state meta II (Fig. 1.2c, d, e). Rhodopsin’s meta II state is able to interact with G proteins in the
cytosol that will augment the signal as one active rhodopsin can stimulate multiple G proteins.
Ultimately, rhodopsin induces a signal from the retina to the brain which results into eye sight
for dim light.
1.1.2 Down-Stream Effect: G Proteins and Adenylyl Cyclase
One of the main interaction partners of active GPCRs on the cell’s intracellular side are G
proteins (Fig. 1.1a and Fig. 1.3a). G proteins consist of three subunits: α, β and γ. While the
GPCR family contains around 800 different GPCRs, the human body includes only a relatively
small variety of G-protein subunits: 21 α, 6 β and 12 γ subunits [Oldham and Hamm, 2008].
When a GPCR is activated via the interaction with an agonist, G proteins can start interacting
with the GPCR’s intracellular region via the C-terminus of the Gα subunit (Fig. 1.3a). Due to
the interaction with the active GPCR, the G protein is able to substitute guanosine diphosphate
(GDP) for guanosine-5’-triphosphate (GTP), located at the interface between Gα and the β
subunit. After the GDP/GTP exchange, Gα dissociates from the βγ subunits and can transmit
the extracellular signal by interacting with other proteins in the cytosol, such as adenylyl
cyclase (AC) or phospholipase Cβ (Fig. 1.1a). An active Gα protein can stimulate or inhibit
enzymes in the cell, depending on which subfamily the subunit belongs to: Gαs , Gαi , Gαq or
Gα12.
While the Gαq and Gα12 subfamilies activate RhoA or PKC, Gαs and Gαi both affect the same
enzyme, AC, in an inverse fashion. Ten isoforms of AC are known of which nine are membrane-
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bound (AC1-9) and one is soluble (sAC). Gαs can stimulate all membrane-bound isoforms
of AC, leading to the conversion of adenosine triphosphate (ATP) to 3’,5’-cyclic adenosine
monophosphate (cAMP) and pyrophosphate (Fig. 1.3b), while Gαi can only inhibit isoforms
AC1, AC5 and AC6 [Sadana and Dessauer, 2008; Sunahara et al., 1996]. Another striking
difference between the two Gα subunits is the lipidation of the N-terminus. Both Gα subunits
undergo palmitoylation, the addition of a saturated 16-carbon fatty acid to the Gα subunit
β2AR
Gα
βγ
extracellular side
intracellular side
c
a
M1 M2
N-terminus
C1B
C1A
C2
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Gαs
Gαi
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, Mg2+
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Figure 1.3: Proteins on a cell’s intracellular side that can become activated or inhibited in response
to an extracellular signal, transmitted via GPCRs. (a) X-ray structure of β2 adrenergic receptor:Gs-
protein complex (PDB code 3SN6) [Rasmussen et al., 2011]. The black lines indicate the location of
the cell membrane. (b) Reaction mechanism that takes place in AC when the enzyme is stimulated
via active Gαs . In this reaction, adenosine triphosphate (ATP) is converted to 3’,5’-cyclic adenosine
monophosphate (cAMP) and pyrophosphate. Taken from Wikipedia. (c) Schematic representation of
the complete membrane-bound AC5 protein in the top panel, showing the unresolved protein regions,
the trans-membrane domains and the CB1 domain via cartoon representation. PDB code 1CJK was
used to describe the catalytic domains, C1A and C2. In the bottom panel the catalytic domains, C1A
and C2, and their pseudo-symmetrical interaction sites for Gαs and Gαi together with the location of
an ATP analog in the active site are depicted. The images were inspired by Hurley [1999].
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via esteriﬁcation of a cysteine residue by a palmitate molecule [Cabrera-Vera et al., 2003],
which is a reversible post-translational modiﬁcation. However, only Gαi is also subjected to
an irreversible addition of a saturated 14-carbon fatty acid, a myristoyl moiety, to Gly2 via
an amide bond. Gly2 becomes the ﬁrst residue of the Gαi sequence, after Met1 is removed
by methionine amino-peptidase [Cabrera-Vera et al., 2003]. The role of lipidation has not
been fully understood yet but it is known that palmitoylation is required to stably anchor
Gα subunits to the membrane [Degtyarev et al., 1994]. Solely myristoylated Gαi subunits
shift from being localised at the membrane to being both present at the membrane as well
as in the cytosol [Degtyarev et al., 1994]. In the case of Gαi , myristoylation impacts not only
the subunit’s location in the cell but also its active conformation and its inhibitory function.
Non-myristoylated Gαi is unable to inhibit AC as the Gα subunit cannot form a complex with
the enzyme anymore [Preininger et al., 2003; Taussig et al., 1993].
Gαs ’s active conformation and its stimulatory interaction with AC are well known as several
X-ray structures exist of active Gαs structures as well as of a Gαs subunit interacting with
AC’s catalytic C2 domain (Fig. 1.3c) [Sunahara et al., 1997a,b]. The Gαs X-ray structures co-
crystallised with AC do not contain the trans-membrane domains and the C1B domain but
this pruned version of AC is still able to convert ATP when the enzyme is in its stimulated form
[Dessauer et al., 1998]. In contrast to the large number of AC:Gαs complexes and active Gαs
structures, no Gαi :AC complex or myristoylated forms of active Gαi are present in the protein
data bank (PDB). Although non-myristoylated active Gαi X-ray structures are available, this
form of Gαi cannot inhibit AC activation and is therefore not an appropriate candidate for
comparison with active Gαs structures [Preininger et al., 2003]. The only currently available ex-
perimental study that has investigated myristoylated Gαi ’s binding site on AC is a mutagenesis
study by Dessauer et al. [1998]. This study indicates that Gαi binds to the pseudo-symmetrical
binding site on the C1A domain (Fig. 1.3c), which will be called C1 domain throughout this
thesis. Hence, structural understanding of how Gαs and Gαi bias AC into an active or inactive
conformation is still unclear.
1.2 Problem: Activation and Regulation
In cell communication, activation as well as its regulation are important. The signal transmis-
sion of active GPCRs to the cytosol can either lead to the stimulation or the inhibition of a
pathway. The GPCR rhodopsin is able to stimulate the brain via photons, resulting in vision
when only dim light is available. After photon exposure, the transfer of retinal’s conﬁgurational
change to the protein environment is generally well understood. However, one of the questions
that remain is: What enables or triggers proton transfer and why is it temperature dependent?
When moving further downstream in the GPCR signal transduction cascade, AC regulation
can take place in the cytosol as GPCRs can activate stimulatory and inhibitory G proteins. The
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conformation of Gαs subunits in their active state and their interaction site on AC are known
from X-ray structures. However, the active conformation of myristoylated Gαi is still under
debate as the available X-ray structures of the Gαi subunit do not incorporate N-terminal
myristoylation. The absence of the myristoyl moiety results in a signiﬁcant change in Gαi
structure as well as an incapability to inhibit AC since no Gαi :AC complex can be formed. Be-
cause no X-ray structures of the Gαi :AC complex have been resolved, the interaction between
myristoylated Gαi and AC is not well understood. Although mutagenesis studies are available,
the results are inconclusive about Gαi ’s speciﬁc interaction site. Hence, due to the uncertainty
of the effect of myristoylation and the absence of X-ray crystallographic data, Gαi ’s interaction
with AC and its mechanism of inhibition as well as the difference in action of Gαs versus Gαi
in spite of their structural similarity have not yet been elucidated.
The study of the inhibitory and stimulatory mechanism that Gα subunits exert on AC was
embedded in the Human Brain project (HBP). In the subgroup within HBP, European labo-
ratories, specialised in systems biology, Brownian dynamics, classical MD and QM/MM MD
simulations, collaborated to obtain a better understanding of AC regulation via G proteins.
The study mainly focussed on the stability of possible complexes AC can form with Gαs and
Gαi as well as each Gα’s effect on AC’s function.
1.3 Organisation of this Thesis
After a short summary of the underlying theory of the computational methods used in this
thesis in Chapter 2, Chapters 3-5 are presenting the obtained results for the three projects. The
ﬁrst step of the GPCR signal transduction cascade described in Chapter 3, is the activation of
rhodopsin. This study focusses on the early intermediates of the protein after photon exposure
and the PSB deprotonation reaction that takes place in the active site. In this project classical
MD and QM/MM MD simulations have been applied.
The next step that follows in the signal transduction pathway is the association of a G protein
to the intracellular region of a GPCR, which leads to the activation of a Gα subunit. This
active conformation of Gα is covered in Chapter 4 in which the active myristoylated Gαi
conﬁguration is studied, located in the cytosol. This investigation was conducted via classical
MD of two different conﬁgurations of the Gαi subunit, with and without the myristoylated
N-terminus.
In Chapter 5, the interaction between the newly determined Gαi conformation and AC is
explored by comparing classical MD simulations of AC interacting with Gαi as well as an AC
protein by itself.
The sixth and ﬁnal chapter summarises the ﬁndings of Chapters 3-5 and discusses future
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perspectives of the performed exploratory simulations.
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2 Theory
I
n this thesis a variety of computational approaches has been used to investigate the G-
protein-coupled receptor (GPCR) rhodopsin, the inhibitory G protein (Gi ) and the enzyme
adenylyl cyclase (AC). This chapter gives a short summary of the theoretical foundations
of the different methods.
The majority of the following sections is based on the textbooks by Atkins, Leach and Frenkel
[Frenkel and Smit, 2002; Atkins and Friedman, 2004a; Leach, 2001]. In this chapter the molecu-
lar dynamics (MD) method (Section 2.1) is described in the form of ab initio MD (QM MD)
(Section 2.2) and force-ﬁeld based MD (MM MD) (Section 2.3). The combination of QM and
MM MD is discussed in Section 2.4. The last section of Chapter 2, Section 2.5, covers the force
matching method, which is used for the automatised parameterisation of MM force ﬁelds
from QM MD data.
2.1 Molecular Dynamics
MD is a widely used computational technique to monitor the classical movement of particles
[Frenkel and Smit, 2002]. To describe the time evolution, Newton’s equations of motion,
fi =miai ,
fi =−dV
dri
, ai = dvi
d t
, vi = dri
d t
,
have to be integrated in time. In these equations f is the force, a is the acceleration, v is the
velocity, V is the total potential energy, r is the position of the particle and i is the index for
particle i. Integration in time is usually achieved by using numerical integration in discrete
time steps Δt. During an MD simulation the positions and velocities are calculated for each
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time step,Δt, – a very short period of time forwhich it is assumed that the forces on the particles
are constant– generating a time series t0 + Δt, t0 + 2Δt,...etc. If the force is not constant within
one time step, the calculation of the equations of motion becomes erroneous. Hence, it is
of great importance to specify a sufﬁciently small time step that generates a minimum of
force divergence during each time step and is still efﬁcient. Two widely used methods for
calculating the force on particles and their velocities in MD simulations are the Velocity Verlet
and the Leapfrog algorithm [Frenkel and Smit, 2002]. These methods have both been applied
during this thesis since the QM MD as implemented in the CPMD code uses the Velocity Verlet
algorithm and the MM MD as implemented in the GROMACS package employs the Leapfrog
technique [Hess et al., 2008; CPMD].
The initial positions of a system are setup before the start of a simulation using a structure
from the protein data bank, for example, and the initial velocities have to be generated e.g.
from a Maxwell-Boltzmann distribution at a given temperature.
Newton’s equations of motion can also be derived from the Euler-Lagrange formula,
d
dt
δL
δr˙i
− δL
δri
= 0, (2.1)
with the classical Lagrangian,
L(rN , r˙N )=
N∑
i=1
mi
2
r˙2i −V(rN), (2.2)
with mi being the mass of atom i , rN being the generalised coordinates and r˙N the time
derivatives of the coordinates. The Lagrangian, L(rN , r˙N ), in equation 2.2, which is especially
suitable for adding constraints to the dynamics of the system, is deﬁned as the difference
between the kinetic energy and the potential energy, V (rN).
As previously discussed, the force on the particles is essential to calculate the system’s motion.
However, the total potential, V (Eq. 2.1), that is required to obtain the forces for each time
step cannot be determined in an exact way for many-body quantum systems of more than
three particles. Consequently, an approximate approach is required to obtain the forces on
the particles. There are different methods to obtain an approximate potential and the choice
for a speciﬁc approach depends on the size of the system and the events under study. If
bond-breaking events occur, a quantum mechanical method has to be applied in order to
accurately calculate the particle forces in the system (see Section 2.2). Yet, at ﬁrst-principles
level this is only feasible to a maximum of several hundreds to thousands of atoms and is
in any case computationally demanding. Molecular mechanics or classical MD (see Section
2.3), based on parameterised force ﬁelds with limited transferability, is computationally more
feasible for large systems of several hundred thousands of atoms.
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2.2 Ab Initio Molecular Dynamics
To study a reaction mechanism, a quantum mechanical MD method has to be applied to
explicitly describe the changes in the electron density. The time evolution of a quantum
system is given by the time-dependent Schrödinger equation,
Hˆ(rN ,RM , t )Φ(rN ,RM , t )= iħ δ
δt
Φ(rN ,RM , t ), (2.3)
where Hˆ is the Hamiltonian, Φ is the wavefunction for the electrons and the nuclei, rN are
the set of spatial coordinates of N electrons, RM are the set of spatial coordinates of all M
nuclear coordinates, t is time and ħ is the reduced Planck constant. In this representation
the electrons and nuclei are taken simultaneously into account, which results in complex
calculations that are not computationally feasible for the simulation of larger systems.
One key simpliﬁcation to solve this problem is the Born-Oppenheimer (BO) approximation
[Atkins and Friedman, 2004a]. This approximation relies on the difference in masses between
the nuclei and electrons which results in the fact that the motion of electrons is signiﬁcantly
faster than that of the nuclei [Atkins and Friedman, 2004a]. Because of this difference in
characteristic time scales, the Hamiltonian Hˆ can be separated for nuclei and electrons and
the electronic Schrödinger equation can be solved in the presence of ﬁxed nuclear positions.
Consequently, a second assumption of the BO approximation is that the nuclear dynamics
follows a single potential energy surface. For regions, where the coupling between different
electronic states becomes signiﬁcant, the BO approximation breaks down and molecular dy-
namics approaches that include non-adiabatic effects [Tully, 1990; Thompson, 1998; Doltsinis
and Marx, 2002] have to be applied. In the case of fully adiabatic dynamics, the potential
energy surface can be determined from a solution of the time-independent non-relativist
electronic Schrödinger equation:
HˆeleΨele(r
N ,RMf )= EeleΨele(rN ,RMf ), (2.4)
with Hˆele being the electronic Hamiltonian,Ψele the electronic wavefunction, Eele the total
electronic energy and RMf are the set of spatial coordinates of the ﬁxed nuclei.
There are several ﬁrst-principles techniques that are able to approximate Eele , such as the
Hartree-Fock method or Density Functional Theory (DFT). These techniques each provide
their own ansatz for the electronic wavefunction, respectively the electronic density, and only
need fundamental constants and atomic numbers to solve the time-independent electronic
Schrödinger equation (Eq. 2.4) using the electronic Hamiltonian [Atkins and Friedman, 2004b]
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(in atomic units),
Hˆele = Tˆele + Vˆnuc−ele + Vˆele−ele
=−1
2
∑
i
∇2i −
∑
i ,I
ZI
| rNi −RMI |
+ 1
2
∑
i = j
1
| rNi − rNj |
. (2.5)
2.2.1 Density Functional Theory
The electronic structure method used during this thesis work is Density Functional Theory
(DFT). DFT is based on two theorems of which the ﬁrst one states that the ground-state
electron density determines a unique external potential (up to an additive constant) and
therefore a unique Hele andψ. Consequently, all properties, including the total energy of the
system, can be expressed as functionals of the electron density. The second theorem asserts
that the minimisation of Eele over all density distributions results in the ground-state energy
and the ground-state density. Formal proofs of these statements were delivered by Hohenberg
and Kohn in 1964 [Hohenberg and Kohn, 1964]. They determined an exact description of the
ground-state electronic energy as a functional of ρ,
Eele = 〈ψ0(R f ) | Hˆele |ψ0(R f )〉
= EHK [ρ0]+
∫
d3rVnuc−ele(r)ρ0(r), (2.6)
in which r is a position vector in Euclidean space [Meijer, 2007]. V nuc−ele describes the
Coulomb potential that arises from the nuclei and is usually called the external potential, Vext ,
ρ0 stands for the exact ground-state density and EHK is a universal functional of the electron
density. Although EHK is exact and proven to exist, the speciﬁc form of the dependence on the
electron density is not stated. In 1965, Kohn and Sham provided a reformation for this problem
that has been used ever since [Kohn and Sham, 1965]. They deﬁned ρ(r) as a summation over
a number of occupied single-electron orbitals, ψi , that describes a non-interacting single-
particle system with the same density as the interacting system:
ρ(r)=
N∑
i=1
|ψi (r) |2. (2.7)
Using the ψi orbitals (Eq. 2.7), denoted Kohn-Sham orbitals, the kinetic energy of a non-
interacting system can easily be calculated, leading to single-particle equations to solve the
Schrödinger equation, called the Kohn-Sham equations:

iψi (r)=HKSψi (r)= [−1
2
∇2+Ve f f [ρ]]ψi (r), (2.8)
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with the ﬁrst term on the right deﬁning the Kohn-Sham kinetic energy of the non-interacting
single-particle system. Ve f f [ρ] includes the external potential Vext (r), the classical Coulomb
potential and the exchange-correlation potential Vxc [ρ],
Ve f f [ρ]=Vext (r)+
∫
d3r′
ρ(r′)
| r−r′ | +Vxc[ρ]. (2.9)
The deﬁnitions of Vext (r) and Vxc [ρ] are:
Vext (r)=Vnuc−ele (r)=−
M∑
I=1
ZI
| r−RI |
, (2.10)
Vxc [ρ]= δExc [ρ]
δρ(r)
. (2.11)
The exchange-correlation energy, Exc , in equation 2.11 is a functional of the density as well
and includes all non-classical electron-electron interactions, i.e. takes all many-body effects
into account that are not incorporated into the other functionals [Atkins and Friedman, 2004b;
Marx and Hutter, 2000]. However, the exchange-correlation energy is the only term that has
not been expressed exactly so an approximation is necessary to determine the Kohn-Sham
orbitals and thus the ground-state density. In most quantum mechanical calculations, the
Kohn-Sham orbitals are expanded into an appropriate basis set:
ψi (r)=
∑
k
cikφk (r). (2.12)
Instead of ﬁnding the functional form of the Kohn-Sham orbitals, the expansion coefﬁcients,
cik , have to be determined by expressing the Kohn-Sham equations (Eq. 2.8) in the basis φk (r).
The resulting matrix equations have to solved in an iterative way via self-consistency.
When Exc has been approximated and the starting density has been constructed, e.g. through a
superposition of atomic densities, the orbitals can be generated via a self-consistent approach
[Atkins and Friedman, 2004b]. When the orbitals are determined, the density can be updated
via the deﬁnition of ρ(r) (Eq. 2.7). Hence, the ﬁrst step to determining the electronic energy via
DFT is the approximation of the exchange-correlation functional. Awidely used approximation
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is the local density approximation (LDA):
Exc =
∫
ρ(r)
xc [ρ(r)]dr. (2.13)
LDA approximates the exchange-correlation energy density per particle (Eq. 2.13), 
xc [ρ(r)], of
an inhomogeneous system with the one of a homogeneous electron gas (at constant density)
[Atkins and Friedman, 2004b]. The correlation part of the exchange-correlation energy per
electron has been determined via highly accurate quantum Monte Carlo calculations by
Ceperley and Alder [Ceperley and Alder, 1981]. The exchange part is calculated analytically
[Dirac, 1930; Mahan, 2013].
Although LDA is used for many problems in solid-state physics, it is not always appropriate
for the description of systems in which the electron density varies a lot, such as molecular
systems. In order to better account for these inhomogeneities, LDA can be augmented by
gradient corrections, which results in the generalised gradient approximations (GGA). There
are many variants of exchange-correlation functionals within the GGA approach. Currently,
one of the popular functionals for chemical systems is the BLYP functional, which combines
the gradient-enhanced exchange energy approximation of Becke with the gradient-enhanced
correlation energy approximation of Lee, Yang, and Parr [Becke, 1988; Lee et al., 1988].
2.2.2 Car-Parrinello Molecular Dynamics
Car-Parrinello Molecular Dynamics (CPMD) is the method that solved the major efﬁciency
problem of QM MD. CPMD includes the electronic structure calculation in the MD method by
extending the original Lagrangian (Eq. 2.2) by introducing electronic degrees of freedom as
additional classical variables with a ﬁctitious (classical) kinetic energy [CPMD]:
LCP (r
N , r˙N ,RM , R˙M )=
M∑
I=1
1
2
mI R˙
2
I +
N∑
i=1
1
2
μi 〈ψ˙i | ψ˙i 〉−EKS(rN ,RM ) (2.14)
−Vnuc−nuc (RN )+
N∑
i , j=1
Λi , j (〈ψi |ψ j 〉−δi , j ),
where μi is a ﬁctitious mass for the electronic degrees of freedom and the last term ensures
orthonormality of the electronic (one particle) wavefunctionsψi via the Lagrange multipliers
Λi , j . The equations of motion for this extended Lagrangian can be obtained from the Euler-
Lagrange equation in equation 2.1 in combination with the Hellmann-Feynman theorem
[Atkins and Friedman, 2004c], which results in two equations of motion, one for the electronic
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degrees of freedom (Eq. 2.15) and one for the nuclei (Eq. 2.16) [Meijer, 2007]:
μi | ψ¨i 〉 =HKS |ψi 〉+
N∑
j=1
Λi j |ψ j 〉, (2.15)
mI R¨I =−δ(E
KS +Vnuc−nuc )
δRI
. (2.16)
When μi <<mI , the extended Lagrangian (Eq. 2.14) approaches the true classical Lagrangian
(Eq. 2.2), which results in exact dynamics of a real classical system. The difference in mass
between the nuclei and the electronic degrees of freedom can be tuned via the ﬁctitious mass
of the electrons, μi , which controls how fast the electronic wavefunctions ψi (respectively
the cik coefﬁcients in a given basis) can adapt to changes in the nuclear positions. The basis
set expansion coefﬁcients, cik , are coupled to the positions of the nuclei, RI, via the potential
energy, V(r, R). When the ﬁctitious mass of the electronic degrees of freedom is small enough,
the response of cik to changes in the position of RI after one time step is so fast that the
electronic wavefunctions remain close to the ground state. When the mass of the electrons has
to be decreased also the time step decreases, which results in a longer time overall to simulate
a given time window. μi should always be chosen in such a way that the minimum electronic
frequency is signiﬁcantly larger than the maximum frequency related to the nuclear motion,
preventing energy transfer between the electronic and nuclear system, while using the largest
μi possible to enable the use of a larger time step.
Besides the ﬁctitious electronic mass, the representation of the single-particle wavefunctions
inﬂuences the efﬁciency of the simulations. In CPMD, plane waves (PW) are used to built the
basis set. PWs have several advantages as, for instance, they are unbiased because the basis
set does not depend on the atomic species or position and they are consistent with periodic
boundary conditions. However, PWs have one disadvantage, which is the necessity of a large
number of PWs to obtain an appropriate representation ofψi (Eq. 2.12) [Carloni et al., 2002].
Due to the highly localised nature of core electrons, it is expensive to represent them in a
PW basis set. Since the rapidly varying wavefunction of core electrons requires high energy
cutoffs, the effect of core electrons are usually integrated out by using pseudopotentials and
only the (slower varying) wavefunctions of the valence electrons are expanded into PWs. This
is justiﬁed by the fact that valence electrons play a dominant role in the chemical behaviour
of the system during reactions, while the distribution of the electrons near the nuclei do not
change signiﬁcantly. Using pseudopotentials, the number of PWs included in the basis set can
be drastically lowered and consequently the computational cost is reduced without signiﬁcant
loss in accuracy.
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2.3 Force-Field Based Molecular Dynamics
When the studied system containsmore than a few thousands of atoms, a quantummechanical
approach cannot be applied anymore as the computational cost becomes too high. In order
to reduce the expense of the calculations, one can choose to apply a molecular mechanics
method or classicalMDbased on a parameterised potential energy surface, using experimental
and theoretical data, a so-called force ﬁeld. This approach describes interatomic interactions
via bonded terms as well as through electrostatic interactions of effective point charges and
Van der Waals interactions, described by Lennard-Jones potentials, instead of describing atoms
as nuclei with explicit electrons:
Vtotal =Vnon−bonded +Vbonded . (2.17)
The part of the force ﬁeld that is computationally the most expensive is the calculation of
the non-bonded interactions. In order to decrease the computational cost of classical MD,
several approximations can be applied. For example, in united-atom force ﬁelds not all atoms
have to be described by explicit interaction sites because speciﬁc hydrogen atoms can also be
treated in an implicit manner in order to decrease the computational cost. This uniﬁcation
results in non-polar hydrogens being excluded from the simulation as single particles and
being included in the atomic mass of the atom originally connected to the hydrogen.
During this doctoral study the AMBER99SB force ﬁeld was used to sample the thermally
accessible conformations of soluble proteins and G-protein-coupled receptors [Case et al.,
2015; Sorin and Pande, 2005; DePaul et al., 2010]. In this all-atom force ﬁeld the non-bonded
interactions are obtained by using a Lennard-Jones potential for specifying the Van der Waals
interactions and a term involving ﬁxed effective point charges to calculate the electrostatic
interactions between particles (Fig. 2.1):
VLJ (ri j )=
∑
i>j
[(Aij
r12ij
)
−
(Bij
r6ij
)]
, (2.18)
VC (ri j )=
∑
i> j
qi q j

ri j
. (2.19)
In equations 2.18 and 2.19, the potentials sum over all atom pairs that experience non-bonded
interactions. The Lennard-Jones potential, V LJ (ri j ), between atom pair i − j with parameters
Ai j and Bi j takes effectively into account Pauli repulsion and attractive dispersion interactions.
In the representation of the Coulombic interactions, qi and q j are the effective charges of two
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particles that interact via a medium with dielectric constant 
 [Leach, 2001].
The bonded interactions are divided into three groups: bond stretching, angle bending and
dihedral terms (Fig. 2.1). The ﬁrst term, bond stretching (Fig. 2.1), is describing the changes in
atomic bond lengths via a harmonic potential
Vbonds =
Z∑
bonds
KdZ (dZ −dZ0)2, (2.20)
with d being the bond length that is compared to the reference bond length d0. In an analogous
way, the bond angle potential (Fig. 2.1) of the AMBER force ﬁeld is described by
Vangles =
L∑
ang les
KθL (θL −θL0)2. (2.21)
Through this potential, the energy increase due to a deviation of the angle, θ, with respect
to the reference value θ0 is obtained. The last term to complete the bonded potential is the
dihedral potential (Fig. 2.1), which is deﬁned by
Vdihedral s =
B∑
dihedral s
∑
n
Vn
2
[1+cos(nφB −γB )], (2.22)
Figure 2.1: Schematic image of the bonded and non-bonded interactions that are being taken into
account during classical MD. The non-bonded interactions are deﬁned by the electrostatic and Van
der Waals interactions. The bonded terms can be described by harmonic bond stretching concerning
the distance between a pair of atoms i and j, dZ , and angle bending concerning the angle, θL , between
three particles i, j, and k. The last term in the bonded segment includes the torsion between particles,
which is calculated via the angle φ between the two planes of consecutive triples of atoms i, j, k and j, k,
l. Taken from Leach [2001].
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with Vn being a barrier for dihedral transitions, n denotes the periodicity and γ represents the
phase shift of the torsional angle φ [Cornell et al., 1995; Weiner et al., 1984].
2.4 QM/MM Molecular Dynamics
The idea of combining QM and MM MD to enhance both accuracy and efﬁciency of large
system simulations, has been a challenge for several decades and is still a topic of development
[Warshel and Levitt, 1976; Singh and Kollman, 1986; Field et al., 1990; Laio et al., 2002a; Bulo
et al., 2009]. The QM/MM approach is important for simulations of biomolecules that are too
large for QM MD but for which classical MD is not adequate to simulate the chemical reactions
that can occur in an active site, for example. Hence, a combination of QM and classical MD is
applied to study these reactive proteins (Fig. 2.2 a). The Hamiltonian of the system is
Htotal =HQM +HMM +HQM/MM . (2.23)
In equation 2.23, HQM is the quantum mechanical Hamiltonian of the QM part (e.g. the active
site), HMM the molecular mechanics Hamiltonian for the MM part of the protein and the
solvent, and HQM/MM describes the interaction between the QM and the MM part. Consistent
with the functional form of the force ﬁeld, this term is divided into non-bonded and bonded
interactions. The bonded terms are included when the QM/MM interface separates atoms
from one another that are connected via covalent bonds (Fig. 2.2 b). After the cut between the
QM part and the MM part, the QM region can become electronically unsaturated if covalent
bonds exist between the QM and the MM region. One approach that can be used to saturate
a
a b
Figure 2.2: (a) Illustration of the devision between the QM and MM region in the system. Taken from
Field et al. [Field et al., 1990]. (b) Representation of the interface between the QM and MM region in
which two atoms are connected to one another, one located in the MM part and the other in the QM
part. Taken from Field et al. [Field et al., 1990].
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the valence orbitals of the QM part and to prevent an unphysical description of the atomic
orbitals at the border of the QM region, is hydrogen capping in which link atoms (hydrogen
atoms) are added to the QM region [Laio et al., 2002a]. The MM region of the system treats the
last QM atom as part of the MM region by using force ﬁeld calculations to obtain its potential
energy and the link atom is not detected by the MM system. In addition, the angular and
dihedral terms of the boundary Hamiltonian remain to be described by the MM force ﬁeld.
Another approach to solve the problem for QM/MM interfaces cutting through covalent bonds
is to apply parameterised monovalent pseudopotentials to atoms at the QM border that are
part of a covalent bond with the MM region [von Lilienfeld et al., 2005].
The non-bonded interactions between the QM part and the MM region are deﬁned by elec-
trostatic and steric effects. The Van der Waals interaction term of the MM region is used to
describe the steric non-bonded interactions, which are a result of the Pauli repulsion and
dispersion interactions. Together with the steric effect, also the bonded interactions are gen-
erated by the molecular mechanics part of the system. However, according to the applied
type of electrostatic coupling, the electrostatic effect is included in the quantum mechanical
system as an addition to the external ﬁeld [Carloni et al., 2002]. These electrostatic interactions
between the classical point charges and the quantum mechanical electron density have a
signiﬁcant impact on the QM system. The general non-bonded interaction Hamiltonian is
HQM/MMnon−bonded =V
QM/MM
C +V
QM/MM
vdw , (2.24)
which includes the Van der Waals and Coulomb interaction terms and can be deﬁned as:
HQM/MMnon−bonded =
∑
i∈MM
qi
∫
d3rρ(r)vi (| r− ri |)+
∑
i∈MM , j∈QM
vvdw (ri j ). (2.25)
For this Hamiltonian i represents the MM atom for which the charge is qi and the position is
ri [Laio et al., 2002a]. ρ in equation 2.25 is the total charge density (of the nuclei and electrons)
of the quantum mechanical system, vvdw is the Van der Waals interaction between atom i
(MM) and atom j (QM). vi is a function for the Coulomb interaction modiﬁed at short-range
vi (r )=
r nci − r n
r n+1ci − r n+1
, (2.26)
with rci representing the covalent radius of the atom i , r = |r− ri | and n=4.
This representation of HQM/MMnon−bonded in equation 2.25 provides a solution for the short-range
interaction problem, which occurs between the QM and MM region. This short-range interac-
tion problem or electron spill-out problem is present because positively charged atoms in the
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MM part of the system are able to overattract the electron density of the QM atoms, which is a
result of the absence of the Pauli repulsion of the MM atom as it does not contain electron
density. This can cause an overpolarisation of the electron density as the positively-charged
MM atom only contains an exclusively attractive potential and provides an incomplete repre-
sentation of the interactions [Laio et al., 2002a]. This form of HQM/MMnon−bonded used in the CPMD
package (Eq. 2.25) is able to prevent the electron spill-out problem.
However, calculating the electrostatic interactions via equation 2.25, which requires summing
over all charges of the MM region interacting with the electron density at every real-space grid
point, would become computationally too expensive when the simulated system includes
100.000 or 200.000 atoms, a common size for protein systems and of the order of 1003 grid
points. Therefore, in large systems the Coulomb interaction is only calculated as in equation
2.25 [Laio et al., 2002b,a] for MM atoms within a particular radius from each QM atom, the
radiusNN (Fig. 2.3).
For MM atoms further away from the QM region that are not included in the NN set but are
part of the ESP region, radiusNN ≤ radius < radiusESP , the Coulomb interaction term is altered
to reduce the computational cost. To this end, the electrostatic potential of the NN atoms (Eq.
2.25) can be used as a target to ﬁt effective point charges on the QM atoms that reproduce the
electrostatic quantum potential that was calculated for the QM region with the NN atoms as
probe sites [Laio et al., 2002b]. These charges are called Dynamically Restrained Electrostatic
Potential (D-RESP) derived charges as the charges are obtained during every step of the MD
trajectory and the ﬁt is restrained through a weighting function that depends on the Hirshfeld
QM 
atom
MM
QM
NN
ESP
Figure 2.3: Schematic representation of the regions of MM atoms (NN in green and ESP in orange)
around an example QM atom that are used to calculate HQM/MMnon−bonded . The red rectangle represents the
QM region while the blue ﬁlled circles depict QM atoms in the QM region.
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charges to prevent large ﬂuctuations in the charges due to conformational changes [Laio et al.,
2002b]. The Coulomb interaction term for the ESP region can thus be deﬁned as:
V ESPC =
∑
i∈ESP, j∈QM
qi qD−RESPj
ri j
, (2.27)
where qi is the classical point charge on an MM atom i in the ESP region, qD−RESPj is the ﬁtted
point charge on a QM atom j and ri j is the distance between ri and r j . When the distance
between the MM and every QM atom becomes sufﬁciently large –larger than radiusESP– the
Coulomb interaction of the MM atoms with the QM region can be expanded into a multipolar
expansion [Laio et al., 2002a]:
V MMC =
∑
i∈MM
qi
[
C
1
| ri − r¯ |
+∑
α
Dα
(rαi − r¯α)
| ri − r¯ |3
+ (2.28)
1
2
∑
αβ
Qαβ
(rαi − r¯α)(r
β
i − r¯β)
| ri − r¯ |5
+O
( Rq
| ri − r¯ |
)]
.
In equation 2.28 r¯ is the origin of the multipolar expansion deﬁned as the geometrical center
of the QM region. C , Dα andQαβ are the total charge, the dipole, and the quadrupole of the
quantum charge distribution, ρ, of which the detailed description can be found in Laio et al.
[2002a]. The charge density of the QM region is located within Rq , the radius of a sphere
around the geometrical centre of the QM region, r¯ [Laio et al., 2002a]. Hence, the complete
non-bonded interaction Hamiltonian that is used in the QM/MM interface of the CPMD
package to describe the interactions between the MM and the QM atoms in large systems is:
HQM/MMnon−bonded =V NNC +V ESPC +V MMC +
∑
i∈NN ,ESP,MM
j∈QM
vvdw (ri j ). (2.29)
2.5 ForceMatching
The most commonly used force ﬁelds in biomolecular simulations have been parametrised us-
ing experimental data sets or quantum mechanical calculations. However, molecular moieties
that are non-standard components of biological molecules, unlike amino acid residues, for
example, require individual parameterisation of the moiety as accurate parameters are usually
not present in the parameter set of the force ﬁeld. AMBER released a general AMBER force ﬁeld
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(GAFF) [Wang et al., 2004], which can be used for pharmaceutical compounds. However, GAFF
does not provide customised parameters for molecules, but assigns atom types that resemble
best the atoms in the molecule. Generating customised parameters for a molecule is time
consuming and can result in non-transferable parameters when the missing parameters of the
molecule highly depend on the environment. This is especially the case when the parameters
are determined from electronic structure calculations of small molecules in a continuum
solvent or in the gas phase [Bayly et al., 1993].
The QM/MM force-matching approach implemented in the CPMD package by Rothlisberger
et al. [Doemer et al., 2013; Maurer et al., 2007] is a technique that is able to parametrise a
molecule in its native environment, such as a protein, by using a QM/MM MD reference
trajectory. Assuming that the force ﬁeld used on the MM region adequately represents this
part of the system, the risk of non transferability in the automatised force-matching proce-
dure is signiﬁcantly lower as the molecule’s environment is taken into account during the
parameter calculations. The calculations are performed on a reference trajectory obtained
via QM/MM MD at ﬁnite temperature with the QM region including the molecular group to
be parameterised. After generating the QM/MM MD reference trajectory, three steps have to
be performed to obtain the new parameters for the molecular moiety in the QM region. The
ﬁrst step involves the storing of all the forces on the atoms in the QM region as well as the
electrostatic potential and ﬁeld on the MM atoms that are within a certain radius of the QM
atoms, the NN region (see Section 2.4). In the third step, atomic point charges qi are calculated
for the QM atoms to reproduce the electrostatic potential and ﬁeld obtained in step two. The
ﬁnal step covers the force matching of the remaining parameters of the molecule in the QM
region, apart from the Van der Waals interactions that are taken from the original force ﬁeld.
The force matching routine can be split into two steps. First the non-bonded contributions
to the atomic forces, computed via the obtained atomic point charges qRESPi from the QM
region and Lennard-Jones parameters for the QM region, taken from the MM force ﬁeld, are
subtracted from the total QM reference forces. In the second step the parameters for bond
stretching, angle bending and dihedral torsion (see Section 2.3) are modiﬁed in such a way as
to reproduce the remaining force components.
2.5.1 Step 1 and 2: Reference Trajectory and Forces
The QM/MM MD trajectory from which frames are used as reference conﬁgurations to cal-
culate the forces, the electrostatic potential and ﬁeld on the nearby MM atoms is generated
with the CPMD package using QM/MM Car-Parrinello MD or Born-Oppenheimer MD. The
time scale that can be reached via this approach lies in the range of picoseconds which is
usually too short to observe spontaneous dihedral transitions. Therefore, the force ﬁeld only
represents a particular conﬁguration of the molecule and additional torsional sampling via
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enhanced sampling techniques has to be performed in order to fully ﬁt these parameters.
When Car-Parrinello MD is employed to propagate the system, the system is close to the
ground state, however, accurate ground-state nuclear forces are needed to perform force
matching. Consequently, the obtained Car-Parrinello MD conﬁgurations are used to compute
BO reference forces for each conﬁguration with tight convergence criteria. Subsequently, these
BO reference forces are used to ﬁt a force-ﬁeld parameter set for the atoms in the QM region.
2.5.2 Step 3: Fit of Atomic Point Charges of QM Region
After obtaining the reference forces of the QM region in the QM/MM MD trajectory as well
as the electrostatic potential and ﬁeld to which the NN atoms are exposed to (see Section
2.4), atomic point charges of the QM atoms are ﬁtted to reproduce the electrostatic potential
and the electric ﬁeld on the NN atoms that is a result of the QM charge density. This is
a modiﬁed scheme from the D-RESP procedure (see Section 2.4) [Laio et al., 2002b, 2004],
used in calculating the non-bonded interactions during QM/MM MD, because besides the
electrostatic potential also the electric ﬁeld on the NN atoms has to be reproduced by the ﬁt of
the atomic point charges. Another important modiﬁcation to the original D-RESP procedure
in the force matching scheme is that the charges are not calculated per conﬁguration but a
single set of atomic point charges on the QM atoms is ﬁtted that performs best on average
over all QM/MM MD reference conﬁgurations included in the ﬁt. The incorporation of several
QM/MM MD conﬁgurations in the charge ﬁt leads to more transferable charge sets compared
to charges obtained via a single conﬁguration [Reynolds et al., 1992]. As a result, a weaker
restraint to the Hirshfeld charges can be used compared to atomic point charge calculations
on one conﬁguration [Maurer et al., 2007]. A restraint to the Hirshfeld charges is necessary to
avoid chemically unreasonable and conformation dependent solutions of the point charge ﬁt
[Laio et al., 2002b].The ﬁt of the atomic point charges qi is obtained by minimising the penalty
function [Doemer et al., 2013; Maurer et al., 2007], χ2:
χ2({qj })=
L∑
l=1
[ ∑
i∈NNi
(
wV (V MMil −V
ρ
i l )
2+ ∑
i∈NNl
wF ||EMMil −E
ρ
i l ||2
)
+ (2.30)
∑
j∈QM
wQ (qj −qHj l )2
]
+wtot (Qtot − ∑
j∈QM
qj )
2,
with l being the index running over all reference conﬁgurations L, j representing a classi-
cal atom from the NNl set which are explicitly coupled to the quantum charge density of
conﬁguration l via equation 2.30 and i including all QM atoms in the system. The different
weighting factors, w , which can be tuned in the force-matching procedure to balance the
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different contributions [Doemer et al., 2013], stand for weighting factors of the electrostatic
potential (wV ), the electric ﬁeld (wF ), the Hirshfeld charges (wQ ) and the total charge of the
QM subsystem (wtot ). V ρi l an E
ρ
i l are the electrostatic potential and ﬁeld, respectively, on the
classical atom i in conﬁguration l due to the presence of the QM system. V MMil and E
MM
il are
the electrostatic potential and ﬁeld resulting from the classical point charges {qj }. The third
restraint on the charges keeps the charges qj close to the Hirshfeld charges qHj l , while the ﬁnal
restraint ensures that the total charge of the QM region adds up to the correct valueQtot .
2.5.3 Step 4: Fit of Bonded Interactions of the QM Region
After ﬁtting a set of atomic point charges {qj } on the QM atoms, the total non-bonded forces,
FMMnbj l , of QM atom j in conﬁguration l are calculated by including the ﬁtted charge as well
as the MM Van-der-Waals interactions. These newly obtained non-bonded forces of the QM
region are subtracted from the QM/MM reference forces, FQMjl , leading to the part of the forces
due to the bonded interactions in the QM region. The bonded interactions described by a set
of parameters {xbn} [Maurer et al., 2007] are ﬁtted according to the penalty function, σ
2:
σ2({xbn})=
L∑
l=1
∑
j∈QM
‖FMMbj l −
(
FQMjl −F
MMnb
j l
)
‖2.
The newly obtained bonded parameters together with the new atomic point charges and
the MM Van-der-Waals interactions from the original force ﬁeld will be used to compose a
new parameter set for the target molecule, which can be used for long time propagation via
classical molecular dynamics simulations of the speciﬁc system.
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3 How Rhodopsin Tunes the Equilib-
rium between Protonated and Depro-
tonated Forms of the Retinal Chro-
mophore
Siri Camee van Keulen1, Alicia Solano2, Ursula Röthlisberger
3.1 Summary
Rhodopsin is a photoactive G-protein-coupled receptor (GPCR) that converts dim light into
a signal for the brain, leading to eyesight. Full activation of this GPCR is achieved after
passing through several steps of the protein’s photoactivation pathway. Key events in the
activation of rhodopsin are the cis-trans photoisomerisation of the retinal moiety followed by
conformational rearrangements and deprotonation of the protonated Schiff base (PSB) which
lead to full activation in the meta II state. Deprotonation of PSB is crucial for achieving full
activation of rhodopsin, however, the mechanism that takes place to reach the deprotonated
state is not well understood. In this study the molecular factors that enable PSB deprotonation
at body temperature in the later stages of the photoactivation process have been investigated
in order to obtain a better understanding of the difference between the deprotonatable state
of the chromophore and the inactive conformation.
1Van Keulen performed the discussed classical MD and QM/MM MD simulations, the ZINDO/S calculations
and the pKa calculations of the dark state and the early intermediates of rhodopsin.
2Solano performed the discussed correlation and causality calculations of the early intermediates in comparison
to the dark state of rhodopsin.
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The deprotonation mechanism has been investigated by applying QM/MM simulations in
combination with thermodynamic integration. The study shows that, compared to the inactive
11-cis-retinal case, trans-retinal rhodopsin is able to undergo deprotonation of PSB due to a
change in the conformation of the retinal and a consequent alteration in the hydrogen-bond
(HB) network in which PSB and Glu113 are embedded. Besides the retinal moiety and Glu113,
also two water molecules as well as Thr94 and Gly90 that are related to congenital night
blindness are part of this HB network.
3.2 Introduction
In vertebrates’ eyes, rod cells are activated when only dim light is available. The protein
that is able to convert these photons into a signal for the brain is rhodopsin. Rhodopsin is a
protein with seven trans-membrane domains (TMs) and is part of class A in the G-protein-
coupled receptor (GPCR) family. For several decades rhodopsin has been intensely studied as
a prototype system to understand the activation process of GPCRs. Besides being viewed as an
example protein for other GPCRs in class A, rhodopsin bears also other properties of interest,
such as low basal activity and a high yield of around 65% for the conversion of its inactive
11-cis-retinal state (Fig. 3.1) to its active trans conﬁguration [Kim et al., 2001]. However, these
features can be perturbed via mutations in the active site of rhodopsin, such as Thr94Ile and
Gly90Asp, that cause congenital stationary night blindness (CSNB) [Singhal et al., 2016, 2013].
Besides mutations, rhodopsin is also affected by changes in temperature that lead to different
activation pathways at low temperatures with respect to room temperature. For example,
depending on the temperature of the system, the deprotonation of the protonated Schiff
base (PSB) is shifted to an earlier (metarhodopsin I) or later step (metarhodopsin II) in the
photoactivation pathway (Fig. 3.1b) [Lewis et al., 2004; Sandberg et al., 2014; Thorgeirsson
et al., 1993]. Besides the change in PSB deprotonation, the blue-shifted intermediate (BSI) is
absent at low temperatures while at room temperature BSI is in equilibrium with the batho
state (Fig. 3.1b)[Hug et al., 1990; Lewis and Kliger, 1992]. Several structures of intermediates of
the photoactivation pathway, dark, batho, lumi and meta II [Nakamichi and Okada, 2006a,b;
Okada et al., 2004; Li et al., 2004; Deupi et al., 2012], have been obtained at low temperatures via
X-ray crystallography (160 Kelvin) and show the relaxation after cis-trans photoisomerisation.
However, in view of the fact that in nature rhodopsin functions at body temperature and the
observed temperature dependence of the activation path, actual early intermediates under
physiological conditions could differ from the conﬁgurations found via X-ray crystallography.
Rhodopsin’s activation pathway starts with inactive, dark state, rhodopsin in which Glu113
forms a salt bridge with the protonated Schiff base. However, after photon exposure, relaxation
of the retinal moiety and deprotonation of the chromophore, the salt bridge is broken and
remains broken in the long-lived later intermediates such as meta II (Fig. 3.1b) [Cohen et al.,
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1992]. During the deprotonation step, a proton is transferred from the protonated Schiff base,
formed by the retinal and the covalently bound Lys296, to Glu113, the counter ion [Jaeger
et al., 1994; Sakmar et al., 1989]. A parameter that plays an important role in the deprotonation
mechanism is the pKa of retinal’s protonated Schiff base. PSB’s pKa, which is estimated to
be greater than 15 in dark state bovine rhodopsin [Ebrey, 2000; Steinberg et al., 1993], can be
decreased to 6 by mutating Glu113 to a glutamine residue [Sakmar et al., 1991], which is close
to PSB’s pKa value of 7.5 ± 0.1 in solution [Gat and Sheves, 1993]. The effect of the Glu113Gln
mutation can thus trigger the deprotonation of the Schiff base and shows that the change from
a charged residue to a polar one near the PSB can affect the chromophore’s protonation state
[Zhukovsky et al., 1992; Gat and Sheves, 1993; Ebrey, 2000].
As temperature dependence plays a signiﬁcant role, the available X-ray structures of the early
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Figure 3.1: Rhodopsin’s photoactivation pathway. (a) Structure of the retinal moiety in the 11-cis
conﬁguration covalently linked to the protonated Schiff base (Lys296). The number of the methyl
groups are depicted in orange, while the number of the nitrogen is shown in yellow. The numbers of
the residual carbons of the retinal moiety are represented in green. (b) Schematic representation of the
photoactivation pathway of rhodopsin at low (between 10 Kelvin to 273 Kelvin) and room temperature
[Sandberg et al., 2014; Lewis et al., 2004; Hug et al., 1990].
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intermediates might not be appropriate structures to start a molecular dynamics study with
as they were obtained at low temperatures [Nakamichi and Okada, 2006a,b]. A feature of the
active site that can be affected by a temperature increase, for example, is the sampling of
different type of conﬁgurations during the relaxation of the trans retinal conﬁguration [Hug
et al., 1990; Lewis and Kliger, 1992]. The positioning and the number of water molecules is a
second important factor that can be altered by the temperature of the system as well as by the
crystallisation process.
In order to investigate PSB deprotonation at body temperature, a dark state X-ray structure
of rhodopsin was used to build an initial homodimer structure to minimise temperature and
crystallisation effects on the activation mechanism of the protein. A homodimeric form of
rhodopsin was employed in the classical MD simulations in order to mimic the native environ-
ment of rhodopsin in the retina [Fotiadis et al., 2006]. Besides in retina, homodimerisation
has also been observed for rhodopsin:G-protein complexes for which a stoichiometry of 2:1
could be determined [Jastrzebska et al., 2011, 2013]. After classical MD simulations, QM/MM
MD simulations were used to follow the relaxation process during the early intermediates
(batho, BSI, lumi) as well as to investigate the deprotonation reaction in the lumi state via
thermodynamic integration (TI). The validity of the conﬁgurations of the early intermediates
was checked through the comparison of their calculated vertical excitation energies with the
corresponding experimental absorption maxima. This comparison showed that the found
conﬁgurations were in good agreement with experiment.
To anticipate our results, the QM/MM MD at body temperature shows that in the early interme-
diates the relaxation of the retinal conformation mainly takes place close to PSB where space
in the active site is present for methyl relocation. The comparison of PSB deprotonation in
the dark and the lumi state suggests that besides the orientation of the retinal moiety also the
hydrogen-bond network around the PSB is important for the feasibility of the reaction. At body
temperature, water molecules in the lumi state appear to impact this HB network severely by
changing the salt bridge between PSB and Glu113 to a bridged water form thereby decreasing
Glu113’s hydrogen-bond accepting interactions from four to three. After the deprotonation
reaction, Glu113’s hydrogen bonds are even decreased to two, of which one Glu113 remains
the hydrogen-bond acceptor and in the second one Glu113 is the hydrogen-bond donor. This
investigation suggests that the retinal orientation within the active-site pocket as well as the
rearrangement of the HB network that takes place during the relaxation of the retinal moiety,
are important to favour PSB deprotonation.
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3.3 Methods
3.3.1 Classical Molecular Dynamics
The periodically repeated simulation box has a size of approximately 120 X 115 X 126 Å3,
which includes around 40 000 water molecules, 400 lipids and four Na+ ions to neutralise
the rhodopsin dimer system (Fig. A.1). The lipids are 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamines (POPEs) for which the force ﬁeld parameters of Jämbeck et al. were
used [Jämbeck and Lyubartsev, 2012]. The rhodopsin homodimer system was simulated at 310
K and at a pressure of 1 bar using a Nosé-Hoover thermostat and a semiisotropic Parrinello-
Rahman barostat. The initial structure of the rhodopsin monomers was taken from the protein
data bank (PDB) [Berman et al., 2000], PDB code 1U19 [Okada et al., 2004], while the missing
residues 214-246 were taken from PDB code 1GZM [Li et al., 2004]. The intradimeric TM4/TM5
interface was used for the homodimer, extracted from PDB code 1N3M [Fotiadis et al., 2006].
Default protonation states were used for the residues in the monomers, except for Asp83
and Glu122 that were protonated [Fahmy et al., 1993]. A disulﬁde bond was formed between
Cys110 and Cys187. Two palmitate groups, for which force ﬁeld parameters were taken from
literature [Röhrig et al., 2002; Dickson et al., 2012] are bound to each monomer via Cys322 and
Cys323. The force ﬁeld parameters for the retinal and Lys296 used in this study were obtained
by Saam et al. [Saam et al., 2002].
The force ﬁelds used for the protein dimer and the water molecules are AMBER99SB [Case
et al., 2015] and TIP3P [Jorgensen et al., 1983], respectively. All MD runs were perofrmed using
GROMACS 4.5.5 [Hess et al., 2008]. Electrostatic interactions were calculated with the Ewald’s
particle mesh method with a real space cutoff of 12 Å. Bonds involving hydrogen atoms were
constrained using the LINCS algorithm. The integration time step was set to 2 fs.
The production run of the rhodopsin dimer system in the dark state was performed for 700
ns after 10 ns of equilibration. Subsequently, the classical MD simulation of the dark state
dimer was used to initiate cis-trans isomerisation of a single retinal. The use of classical MD
simulations to perform the restrained conversion from cis to trans was previously validated
by Röhrig et al. [Röhrig et al., 2004, 2005] and shows that excited state calculations lead to a
very similar conﬁguration of the isomerised retinal as restrained classical MD simulations.
The cis-trans isomerisation was performed in one monomer by putting restraints on the C10-
C11-C12-C13 and C11-C12-C13-C14 dihedrals to secure the desired trans conﬁguration (Fig.
3.1a). After the isomerisation has taken place in around 200 fs, the restraints were released
and snapshots were taken that were used as initial structures for the QM/MM simulations.
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3.3.2 Quantum Mechanics/Molecular Mechanics Molecular Dynamics
The QM part of the QM/MM MD simulations included the retinal moiety, Lys296, Glu113 and
two nearby water molecules (Fig. A.2). The CPMD 3.15 package [CPMD] was employed to
perform the QM/MM MD simulations with Car-Parrinello molecular dynamics (CPMD) using
the BLYP functional and a plane wave energy cutoff for the wavefunction of 70 Ry. Martins-
Troullier pseudopotentials were used for the QM atoms. In order to cut the QM residues
from the rest of the protein, monovalent pseudopotentials [von Lilienfeld et al., 2005] were
employed. QM/MM simulations were performed at an average temperature of 310 K using
a Nosé-Hoover thermostat. A time step of 0.12 fs and a ﬁctitious electronic mass of the CP
Lagrangian of 700 au were used. The AMBER force ﬁeld was used to account for interactions
among the atoms of the MM region. In case of the simulations performed for thermodynamic
integration, the QM region was extended, compared to the QM/MM MD for the spectra
calculations, by the incorporation of the backbone of Glu113, Thr94, and the backbone of
Cys187 (Fig. A.2). These residues were added to the QM region as Thr94 and Cys187 are
hydrogen bonded to Glu113. The backbone of Glu113 was included because it interacts with
the water molecules in the QM region (Fig. 3.2c).
In the TI simulations, the constrained distance in the dark state was deﬁned as the distance
between the proton of the protonated Schiff base and the oxygen of Glu113 that form a salt
bridge with the proton (Fig. 3.2a). In the lumi state the constrained distance was described by
the distance between a hydrogen of a water molecule that bridges the PSB and Glu113 and the
oxygen of Glu113 that forms a hydrogen bond with the bridging water molecule (Fig. 3.2c). The
interval in the constraint distance between each window was 0.1 Å except for three windows,
between 1 Å and 1.15 Å for the dark and lumi state of 1 Å, 1.05 Å and 1.15 Å, in which an
interval of 0.05 Å was applied. Each constraint window for both dark and lumi thermodynamic
integration procedures was sampled for a minimum length of 2.4 ps, unless stated otherwise
in the supplementary information.
3.3.3 pKa Calculations
pKa values for Glu113, Asp83 and Glu122 were calculated via the H++ webserver [Gordon et al.,
2005; Myers et al., 2006; Anandakrishnan et al., 2012]. The input ﬁle for the pKa calculations
contained a dark, lumi or pre-meta-I conﬁguration of the rhodopsin monomer that was
isomerised and included water molecules within a 7 Å radius around the retinal moiety of the
rhodopsin monomer. All aspartates and glutamates were not protonated. The retinal moiety
was not included in the pKa calculations as it could not be taken into account by the H++
server. In the performed calculations, the salinity was kept at 0.15 M and the external dielectric
was set to 80. Values for the interior dielectric were varied from 4, 6, 8, 10 to 20.
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3.3.4 Spectra Calculations
The ZINDO/S method implemented in Gaussian 09 [Frisch et al.] was used to calculate
the vertical excitation energies for rhodopsin, bathorhodopsin, BSI, lumirhodopsin and pre-
metarhodopsin-I conﬁgurations. Previously obtained vertical excitation energies via ZINDO/S
of retinal and related polyenals have been shown to be in line with experiments [López et al.,
2006]. The four lowest roots were taken into account together with their corresponding
oscillator strengths in order to obtain the absorption spectra. The QM cluster model that was
used to calculate the vertical excitation energies included the retinal moiety and residues
within a distance of 7 Å from the retinal group. The sufﬁciency of the use of a 5 Å radius for the
rhodopsin system has been previously determined by Campomanes et al. [Campomanes et al.,
2014]. In addition, the backbone of each residue was removed in the model and the position
of the Cα carbons was substituted for a hydrogen atom to saturate the system.
3.3.5 Correlation Feature Selection and Causality Inference Analysis
A two-step protocol was employed to identify the set of electronic and geometrical features
responsible for the shifts in the batho, lumi and pre-meta I absorption spectra with respect to
the dark conformation. The initial set of features was composed of the bond length alternation
(BLA) [Gieseking et al., 2015] as well as all intramolecular and intermolecular distances, angles
and dihedrals in and around the retinal moiety with a distance cutoff of 7 Å. The BLA is
deﬁned as the difference between the sum of all the single-bond lengths minus the sum of
all the double-bond lengths along the chromophore’s conjugated polyene chain, from C5 to
the N atom of the protonated Schiff base (Fig. 3.1a). Within the selected region all atoms
were taken into account except for the hydrogen atoms and the protein backbone. For each
photointermediate, the 100 snapshots used in the ZINDO/S calculations were included and
resulted in an initial set of over 48∗106 features. Since the number of features in the initial
set is computationally unfeasible, the dimensionality of the initial set of descriptors had to be
reduced to a smaller subset of features, which is still indispensable and sufﬁcient to describe
the target parameter, the spectral shift. The spectral shift is deﬁned as the maximum of the
calculated vertical absorption spectra of the excitation energy of the intermediate in each
snapshot minus the one of the dark state (2.39 eV) (Table 3.2). Once the dimensionality
problem is sufﬁciently reduced, causality can be inferred between the features in the reduced
set and the spectral shift.
Hence, the ﬁrst step towards performing the correlation and causality analysis includes reduc-
ing the number of features by removing features that are irrelevant, redundant and noisy with
respect to the target property, the spectral shift. Two feature selection algorithms implemented
in the WEKA 3.8 machine learning package [Witten and Frank, 2005] were employed to perform
this task. Previously, WEKA has already been used successfully for an analysis of the spectral
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features of rhodopsin [Campomanes et al., 2014], taking into account all intermediates at once,
up to the lumi state. The Regressional ReliefF (RReliefF) attribute evaluator algorithm [Robnik-
Šikonja and Kononenko, 1997] together with a ranker search method was used ﬁrst to reduce
the dimensionality of the initial set of features to a reduced set of features. Subsequently, the
Correlation Based Feature Selection (CBFS) algorithm [Hamilton, 1998], using the BestFirst
search method, was employed to perform a correlation analysis on the reduced feature set to
select features that are highly correlated with the spectral shift. CBFS is a ﬁlter algorithm that
evaluates the heuristic merit of a subset of features considering the correlation to the target,
and the correlation within features. Therefore, the selected subset, showing the highest merit,
contains highly correlated features with the spectral shift, which are minimally correlated with
each other. The heuristic merit is deﬁned as:
Ms =
k < r f t >√
k+k(k−1)< r f f >
, (3.1)
where Ms is the heuristic merit of a subset s, containing k features,< r f t > is the mean feature-
target correlation, and < r f f > is the mean feature-feature intercorrelation. Hence, the merit
numerator provides a measure of the predictive ability of the subset of features to the target,
whereas the denominator gives an indication of the feature’s redundancy.
After applying the CBFS algorithm on the reduced set of features, the PC-LiNGAM algorithm
[Hoyer et al., 2012], implemented in the TETRAD V causal inference package [Glymour and
Scheines, 1986], was used to deduce a causal relationship between the spectral shift and the
features included in the set provided by the results of the CBFS algorithm. By combining two
different approaches, the PC (Peter-Clark) algorithm [Spirtes et al., 2000] and the LiNGAM
(Linear Non-Gaussian Acyclic Model) algorithm [Shimizu et al., 2006], the PC-LiNGAM method
accepts an arbitrary distribution, meaning that Gaussian and non-Gaussian data sets can be
used to obtain the structural equation model (SEM). The SEM represents the causal structure
of the model in the form of linear equations and is graphically modelled by a direct acyclic
graph (DAG) [Lacerda et al., 2012]. The inference of this approach is based on conditional
independences between the variables. Conditional independences between variables were
estimated via the Fisher’s z-transform, using a signiﬁcance level, α, of 0.001. Moreover, the
Markov blanket of the spectral shift was built and the values for the edge coefﬁcients in the
SEM were estimated using a regression optimiser after standardisation (zero mean and unit
variance) of the data set variables.
3.3.6 Structure Superpositions and Images
Multiprot [Shatsky et al., 2004] and VMD [Humphrey et al., 1996] were used to align protein
structures. Images were prepared with VMD [Humphrey et al., 1996].
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3.4.1 Possible Deprotonation Pathway for Nitrogen of PSB in Rhodopsin
The experimental study by Sandberg et al. [Sandberg et al., 2014] shows that at room tempera-
ture the deprotonation of PSB already takes place between the lumi and meta I state, instead
of taking place between the meta I and meta II state, which is the case at low temperatures.
Therefore, a QM/MM equilibrated lumi structure at body temperature was used to follow the
deprotonation reaction via thermodynamic integration. For the sake of comparison, analo-
gous calculations were performed for the dark state. For both conﬁgurations, the distance
between Glu113’s O1, which is part of the salt bridge with PSB in the dark state (Fig. 3.2),
and the hydrogen to which it is hydrogen bonded was used as reaction coordinate in the TI
simulations. Hence, in the lumi state the distance between H(WAT1) and O1(Glu113) was
used as a constraint, while for the dark state O1(Glu113) and the hydrogen on the nitrogen of
the PSB, H(PSB), was used (Fig. 3.2 and Fig. 3.3a). In the TI simulations of the lumi state, the
protonation of Glu113 via the proton of WAT1 results in the spontaneous deprotonation of
retinal’s PSB and reprotonation of WAT1 (Fig. 3.3 and Fig. A.10, A.11), which suggests that the
used reaction coordinate is a valid one.
Figure 3.4 shows that a signiﬁcant difference can be found in the free energy barrier of the two
states. While the lumi state reaches a plateau after deprotonation and its conformation is stable
in the unconstrained simulation after TI (Fig. A.7), the dark state does not reach a minimum
after deprotonation and the Schiff base is spontaneously reprotonated after the constraint is
released (Fig. 3.4 and Fig. A.8, A.12, A.13). When the conformational rearrangements upon
deprotonation are compared between the dark and lumi state TI simulations, it becomes
apparent that in the dark state, the three hydrogen bonds, present between O1(Glu113) and
the active-site environment (Fig. 3.2a), do not change during the TI simulations or in the
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Figure 3.2: Difference in hydrogen-bond network around the protonated Schiff’s base between the
dark (a), batho (b) and lumi state (c). The hydrogen-bond network in the BSI state is the same as in
bathorhodopsin.
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the TI calculations (Fig. 3.4). The red rectangle depicts the distance constraint between H(WAT1) and
O1(Glu113) that was used during the TI simulations of the lumi state. (b) Change in the hydrogen-bond
network after deprotonation of the protonated Schiff base in the lumi state in the last window (1.00 Å)
of the TI QM/MM MD simulations and the unconstrained QM/MM MD simulation.
unconstrained simulation after the TI simulations have taken place (Fig. A.8, A.12, A.13). In
the lumi state, however, the initial number of HBs of Glu113’s O1 with the protein environment
is two (Fig. 3.2), due to the presence of a bridging water (WAT1), which is decreased by one in
the deprotonated lumi state or pre-meta-I conﬁguration (Fig. 3.2 and Fig. 3.3). The pre-meta I
state is a conﬁguration obtained after 6 ps of unconstrained QM/MM MD post deprotonation
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Figure 3.4: Free energy proﬁle of the deprotonation of the chromophore in rhodopsin in the dark and
lumi state. For the thermodynamic integration of the lumi state, the distance between one hydrogen of
WAT1 and an oxygen of Glu113, O1, was used to perform the deprotonation reaction (see red rectangle
in image 3.3b). In the dark state, the distance between the hydrogen on the nitrogen of the PSB, H(PSB),
and Glu113’s O1 oxygen was used as reaction coordinate in the TI simulations.
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of the chromophore. The decrease in the number of HBs between the lumi and the pre-meta-I
state is due to the reorientation of Thr94, which is initially interacting with Glu113, but forms
a HB with the backbone oxygen of Gly90, Obb(Gly90), in the deprotonated form (Fig. 3.3, Fig.
A.7, A.10, A.11).
Although the deprotonated retinal form is stable in the lumi state (Fig. A.7), the protonated
Schiff base still has a lower free energy compared to the deprotonated form (Fig. 3.4). Therefore,
thermodynamically, the deprotonated structure would still appear to be less stable than the
protonated chromophore conﬁguration. However, long-time scale rearrangements that occur
upon proton transfer, which are not captured in the picosecond time scale QM/MM MD
simulations, could further stabilise the deprotonated form. An approximate analysis tool, H++,
was used to study the effect of the change in electrostatics of the active site upon deprotonation
of the chromophore by calculating the pKa value of Glu113. Glu113, the glutamate that is
protonated during deprotonation of the chromophore, instead of the chromophore itself was
used as an indicator of the change in electrostatics, since H++ is unable to incorporate the
charges of the chromophore into the pKa calculations. Nonetheless, the charge state of Glu113
can highly affect the pKa of the nearby retinal moiety [Sakmar et al., 1991] and could therefore
be a measure of the changes in the electrostatic environment that favour/accompany the
deprotonation reaction.
The pKa value of Glu113 has been calculated with several internal dielectric constants (Table
Table 3.1: pKa calculations of Glu113 in different rhodopsin intermediates. In addition, the pKa values
for Asp83 and Glu122 are shown as reference values since these residues are believed to be protonated
all throughout the activation [Fahmy et al., 1993]. pKa calculations were performed with internal
dielectrics of 8, an external dielectric of 80 and a salinity of 0.15 M. The calculated shift is the total
difference between the full (all) and the minimal (no Gly90, Thr94, WAT1, WAT2) model system, called
no G90, T94, waters. Each time a molecule or residue is removed, the charges of the group are set to
zero, but the radii are maintained. The full model includes rhodopsin without the chromophore and all
water molecules present in the active site.
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3.1 and Table A.2) in several protein conformations and distributions of charge in the active
site to provide a qualitative evaluation of the changes in the electrostatic environment when
changing from the dark to the pre-meta-I conformation. In order to investigate the direct
effect of the environment on Glu113, the presence/absence of the charge of all moieties that
are hydrogen bonded to Glu113’s O1 –the oxygen that is protonated during the chromophore’s
deprotonation– are taken into account (Fig. 3.2 and Fig. 3.3). Also the effect of Gly90 was
studied because the residue substitutes Thr94’s hydrogen-bond donor Glu113 and stabilises
Thr94’s change in orientation after deprotonation of the chromophore (Fig. 3.3).
The results in table 3.1 appear to suggest that although the pKa of Glu113 does not change
signiﬁcantly when moving from the dark state to the lumi conformation, the environmental
dependence increases. In the dark state Glu113’s pKa value is lowered by two units (mainly
due to Thr94 and WAT1), while lumirhodopsin is lowered by three units (ca. one unit for Thr94,
WAT1 and WAT2). Gly90 is not directly hydrogen bonded to Glu113 or a group in Glu113’s HB
network in the dark and lumi conformation and does not seem to have a signiﬁcant effect
on Glu113’s pKa value. However, in pre-meta I, Gly90 appears to have an impact on the pKa
value of Glu113, which could be due to the fact that upon deprotonation of the nitrogen of
the PSB Gly90 is able to stabilise Thr94’s change in orientation, leading to the removal of a
hydrogen-bond donor from Glu113’s HB network (Fig. 3.3).
While the change in the conformation of the active site from dark to lumirhodopsin is not
reﬂected in the pKa value of Glu113 in the all conformation (Table 3.1), the nearby environment
appears to have a strong effect on tuning the Glu113’s pKa value when moving from the dark
to the pre-meta-I state as the pKa value is increased by four units in pre-meta-I compared to
the dark form. When removing charge from nearby moieties of Glu113, pre-meta I appears
to be less affected than the dark state because pre-meta I is only increased by ca. one unit,
mainly due to WAT1 and Gly90, slightly compensated by WAT2.
Hence, these pKa calculations appear to suggest that the protein environment has a signiﬁcant
effect on Glu113’s protonation state. Moreover, after deprotonation, the HB network around
Glu113 seems to cause Glu113’s pKa to increase drastically, leading to values that favour a
protonated form of Glu113 (Table 3.1, Table A.2).
3.4.2 Determination of Intermediates
The lumi and dark state structures, employed as initial conﬁgurations for the TI simulations
described in Section 3.4.1, originated from snapshots taken from unrestrained classical MD
simulations before and after cis-trans isomerisation, which were subsequently used to perform
unconstrained QM/MM MD simulations. The QM/MM simulations of the lumi state were
used to identify the lumi conformation via its optical and structural properties and lead to the
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selection of an initial structure for the investigation of the deprotonation reaction from which
the pre-meta-I conﬁguration resulted. The unconstrained QM/MM MD simulations of pre-
meta I were generated after applying TI to the selected lumi state (see Section 3.4.1). Besides
the dark, lumi and pre-meta-I conformations, additional snapshots of early intermediates
were extracted from the unrestrained classical MD simulation after cis-trans isomerisation,
to which also unconstrained QM/MM MD was applied in order to obtain simulations of the
batho and the BSI state. All these QM/MM simulations of dark, batho, BSI, lumi and pre-meta
I were used to generate conﬁgurations for the spectra calculations.
The calculated excitation energies of dark, batho, BSI and lumi closely reproduce the ex-
perimental data, which suggests that the obtained structures are good representatives of
experimentally observed intermediates (Table 3.2). This conclusion is also supported by the
alignment of the X-ray structures of the batho and lumi states with the QM/MM results (Fig.
A.3, A.4). The obtained bathorhodopsin conformation is also in good agreement with previous
computational studies [Campomanes et al., 2014; Lemaître et al., 2005]. Remarkable about the
alignment of the lumi state (Fig. A.4) is that, while the overlap between the lumi structures is
not as good as for the batho conformation (Fig. A.4), the space for a bridging water molecule is
present in the X-ray structure, although the water molecule itself is absent in the experimental
data. The absence of the water molecule could be due to the crystallisation techniques that
were used to obtain the lumi form. The BSI conﬁguration is more difﬁcult to extract from the
MD simulations as the conﬁguration is in equilibrium with the batho state (Fig. A.5).
Table 3.2: Absorption spectra obtained via ZINDO/S for rhodopsin, bathorhodopsin, BSI, lu-
mirhodopsin, pre-metarhodopsin I. ∗ 100 Conﬁgurations were used with a time interval of 12 fs
to calculate the absorption maxima for dark, batho, lumi and pre-meta I rhodopsin. 44 Frames with a
time interval of 12 fs were isolated for BSI. In the vertical-excitation energy calculations residues and
water molecules closer than 7 Å to the retinal moiety were taken into account. Pre-metarhodopsin I
represents the protein structure after deprotonation of the lumi state via QM/MM MD with TI. † The
experimental absorption spectra were obtained at room temperature by Lewis et al. [Lewis et al., 2004].
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Besides the shifts in excitation energies also a modiﬁcation of retinal’s conformation can be
clearly observed for the different states of rhodopsin. After cis-trans isomerisation, the methyl
group on C13, C20, (Fig. 3.1a and Fig. 3.5) reorientates from a conformation that is more or
less parallel to the membrane in the dark state to one that points towards the extracellular
region in the lumi state (Fig. 3.5). The relaxation of the trans conﬁguration via C20 is not
surprising as the volume for the retinal moiety of the mainly hydrophobic/non-polar active
site is tightly ﬁtted around the β-ionone ring and the methyl group on C9 (C19) (Fig. 3.6). The
only region in the active site that shows a relatively looser ﬁt is the region around PSB, close to
C20 (Fig. 3.6).
Together with the change in C20’s location, the protonated nitrogen of Lys296 also alters its
orientation in the active site due to retinal’s change in conformation (Fig. 3.5). From the
dark to the lumi state, the nitrogen moves from a position in which the atom points in a
direction parallel to the membrane to a position in which it points more to the intracellular
region. In addition to alterations in PSB’s orientation, a shift in the hydrogen-bond network
around PSB occurs, which takes place between the BSI and the lumi state. Consequently,
batho and BSI contain a similar HB arrangement as the dark state (Fig. 3.2). The change in
HB network in the lumi state implies the breakage of the direct salt bridge between PSB and
Glu113 and the formation of an indirect hydrogen bond between Glu113 and PSB which is
bridged by a water molecule (WAT1) (Fig. 3.2). The alteration in the hydrogen-bond network
also contains a relocation of WAT2 and a decrease of hydrogen bonds from three to two for
Glu113’s O1 (Fig. 3.2). The changes in the hydrogen-bond network of pre-meta I in comparison
to lumirhodopsin are shown in ﬁgure 3.3 and have been addressed in detail in Section 3.4.1.
intracellular region
extracellular region
Figure 3.5: Overlay of rhodopsin structures in the dark (red) and three short-lived intermediate states:
bathorhodopsin (pink), BSI (orange), lumirhodopsin (yellow). These structures were obtained via
QM/MM MD and aligned on the retinal moiety and Lys296. The protonated nitrogen is highlighted
through a blue ball representation.
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ba
Figure 3.6: Volume of rhodopsin’s active site showing the 11-cis conﬁguration of the retinal moiety. (a)
View of retinal moiety from the extracellular region. (b) View of the retinal moiety, turned 90◦ compared
to image (a), with the Lys296 part located in front.
Although some structural rearrangements have already taken place in the pre-meta-I con-
formation and the optical properties have undergone a signiﬁcant shift towards the meta I
form, the chromophore and the protein surrounding are not yet fully relaxed (Table 3.2). While
retinal’s carbon chain has straightened compared to the lumi structure on the picosecond
timescale, the β-ionone ring is still in the same location in the deprotonated trans confor-
mation as prior to deprotonation (Fig. 3.7). This location of the β-ionone ring is not in line
with experimental studies that show that the ring alters its location slightly in the meta I state
due to a fully straightened conjugated chain compared to retinal’s conformation in the early
intermediates [Struts et al., 2011].
The conformational changes of the active site across the different intermediates is clearly evi-
Figure 3.7: Overlay of the chromophore structures in the lumi state (yellow) and pre-meta-I conﬁgura-
tion (cyan) viewed from the extracellular region. These snapshots were extracted from unconstrained
runs of the conﬁgurations obtained before TI and as a result of the TI.
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dent (Fig. 3.2). However, the interplay between the structural changes and the accompanying
changes in the optical properties is not obvious. To identify the factors that are responsible
for the spectral shifts of batho, lumi and pre-meta I, a correlation and causality inference
analysis has been performed, which has already been applied by Campomanes et al. in a
similar study [Campomanes et al., 2014]. This former study investigated the common factors
that determine all shifts for the early intermediates up to lumirhodopsin by performing a
single causality inference analysis over all snapshots from the included intermediates. Here,
factors that inﬂuence individual shifts of the intermediates before deprotonation are studied
as well as the pre-meta-I form. The BSI state was not taken into account because this state is
in equilibrium with the batho state (Fig. A.5) and therefore only relatively few conﬁgurations
can be unambiguously assigned to this intermediate.
The input for the correlation analysis of batho, lumi and pre-meta I included 48∗106 geomet-
rical features per intermediate, which were composed of distances, angles, dihedrals and the
BLA. The correlation proﬁles show that the 48∗106 features can be decreased to roughly 20 or
30 features having the highest heuristic merit by using Correlation-Based Feature Selection
[Hall, 1999] (Fig. A.6). Remarkable is the fact that the shift for batho and lumi are deﬁned by
around 30 features, while the pre-meta I conformation (Fig. 3.3) only includes 19. Within the
top ten of each intermediate, distance d(C9-C10) is present and the BLA is number one (Fig.
A.6). The correlation between these two descriptors and the spectral shift has also been found
in a computational study of rhodopsin by Campomanes et al. [Campomanes et al., 2014].
Distance d(C11-C12), the bond around which the cis-trans isomerisation takes place, appears
to be correlated with the spectral shift in batho and lumi, but is replaced in the pre-meta I
state by d(C12-C13) (Fig. A.6). This substitution of a double bond, d(C11-C12), for a single
bond, d(C12-C13), in the causality of the spectral shifts could be caused by the deprotonation
of the PSB that affects the properties of the conjugated chain. However, the origin of the bond
exchange requires further investigation. Dihedrals are the most represented in the correlation
proﬁles of the three intermediates, but they are not the same for different intermediates. Fur-
thermore, a residue that has been reported to play an important role in rhodopsin’s activation
mechanism, Trp265 [Crocker et al., 2006; Standfuss et al., 2011], is also included in dihedrals
and angles that describe the spectral shifts of batho, lumi and pre-meta I, showing that Trp265
is sensitive to the location of the retinal in the active site (Fig. A.6).
Investigating the inference of the causal relationship between features and the spectral shift
provides away to understandwhich features directly affect the spectral shift andwhich features
only inﬂuence other features with a direct impact. The results for the three intermediates
show that all intermediates are highly inﬂuenced by the BLA, pre-meta I>batho>lumi, as
well as d(C9-C10), lumi>pre-meta I>batho (Fig. 3.8 and Table A.1). Similar to the correlation
proﬁles, d(C11-C12) is substituted in the causality proﬁle by d(C12-C13) when moving from
lumi to pre-meta I. The causality between the spectral shift and the dihedrals is remarkable
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as well because, although speciﬁc dihedrals have a similar impact on the spectral shifts for
each intermediate as the distances, the dihedral selection per intermediate is unique (Fig.
3.8). This could be due to the fact that the dihedrals are more sensitive to the orientation of
the retinal and the conformation of the active site than the BLA and the distances. However,
signiﬁcant environmental alterations that take place from dark to pre-meta-I rhodopsin, such
as the change in counter-ion distance, the rearrangement of water molecules in the active site
or the protonation state of the chromophore, do not appear in the causality analysis or the
correlation proﬁles (Fig. 3.8 and Fig. A.6).
Overall, the causality and correlation results appear to suggest that the descriptors with the
most impact on the spectral shifts are intramolecular parameters such as the BLA and distances
in the conjugated retinal chain. In addition, unique sets of dihedrals inﬂuence the optical
properties of each intermediate.
batho lumi
pre-meta Ic
a b
Figure 3.8: Markov blanket of the spectral shifts for the batho (a), lumi (b), and pre-meta I (c) conﬁgura-
tions. The edge strength indicates the relative magnitude of the dependency between two variables,
given the other inter-relationships.
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3.5 Conclusions
The protonation/deprotonation equilibrium of rhodopsin’s protonated Schiff base at body
temperature is inﬂuenced by the conformational change of retinal after cis-trans isomeri-
sation as well as the induced active site alterations, in particular the presence/absence of
water molecules and accompanying rearrangements of the HB network. The ﬁrst step in the
relaxation pathway of the trans retinal group is governed by the anchoring of the β-ionone ring
in the hydrophobic/non-polar pocket, the only available additional volume around C20 and
the salt bridge between Glu113 and the chromophore. This step includes a clock-wise rotation
of the C13-C14 bond, which induces the formation of the batho and BSI state, resulting in a
C20 oriented towards the extracellular region together with a hydrogen-bond rearrangement
near the PSB, leading to the lumi state. This HB rearrangement includes a water molecule
that starts disrupting the salt bridge between Glu113 and the PSB in the lumi state as well as a
decrease in hydrogen-bond donors for Glu113. Deprotonation in the lumi state results in a
stable deprotonated form of the Schiff base, which neutralises the active site. As an effect of
the proton transfer, further changes in the hydrogen-bond network take place that lead to a
state in which the proton is stabilised on Glu113. Groups that appear to play a particularly
important role in the deprotonation of PSB are two water molecules, WAT1 and WAT2, Gly90
and Thr94. The inﬂuence of the conformational rearrangements in the active site that occur
during the transition from the dark to the pre-meta-I state is reﬂected by the performed pKa
calculations of Glu113. While in the pKa calculations the effect of the environment is clear, the
calculations of the spectral shift mainly show an impact of intramolecular descriptors, such as
the BLA and the bond distances in the conjungated chain of the retinal moeity.
Further relaxation of the retinal moiety after deprotonation is required to reach the fully
relaxed trans conﬁguration of the meta I state as the shift between the absorption maxima
of the experimentally observed meta I and the simulated early deprotonated form, pre-meta
I, is signiﬁcant. In a future study of the later intermediates in the photoactivation pathway,
the relaxation of retinal towards the meta I state will be investigated by obtaining a new force
ﬁeld for the neutral trans-retinal conﬁguration via the Force Matching method [Doemer et al.,
2013] implemented in the CPMD package. This new force ﬁeld will be employed in a classical
MD simulation of rhodopsin in which cis-trans isomerisation and deprotonation have taken
place to study the further relaxation of the chromophore.
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4 Effect of N-Terminal Myristoyla-
tion on the Active Conformation of
Gαi1:GTP
Siri Camee van Keulen, Ursula Röthlisberger
4.1 Summary
G proteins are part of the G-protein coupled receptor (GPCR) signal-transduction cascade in
which they transfer a signal from the membrane-embedded GPCR to other proteins in the
cell. In case of the inhibitory G-protein heterotrimer, permanent N-terminal myristoylation
can transiently localise the Gαi subunit at the membrane as well as crucially inﬂuence Gαi ’s
function in the GTP-bound conformation. The attachment of lipids to proteins is known to be
essential for membrane trafﬁcking, however, our results suggest that lipidation is also impor-
tant for protein-protein interactions during signal transduction. Here we investigate the effect
of myristoylation on the structure and dynamics of soluble Gαi1 and its possible implication
for signal transduction. A 2 μs classical molecular dynamics simulation of a myristoylated
Gαi1:GTP complex suggests that the myristoyl-induced conformational changes of the switch
II and alpha helical domains create new possibilities for protein-protein interactions and em-
phasise the importance of permanent lipid attachment for the conformation and functional
tunability of signalling proteins.
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4.2 Introduction
G-protein-coupled receptor (GPCR) pathways are of high interest since their signal-transduction
cascades play an important role in several diseases such as heart failure, hypertension and
obesity. The ﬁrst proteins that will transfer an extracellular signal, received by a GPCR, to other
regions in the cell, are G-proteins, which are therefore crucial messengers in GPCR regulated
signalling. G proteins are built from an α, β and γ subunit of which the α subunit is able to
interact with guanosine diphosphate (GDP) in the protein’s inactive state or with guanosine-
5’-triphosphate (GTP) in the active conformation. The interaction between a heterotrimeric
G protein and an active GPCR induces GDP/GTP exchange in the Gα subunit [Dror et al.,
2015; Louet et al., 2012; Schröter et al., 2015]. A concurrent destabilisation of the interface
between Gα and the Gβγ dimer [Galés et al., 2006] leads to soluble Gα, thereby decreasing
its concentration close to the membrane, in favour of the one in the cytosol [Preininger et al.,
2012]. The speciﬁcity by which G-protein subunits interact with receptors and effectors deﬁnes
the variety of responses that a cell is capable of providing due to an extracellular signal. Hence,
understanding the molecular mechanism of G proteins’ binding to their cellular partners
is a key step in understanding GPCR signalling cascades and can shed more light on the
malfunctioning of GPCR signalling in humans.
Similarly to G proteins, smaller monomeric GTPases such as the ADP-ribosylation factor (ARF)
proteins are also activated by GDP/GTP exchange. The localisation of ARF proteins, like ARF1,
at the membrane depends on whether the protein is interacting with a GDP or a GTP molecule
[Liu et al., 2009, 2010]. In addition, ARF1’s location is not only determined by nucleotide
interaction but also by lipidation of the N-terminus through myristoylation. The myristoyl
group interacts with the membrane in ARF1’s active conformation while it is interacting with a
hydrophobic pocket on the protein in the inactive soluble state. Hence, GDP/GTP exchange
and the myristoyl moiety are important for membrane localisation and the solubility of ARF1
[Behnia and Munro, 2005]. In the case of G proteins, similar factors can be found that inﬂuence
the localisation of Gα subunits. Besides GDP/GTP exchange, also lipidation plays a role in Gα
localisation. All Gα families (Gαs (stimulatory), Gαi (inhibitory), Gαq , Gα12) can reversibly
bind palmitoyl groups to the N-terminus of their α subunit (except for Gαt from the Gαi
family), which anchors the subunit to the membrane, but only the Gαi family has a myristoyl
group attached to its N-terminus in addition to the palmitoyl moiety [Chen and Manning,
2001; Cabrera-Vera et al., 2003]. Unlike palmitoylation, myristoylation only enables transient
binding to the membrane, which can lead to an equilibrium between a membrane-bound and
a solvated state [Wright et al., 2010]. Moreover, myristoylation is an irreversible process which
results in myristoyl attachment throughout the lifetime of the protein [Cabrera-Vera et al.,
2003]. Hence, the increased solubility of all Gα families’ active Gα:GTP complex is achieved by
a combination of (i) dissociation of the G-protein heterotrimer, (ii) depalmitoylation [Loisel
et al., 1999; Wedegaertner and Bourne, 1994] and (iii) detachment of the α-subunit N-terminal
44
4.2. Introduction
helix from the lipid bilayer. The solubility of the Gαi family is also inﬂuenced by myristoylation
as the post translational modiﬁcation induces an equilibrium between membrane-bound and
cytosolic forms [Degtyarev et al., 1994].
Besides the solubility, also the conformation of active Gαi1 has been shown to be affected by
myristoylation [Preininger et al., 2003], as the soluble non-myristoylated Gαi1:GTP complex
does not maintain the secondary structure of its N-terminal helix, while the active soluble
myristoylated Gαi1 subunit shows a more structured N-terminal tail and is able to position the
N-terminus close to the Gαi1 subunit [Preininger et al., 2003]. The importance of permanent N-
myristoylation of the Gαi1 subunit is not only shown by its inﬂuence on Gαi1:GTP’s structure
but also by the dependence of the function of the α subunit on the presence of the myristoyl
moiety [Dessauer et al., 1998; Taussig et al., 1993]. In the case of adenylyl cyclase type 5 (AC5),
for example, myristoylated Gαi1 (Gα
myr
i1 ) can interact with the catalytic domain of AC5 and
inhibit its catalytic function. However, a non-myristoylated Gαi1 (Gαnoni1 ) subunit is incapable
of interacting with AC and can therefore not inhibit AC’s ATP conversion pathway [Dessauer
et al., 1998]. For the stimulatory Gαs though, the presence of the N-terminus is not crucial
for its interaction with AC as is demonstrated by the obtained X-ray structure of Tesmer et
al. [Tesmer et al., 1999]. It can be proposed that in the active Gαs state, the N-terminus is
less structured, similar to the results of Preininger et al. for the non-myristoylated Gαi1:GTP
complex, which could suggest that the overall active Gαs conformation is not signiﬁcantly
altered by the structure of the N-terminal helix [Preininger et al., 2003].
Although myristoylation appears to be an important difference between the stimulating Gαs
and inhibiting Gαi families and is furthermore crucial for Gαi1’s conformation, no X-ray
structures of myristoylated Gαi proteins are currently available in the Protein Data Bank (PDB)
[Berman et al., 2000]. The available X-ray structures of active Gαs and Gαnoni1 are similar as is
shown via a root mean square deviation (RMSD) of 1.07 Å between the two structures (Fig. B.1).
Especially around the proposed protein interaction site, the switch II region, the subunits align
well, while their function is inverse in the cytoplasmatic domain. Therefore, it is unclear towhat
extent the available Gαnoni1 structures are representative of the complete conformational range
of the active Gαi1 protein. Hence, understanding the effects of myristoylation on Gαi1 can
possibly help rationalise the impact on Gαi1’s conformation and the difference in biological
function between Gαs and Gαi1. Additionally, it can contribute to a better understanding of
G-protein activation and provide a new perspective on the role of lipid attachment in protein
function.
To shed light on this issue, we have studied Gαmyri1 protein in its active state using classical
molecular dynamics (MD) simulations of a Gαmyri1 model (Fig. 4.3) based on Gα
non
i1 X-ray
structures and an ARF1 protein NMR structure (Fig. 4.1 and see Section 4.3.1). A second simu-
lation was performed as well with the same Gαi1:GTP model in the absence of its myristoylated
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N-terminus as a cross validation.
A 2 μs simulation of the Gαmyri1 :GTP complex, identiﬁes a stable binding site for the myristoyl
group in between α1, α5 and β2-β3, and demonstrates the effect of myristoyl binding for
important interaction sites such as the switch II region and the nucleotide binding pocket.
Signiﬁcant changes occur in the conformation of the switch II region upon incorporation
of the myristoyl moiety. Moreover, a large rearrangement of αB in the alpha helical (AH)
domain of the α subunit takes place. These changes in the secondary structure of the switch II
region and the AH domain could have an important effect on the way the Gαmyri1 subunit is
able to interact with proteins in the cytosol. The proposed mechanism for Gmyri1 activation is
described in ﬁgure 4.2.
4.3 Methods
4.3.1 Homology Modelling
The reﬁnement protocol automodel from Modeller 9.14 [Eswar et al., 2006; Martí-Renom
et al., 2000] was employed to obtain the initial homology model of the myristoylated Rattus
norvegicus Gαi1 subunit (UniprotKB P10824) that was used to start the classical MD runs
(Fig. 4.3a and Fig. B.2). In total 100 structures were obtained with Modeller 9.14. Besides
maintaining the secondary structure of the main template, 4PAQ, and avoiding bad contacts
within the structure, the selection of the initial model for simulation was based on (I) the
presence of important hydrogen bonds between GTP and the active site that are shown in the
X-ray structure, (II) maintaining the secondary structure present in the included templates
ba
Figure 4.1: Comparison of ARF1 and Gαi1. (a) Alignment of the Cα atoms of the ARF1:GTP complex in
purple (PDB code 2KSQ) and the Gαnoni1 :GDP conformation in cyan (PDB code 1AS3) zoomed in on
ARF1’s myristoyl binding site (orange diamond) in the inactive conformation. (b) Alignment of the Cα
atoms of the ARF1:GDP complex in pink (PDB code 2K5U) and the Gαnoni1 :GTP conformation in blue
(PDB code 1GIA) zoomed in on ARF1’s myristoyl binding site. The myristoyl moiety of ARF1 is depicted
in green and is interacting with a hydrophobic pocket, located on ARF1.
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Figure 4.2: Proposed activation mechanism of Gmyri1 in which an activated GPCR induces GDP/GTP
exchange that leads to dissociation of the Gαi1 and Gβγi1 interface. A represents the activation of
Gαmyri1 in which the N-terminal palmitoyl group is still present. B shows the conversion to activated
depalmitoylated Gαmyri1 which results in an equilibrium (C) between a solvated Gα
myr
i1 :GTP and a
membrane-bound Gαmyri1 :GTP complex. D represents the palmitoylation of active membrane-bound
Gαmyri1 .
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of the regions that were not part of the main template, PDB code 4PAQ, (III) the position of
the myristoyl moiety that had to be located within 4 Å of the hydrophobic pocket as an initial
guess for the moiety’s location.
A combination of three different X-ray structures (PDB codes: 2K5U, 1AS3 and 4PAQ) were
incorporated in the initial homology model [Kaya et al., 2014; Liu et al., 2009; Raw et al., 1997].
4PAQ, a Rattus norvegicus Gαnoni1 :5’-guanosine-diphosphate-monothiophosphate (GTPγS)
complex, was used as a main template. GTPγS is an analog of GTP, which is used in the crystalli-
sation process of the Gαi1 subunit as GTPγS is not able to undergo the hydrolysis mechanism
in the active site of the protein. 1AS3, a Rattus norvegicus Gαnoni1 :GDP conformation, covered
the N (residues 9-34) and the C (residues 328-354) terminus of the Gαi1 subunit. In order
to obtain an initial guess for the location of the myristoyl moiety, a myristoyl conformation
of ARF1 from saccharomyces cerevisiae (UniprotKB P11076) with PDB code 2K5U was used
(myristoyl group and residues 1-7). The 2K5U NMR structure was also employed to model the
interswitch toggle (see Section 4.4 and Supporting Methods in Appendix B), residues 179-220
of Gαi1, which enables communication between the myristoyl and the nucleotide binding site
[Pasqualato et al., 2002].
The location of GTPγS and the Mg2+ ion were taken from 4PAQ in order to place the ion and
guide the GTP molecule in the nucleotide binding site. Also water molecules (16 molecules in
total) surrounding GTPγS in 4PAQ were incorporated in the model. Since different structures
were used to obtain the homology model, restraints were employed for the construction of
the initial model to maintain important hydrogen bonds in the nucleotide binding site and to
position the myristoyl moiety close to the hydrophobic pocket (Fig. B.2).
4.3.2 Classical Molecular Dynamics Simulations
The Gαi1 together with its bound myristoyl group, Mg2+ ion and GTP were simulated for 2μs at
310 K and 1 bar using a Nosé-Hoover thermostat and an isotropic Parrinello-Rahman barostat.
Additionally, about 42 000 water molecules and 150 mM KCl are present in the simulated
system. The force ﬁelds used for the protein and the water molecules are AMBER99SB [Hornak
et al., 2006] and TIP3P [Jorgensen et al., 1983], which were employed by Gromacs 4.6.6 [Bekker
et al., 1993; Hess et al., 2008] to perform the runs. For GTP, the force ﬁeld parameters generated
by Meagher et al. were used [Meagher et al., 2003]. The adjusted force ﬁeld parameters
for K+ and Cl− were taken from Joung et al. [Joung and Cheatham III, 2008]. The Mg2+
parameters originated from Allnér et al. [Allnér et al., 2012]. The charges for the myristoyl
group were obtained with Gaussian 09 [Frisch et al.] based on Hartree Fock calculations in
combination with a 6-31G* basis set and using the AMBER RESP procedure [Case et al., 2015]
(Fig. B.4). Appropriate atom types from the AMBER99SB force ﬁeld were selected to complete
the myristoyl description.
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Electrostatic interactions were calculated with the Ewald particle mesh method with a real
space cutoff of 12 Å. Bonds involving hydrogen atoms were constrained using the LINCS
algorithm. The time integration step was set to 2 fs.
4.3.3 Calculation of Electrostatic Surfaces
The electrostatic surface of several Gαi1 subunits was calculated via APBS 1.3 [Baker et al., 2001;
Unni et al., 2011]. The multigrid method together with the monopole boundary conditions
and spline-based discretisation of the delta functions were used. The ion concentration was
set to 150 mM at a temperature of 310 K. The default settings for the biomolecular (2.00) and
solvent (78.54) dielectric constants were used. PDB2PQR 2.0.0 [Dolinsky et al., 2007; Unni
et al., 2011] was employed to perform the preprocessing of the conformations with the AMBER
force ﬁeld in order to calculate the atomic radii, charges and position of the hydrogen atoms.
4.3.4 Structure Superpositions and Images
Multiprot [Shatsky et al., 2004] and VMD [Humphrey et al., 1996] were used to align protein
structures. The Align tool in Uniprot [Consortium, 2014] was used to align protein sequences.
Images were prepared with VMD [Humphrey et al., 1996].
4.4 Results and Discussion
4.4.1 Classical Molecular Dynamics Simulations of Gαmyri1
During the 2 μs of classical MD simulation, the effects of the myristoyl group on the structure
of the active Gαi1 subunit become apparent (Fig. 4.3 and Fig. B.5). In the equilibrated
conformation, the covalently-bound myristoyl group interacts with the Gαi1 protein via β2-β3,
the α5 helix and the α1 helix (Fig. 4.3b-4.3d). One direct effect of the presence of the myristoyl
group is an outward conformation of β2-β3 in order to provide space for the lipid moiety (Fig.
4.4a). The β2-β3 strands are shifted down by two residue units (Fig. 4.4b), which increases
the number of residues that are part of the switch II region. This shift of two residue units
has also been observed in myristoyl containing ARF proteins and is called the interswitch
toggle [Pasqualato et al., 2002]. This is not too surprising since ARF’s signature sequence
for the interswitch toggle, wDvGGqxxxRxxW, is also present in Gαi1’s sequence in the region
that includes β3 and the switch II region (Fig. 4.5) [Pasqualato et al., 2002]. The interswitch
toggle facilitates communication within the Gαi1 subunit between the nucleotide binding site
and the myristoyl moiety [Pasqualato et al., 2002]. The effect on the nucleotide binding site
(see Supporting Results and Discussion in Appendix B) is that since there are more residues
available from the switch II region, the N-terminal region of the switch II region is able to
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Figure 4.3: Structural overview of Gαmyri1 :GTP and comparison with X-ray structures. (a) Representation
of the initial homology model that was used to start the classical MD simulation. The template for the
cyan region was PDB entry 4PAQ, for the orange area the PDB structure 1AS3 was used and the blue part
was modelled after PDB entry 2K5U. The myristoyl moiety is depicted in yellow. (b, c, d) Three different
views of the ﬁnal Gαmyri1 structure in which the myristoyl moiety, GTP and Mg
2+ are also shown.
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Figure 4.4: (a) Zoom on the proposed myristoyl binding site of aligned Gαi1 subunits interacting with
GTP, a GTP analog or GDP. The mauve coloured structure is a Gαnoni1 :GTPγS complex (PDB code 1GIA)
and the model, Gαmyri1 :GTP, after about ∼ 1.8 μs is shown in cyan. The Gnoni1 :GDP conformation (PDB
code 1GP2) is coloured blue. By the orange diamond it is shown where the myristoyl group is connected
to the Gαi1 subunit of the model. The yellow arrow speciﬁes the outward movement of the β2-β3
domain upon myristoyl binding. Additionally, Phe336’s orientation is shown for all three structures
in the previously described structure colours. (b) The β2-β3 shift between the Gnoni1 :GDP and the
Gαmyri1 :GTP complexes is shown by the red arrow and the myristoyl binding site is depicted as an orange
diamond. The color scheme for the structures is the same as in the a image. (c) Alignment of Gαi1
subunits in which the difference in the switch II region is shown. The red pentagon is showing the
location of the guanine nucleotide binding site. The colour scheme of the Gαi1 structures is the same
as in the a image, except for the fact that the tan structure is the X-ray conformation of the Gαs :GTPγS
complex (PDB code 1AZT) [Sunahara et al., 1997b].
interact with the α3 helix, which stabilises the structure of the switch II region (Fig. 4.4c). A
cross-validation simulation was also performed in which the N-terminus was cut off until
the 31th residue, Gαnoni1 :GTP, to monitor the effect on the initial model (Fig. B.6). The result
showed indeed a hydrophobic pocket that was closed by β2-β3 and a switch II region that
returned to the conformation of the switch II region of the Gαnoni1 :GTPγS X-ray structure (PDB
code 1GIA). The upward movement of the interswitch toggle and the full rearrangement of the
nucleotide binding site was not observed in the 1 μs classical MD simulation, which could
be due to the limited length of the simulation. Overall, the structural rearrangements of the
simulated Gαmyri1 as a result of myristoyl binding, show that the effect of the myristoyl moiety
on the conformation of the Gαmyri1 subunit is not limited to the hydrophobic binding pocket
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Figure 4.5: Alignment of several Gα sequences and ARF1 from saccharomyces cerevisiae.
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but inﬂuences also other parts of the protein.
The change in conformation of Gαmyri1 :GTP is likely to also have implications for the interaction
with other proteins, which could affect the overall function of Gαmyri1 in the cytosol. In order
to address the role of the altered conformation and to identify if it has an impact on protein-
protein interactions in which active Gαi1 is involved, the equilibrated model was compared to
X-ray structures of Gαnoni1 and Gαs . First, the overall changes in conformation are compared
and a mechanism for Gαmyri1 localisation in the cytosol is proposed. Moreover, the important
regions for myristoyl binding, GTP binding (see Supporting Results and Discussion in Appendix
B), and protein-protein interactions are discussed to obtain a better understanding of the
effect of permanent lipid attachment.
4.4.2 Two Conformations of Active Gαmyri1
When comparing the simulated model with the crystal structure of the Gαnoni1 :GTPγS complex
(PDB code 1GIA) [Coleman et al., 1994] in which the N-terminus is absent, it becomes evident
that in the myristoylated Gαi1:GTP complex an outward orientation of β2-β3 is stabilised by
the myristoyl in the hydrophobic pocket. Because of this change in conformation also the con-
formation of the switch II region is modiﬁed. In the X-ray structure of Gαnoni1 :GTPγS, however,
the conformation of the complex is strikingly identical to the active Gαs :GTPγS conformation
as the myristoyl binding pocket remains closed (Fig. 4.4c and Fig. B.1) [Coleman et al., 1994;
Sunahara et al., 1997b]. Although in both X-ray structures, Gαs :GTPγS and Gαnoni1 :GTPγS, the
N-terminus is not present, the N-terminus of Gαs :GTP is suggested to be less structured in
solution as it is not anchored on the protein by a myristoyl group or by the membrane, while
in the case of Gαmyri1 :GTP, the N-terminus adopts a more structured conformation in close
proximity to the protein [Preininger et al., 2003]. This difference in myristoyl presence could
suggest that the impact of the missing N-terminus is less severe for the conformation of the
protein in the case of Gαs :GTPγS than the one of Gαi1:GTPγS [Preininger et al., 2003].
The X-ray structure of activated Gαnoni1 and the simulated active Gα
myr
i1 appear to represent
two different conformations of Gαi1 in the active state. The main difference between the
two structures is the absence or presence of the myristoylated N-terminus. Possibly, both
conformations are able to exist under two different circumstances: one in which the myristoyl
group is interacting with the protein’s hydrophobic binding pocket and one in which it is
immersed into the membrane, localising Gαi1 in close proximity to the membrane surface.
This suggestion is consistent with experimental ﬁndings in which both membrane-bound
and solvated conformations are simultaneously observed for active Gαmyri1 [Degtyarev et al.,
1994]. Consequently, in this view two forms of activated depalmitoylated Gαmyri1 are present
in equilibrium in the intracellular domain: the membrane-bound and the solvated form of
Gαmyri1 :GTP (Fig. 4.2). This also proposes that palmitoylation in combination with myristoyla-
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tion could be responsible for different conformations of the Gαi1:GTP complex by transiently
or permanently binding the subunit to the lipid bilayer. This directionality induced by lipid at-
tachment could supposedly result in selectivity for particular proteins, depending on Gαmyri1 ’s
location in the cell.
The X-ray structure of Gαnoni1 :GTPγS is likely to represent the membrane-bound-like confor-
mation of active Gαmyri1 as the hydrophobic pocket for the myristoyl moiety, that is identiﬁed
by the classical MD simulation to be between β2-β3, the α5 helix and the α1 helix, is unavail-
able. Consequently, the lipid will have to be located in a different hydrophobic site, most
probably at the membrane itself [Linder et al., 1991]. It is known from experiments that the
myristoyl group alone is not enough to locate Gαi1 at the membrane permanently but enables
a transient stability which results in a fraction of the protein being in the membrane-bound
state and another fraction in the solvated state [Degtyarev et al., 1994]. In fact, in order to
stabilise its location on the membrane in a deﬁnitive manner, Gαmyri1 has to be palmitoylated,
which results in a ﬁrm anchoring of the protein to the lipid bilayer [Chen and Manning, 2001;
Degtyarev et al., 1994; Galbiati et al., 1996]. In view of this, the active conformation of Gαmyri1
observed in the simulations appears to be a structural representative of solvated depalmitoy-
lated Gαmyri1 :GTP with the myristoyl group packed away in a hydrophobic protein pocket (see
Section 4.4.3).
In the next sections, the Gαmyri1 :GTP structure in the solvated state will be described in more
detail and compared to the Gαnoni1 :GTPγS conformation.
4.4.3 Myristoyl Binding Site
Conformational changes induced by the myristoyl moiety start with the modiﬁcation of
Gαmyri1 ’s hydrophobic pocket (Fig. 4.6a, 4.6b). Within the time scale of the 2 μs simulation,
the hydrophobic site in the Gαmyri1 :GTP complex assumes a more stable conformation. β2-β3
gets closer to α1 and the myristoyl tail reorients (Fig. B.7) while the region of the hydrophobic
pocket remains similar to the ARF1:GDP complex (Fig. 4.6c). The location of the myristoyl
moiety in the pocket is close to the position of the myristoyl group in ARF1, but the orientation
of themyristoyl tail differs betweenGαmyri1 :GTP and ARF1:GDP. In the ARF1:GDP conformation
the majority of the myristoyl is positioned between β2-β3 and α5, while the tail is pointing
towards the C-terminal end ofα5. In the Gαmyri1 :GTP system, the myristoyl group is in between
β2-β3 and α5 as well, but the tail is oriented towards α1 (Fig. 4.6c). These alterations are
not surprising in view of the fact that the changes in the hydrophobic pocket conformation
could originate from the difference in the Ras domain between the two proteins. Gαi1, for
instance, has a longer α1 helix than ARF1, that can stabilise β2-β3. Additionally, an alpha
helical domain is located between α1 and switch I in the Gαi1 protein, which restrains the
conformational ﬂexibility of switch I in comparison to ARF1.
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Figure 4.6: Detailed representation of Gαmyri1 ’s myristoyl binding site and N-terminus. (a) Zoom
on Gαmyri1 ’s hydrophobic binding pocket in which the myristoyl group (pink) is binding. Non-polar
residues are colored in white, polar residues are shown in green. (b) Myristoyl binding pocket of the
simulated Gαmyri1 :GTP complex in which the myristoyl moiety (pink) and several residues are shown:
Met53 (blue), His57 (orange), Phe189 (green), Phe191 (gray) and Phe336 (purple). In addition, the
molecular volume sampled over a period of 500 ns, from 1.6 to 2.1 μs, is shown for all described
moieties. (c) Alignment of Gαmyri1 :GTP in the equilibrated conformation (cyan) at ∼ 1.8 μs of classical
MD and ARF1:GDP (pink), PDB code 2K5U. Besides the protein, also the location of the myristoyl
group, GTP , GDP and Mg2+ are shown for both conformations. (d) Location of the N-terminus with
respect to the rest of the Gαmyri1 subunit. The myristoyl moiety is shown in pink. Negatively (red) and
positively (blue) charged residues are shown on and around the N-terminus that keep the N-terminal
tail into place on the Gα subunit.
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Several features of the hydrophobic pocket of Gαmyri1 :GTP can be rationalised through com-
parison with experimental ﬁndings (see Supporting Results and Discussion in Appendix B).
For instance, due to the location of the myristoyl group, an outward motion of Phe336 occurs
during the classical MD simulation (Fig. 4.4a), which has been linked to activation of the
Gαi1 subunit [Kaya et al., 2014] (see Supporting Results and Discussion in Appendix B).The
identiﬁed hydrophobic pocket also opens up a new region for the investigation of myristoyl
binding to Gαi1. The presented data show that residues Met53 and Phe196, for instance, are in
close proximity to the myristoyl group and therefore these residues could be candidates for
mutagenesis studies as mutating these residues into a bulky hydrophobic residue, such as a
tryptophan, could prohibit the myristoyl moiety from entering the hydrophobic pocket. Via
these mutations a change in the conformation of the Gαi1 subunit could be initiated, resulting
in a hydrophobic pocket that is unavailable for the myristoyl moiety. This mutated α subunit
would be myristoylated, however, it would be unable to interact with adenylyl cyclase type 5
due to the change in the hydrophobic pocket.
Besides the hydrophobic pocket, the conformation of the N-terminus is also adjusted by
the presence of the myristoyl group (see Supporting Results and Discussion in Appendix B),
which becomes anchored through the embedding of the myristoyl moiety in the hydrophobic
binding pocket. In the Gαmyri1 :GTP complex, the N-terminus is closely packed to the rest of the
protein and is not only able to interact with β2-β3 and α3-β5, stabilising the conformation of
the hydrophobic pocket, but can also form interactions with the C-terminal part of the switch
II region (Fig. 4.6d). The presence of the myristoyl moiety anchors the N-terminus in a more
rigid conformation that enables further stabilisation of the hydrophobic pocket.
4.4.4 Switch II Region and Alpha Helical Domain
Available X-ray structures and the data from the classical MD propose at least two possible
locations of the myristoyl moiety during different states of the Gαi1 subunit (Table 4.1). The
Gαnoni1 :GDP complex, in which the majority of the N-terminus is resolved, suggests that the
myristoyl group is located near the membrane and is not able to interact with the hydrophobic
pocket. The Gαnoni1 :GTPγS structure is a conformation in which the entire N-terminus is
absent and could therefore be perceived as a conformation of active Gαi1 with the myristoyl
group not docked in the hydrophobic pocket but in a different hydrophobic region, such as the
membrane. When Gαnoni1 :GTPγS, Gα
myr
i1 :GTP and Gα
non
i1 :GDP are compared, the location of
the myristoyl appears to affect also other regions of the subunit than the hydrophobic binding
pocket, such as the switch II region (Table 4.1).
The differences in the switch II region between the three states is evident. A unique feature of
the solvated Gαmyri1 state, for instance, is the addition of two residues to the switch II region
due to the downward shift of β2-β3 (Fig. 4.7). This elongation of switch II leads to a stability
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enhancement of this domain because of its ability to interact with the α3 helix (Fig. 4.3). The
C-terminal region of the switch II region is structured via two or three helical turns that lead
to a hydrophobic pocket for Trp211 (Fig. 4.7 and Fig. B.8). The obtained structure of the
Gαmyri1 :GTP switch II region is consistent with experimental data [Preininger et al., 2012] that
show that Trp211 becomes located in a more hydrophobic environment when a myristoyl
group is attached to the N-terminus of Gαi1. Figure 4.7 depicts the conformation of switch II
in both Gαnoni1 :GTPγS and Gα
myr
i1 :GTP. From a structural inspection it can be concluded that
Trp211 in Gαmyri1 :GTP is mainly shielded from water by the switch II region itself and by α3-β5.
However, due to the conformation of switch II in the Gαnoni1 :GTPγS X-ray structure, Trp211
appears to be solvent exposed, which is not in line with the hydrogen/deuterium exchange
analysis performed by Preininger et al. [Preininger et al., 2012].
Besides the structural changes of the Ras domain, the AH domain also adjusts upon myristoyl
Table 4.1: Comparison of different Gαi1 states.
(I) Structures of Gαi1 in different states speciﬁed via their PDB code. The middle column describes the presented
model. (a1) Residues 200 to 219 are shown in the depiction of the switch II region together with ligands: Mg2+
and GTP, GTPγS or GDP. (a2) Shows the sequence of residues that are included in the helical parts of the switch
II region. (b) Shows if the structure is able to interact with the down stream protein adenylyl cyclase type 5. (c)
Speciﬁes which guanine nucleotide is interacting with the Gαi1 subunit. (d) Shows the location of the myristoyl
group (MYR) in comparison to the rest of the protein. If MYR is in, the N-terminal tail is interacting with the
hydrophobic binding pocket. If MYR is out, the myristoyl group is not present in the system and therefore the
moiety is not interacting with the rest of the Gαi1 subunit.
StructuresI
Features 1GP2[Wall et al., 1995] Model 1GIA[Coleman et al., 1994]
Switch IIa1
Switch IIa2 207-216 208-215 204-214
Stateb Inactive Active Inactive
Ligandc GDP GTP GTPγS
MYRd Out In Out
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binding. Especially the region that is not part of the interaction site with the Ras domain is
signiﬁcantly altered compared to the initial conformation. The regions in which the largest
change can be observed are in the αA and the αB helices (Fig. 4.7c and Fig. B.5a). αB’s initial
conformation consists of four helical turns from Asp97 to Ala111 and two helical turns from
Gly112 to Gly117. The ﬁnal conformation of αB includes a double helical turn from Asp97 to
Ala104 and three helical turns from Arg105 to Ala113. Since the secondary structure around
the Ras domain and the AH domain is marginally changed, the only driving force behind these
alterations in αB is the conformational change of the switch I region. During the classical MD
simulation, the switch I region optimises its interactions with the environment, which leads to
an altered conformation that is able to get into close proximity of the AH domain. Residues
Glu115 and Glu116 in helix αB are biased towards the highly charged region around the GTP
binding site that is located more on the Ras domain in the Gαmyri1 :GTP complex than in the
Gαnoni1 :GTP structure (Fig. 4.8). Furthermore, the switch I region is able to come closer to
αB because of this conformational change. These two characteristics lead to a kinked helix
that includes an unstructured region between Ala114 and Met119 that connects the αB helix
to αC. This unstructured region contains Glu115 and Glu116 that can interact with switch I
through interactions with Thr181 and the backbone of Lys180. Due to its structural changes,
the αB helix modiﬁes the surface and electrostatics of the protein and is able to interact with
the switch I region.
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Figure 4.7: Comparison of the switch II region of Gαmyri1 :GTP and Gα
non
i1 :GTPγS together with the
change conformation of the AH domain. (a) Detailed description of the switch II region of the 1GIA
PDB structure. Non-polar residues are depicted in white, polar residues in green, positively charged
residues in blue and negatively charged residues in red. The nucleotide binding site is shown via the
red pentagon. (b) Detailed description of the switch II region of the solvated Gαmyri1 :GTP structure.
The color scheme for the residues and nucleotide interacting site is the same as in the a image. (c)
Conformational changes in the AH domain when comparing the initial conformation (yellow) to a
conformation of the protein after ∼ 1.8 μs (blue). The red regions on the helices depict the location of
Glu115 and Glu116. The red pentagon represents the location of the GTP binding site.
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4.4.5 Electrostatic Properties and Protein-Protein Interaction Site
Besides the structural changes, also the electrostatic properties around the switch II region
are signiﬁcantly different when myristoylated and non-myristoylated active Gαi1 states are
compared (Fig. 4.8). First, the positively charged region around the GTP binding site is more
narrowly localised on the Ras domain in the soluble Gαmyri1 conformation compared to the
Gαnoni1 :GTPγS structure. Second, the area around the α3 helix is less negatively charged in the
Gαmyri1 :GTP complex with respect to the Gα
non
i1 :GTPγS conformation. Third, the negatively
charged patch created by the N-terminus near the C-terminal side of switch II (Fig. 4.8e-4.8h),
is not present in Gαnoni1 :GTPγS as this region is resolved in the X-ray structure.
Commonly, Gαi1’s switch II region, close to the GTP binding site, is proposed to be the main
interaction site for down stream proteins like adenylyl cyclase. In the case of AC, two pseudo
symmetrical sites are present on the protein of which one, the one located on the C2 do-
main, is known to interact with the activated form of Gαs via its switch II region (Fig. B.10).
Gel-ﬁltration and activity experiments have shown that the interaction of AC5 with both G
proteins is mainly non competitive and that Gαs can only form a complex with C2 while
Gαmyri1 complexes solely with the C1 domain (Fig. B.11) [Dessauer et al., 1998; Preininger
et al., 2012] . Hence, the C1 domain is proposed to interact with Gαmyri1 :GTP’s switch II region
as X-ray structures of both activated Gαs and Gαnoni1 are structurally similar (Fig. 4.8a, 4.8e).
However, upon solvation, the conformation of Gαmyri1 signiﬁcantly changes compared to the
non-myristoylated X-ray structure, including the switch II region. Therefore, a similar inter-
action site on Gαmyri1 :GTP for C1 as the one on Gαs :GTP for the C2 domain, located between
α3 and switch II, appears to become less favourable as both switch II and the N-terminus are
shielding this region (Fig. B.11 and Fig. 4.8c, 4.8g). This change in conformation could indicate
that a different interaction site for AC type 5 exists on the soluble Gαmyri1 :GTP structure. Such
a view is also supported by the fact that AC type 5 is only inhibited by Gαmyri1 :GTP (Table 4.1),
as Gαnoni1 :GTP loses its inhibiting function and is unable to interact with AC5 [Taussig et al.,
1993]. Furthermore, Gαmyri1 :GTP is even able to inhibit AC5 when only the catalytic domains
(C1:C2) are taken into account, which suggests that Gαmyri1 :GTP is able to interact with AC5
in the cytosol [Dessauer et al., 1998]. Therefore, we propose here that the soluble form of
Gαmyri1 :GTP could be a good candidate for AC5 binding.
4.5 Conclusions
In the absence of myristoylation of the N-terminus, experimental studies have been able to
elucidate the structure of active and inactive Gαnoni1 . However, this N-terminal modiﬁcation
is present under physiological conditions and is known to affect the subunit’s conformation
and function in the protein’s GTP-bound state. In the case of inactive Gmyri1 :GDP, the complex
is membrane bound, the myristoyl group interacts with the membrane and is not located
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Figure 4.8: Comparison of the Gαnoni1 :GTPγS complex and Gα
myr
i1 :GTP. Front (a) and top (e) view of the
Gαnoni1 X-ray structure (PDB code 1GIA) in complex with GTPγS, a GTP analog. The pentagon indicates
the location of the GTPγS molecule and the orange dotted rectangles represent the regions at which
AC5 binds to Gαs in the X-ray structure (PDB code 1CJK). The blue region shows the switch II region,
the purple helix is α3 and the yellow part of the protein is α3-β5. (b, f) Electrostatic surface maps the
front (b) and top (f) view of a Gαnoni1 X-ray structure (PDB code 1GIA) interacting with GTPγS. Three
colours are employed: blue for positive values of the electrostatic potential,white for uncharged regions
and red for negatively charged areas. The surface of the Gαi1 protein is contoured from -3 (red) to +3
(blue) kT/e based on the electrostatic potential present at the solvent accessible surface. (c, g) Front
(c) and top (g) view of the Gαmyri1 structure after about 1.8 μs. The colouring scheme is the same as in
image a. (d, h) Electrostatic surface map of the front (d) and top (h) view of the Gαmyri1 structure after
about 1.8 μs of classical MD. The colour coding is the same as in image b.
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close to the Ras domain of the Gαi1 subunit. However, the conformation of an active myris-
toylated α subunit can be affected by the myristoyl group as the α subunit can relocate to the
cytosol due to the dissociation from the βγ dimer and the depalmitoylation of the N-terminus,
therefore providing the opportunity for the myristoyl group to interact with the α subunit.
The performed 2 μs simulation of the conformation of active Gαmyri1 shows that a solvated
Gαi1:GTP’s structure is able to adopt a conformation in which the myristoyl moiety is embed-
ded in a hydrophobic binding pocket on the protein itself. The presented conformation of
the Gαmyri1 :GTP complex provides a possible explanation for the disagreement between the
Gαnoni1 :GTPγS X-ray structure and other experiments on active Gα
myr
i1 , such as ﬂuorescence
and hydrogen/deuterium exchange experiments.
The structural rearrangements in solvated Gαmyri1 :GTP present a new view on Gαi1’s possibili-
ties for protein-protein interactions as for its interaction with AC5, for instance. AC5 is present
in high concentrations in the brain and heart, which has been associated to congestive heart
failure and pain perception [Pierre et al., 2009; Sadana and Dessauer, 2008]. Inhibitors of AC5
are therefore proposed as possible drug target for treatment of heart failure and analgesics
[Pierre et al., 2009]. Hence, obtaining a better view on how these proteins interact could be
important for the development of AC5 inhibitors. Additionally, the presence of two active Gαi1
conformations, membrane-bound and solvated, constitutes a signiﬁcant difference between
Gαi1 and Gαs as it is suggested that Gαs only adopts one conformation of the Ras and the
alpha helical domain with a structured or unstructured N-terminus in the active state, depend-
ing on its location in the cell. Consequently, although Gαs is proposed to lose its structure of
the N-terminus upon activation and depalmitoylation, the overall conformation of the protein
could remain the same in the solvated state compared to the membrane-bound conformation
as Gαs , without its N-terminus, is still able to interact with AC5 [Tesmer et al., 1999]. This
striking difference between Gαi1 and Gαs could provide an alternative view on the function
of G proteins in their active conformation. Moreover this study shows that lipid interactions
can be crucial for the conformation of proteins and that through lipidation the function of
structurally highly similar proteins can be altered and regulated.
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5 Exploring the Inhibition Mecha-
nism of Adenylyl Cyclase Type 5 by
N-Terminal Myristoylated Gαi1:GTP
Siri Camee van Keulen, Ursula Röthlisberger
5.1 Summary
Adenylyl cyclase (AC) is an important messenger involved in G-protein-coupled-receptor
signal-transduction pathways. AC is regulated by stimulatory (Gαs) and myristoylated in-
hibitory (Gαi ) G proteins. Understanding the interaction between Gαi1 and AC type 5 is
important as it provides more insight into the unknown mechanism of AC5 inhibition, which
is a possible target for the treatment of heart failure and analgesics. This study demonstrates
via classical molecular dynamics simulations that the myristoylated Gαi1 structure is able to
interact with adenylyl cyclase type 5 in a way that causes inhibition of the catalytic function of
the enzyme.
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5.2 Introduction
Many proteins are involved in cell communication of which one type is the G-protein-coupled
receptor (GPCR), embedded in the membrane. GPCRs are part of a major signalling pathway,
the GPCR signal-transduction pathway, which enables the transfer of a signal from the ex-
tracellular region to the intracellular side and is a key target for drug development. A large
diversity of GPCRs can be found in nature as about 800 human genes are involved in storing
different types of GPCRs that can interact with neurotransmitters, hormones or exogenous
ligands, for example [Oldham and Hamm, 2008].
In the cytosol, G proteins are the ﬁrst interaction partner of the membrane-bound activated
GPCRs. G proteins are composed of an α, β and γ subunit. When a heterotrimeric G protein is
activated by a GPCR, the trimer dissociates, resulting in an α subunit and a βγ dimer [Galés
et al., 2006]. Activated Gα subunits transport the signal from the membrane to other regions of
the cell by stimulating or inhibiting reactions via protein-protein interactions. Besides direct
activation by GPCRs, the function of G proteins can also be inﬂuenced by other environmental
factors, such as lipidation. Permanent N-myristoylation, for instance, is known to change the
structure and function of the inhibitory G-protein subunit Gαi1 in its active GTP-bound state
[Degtyarev et al., 1994; Preininger et al., 2003; Dessauer et al., 1998; Taussig et al., 1993].
While a wide range of GPCRs exists, a relatively low diversity is present in the G protein family,
e.g. the human body. The human body includes only a relatively small variety of 21 α, 6 β
and 12 γ subunits [Oldham and Hamm, 2008]. The Gα subunits are divided into four major
subfamilies based on their sequence homology and function [Simon et al., 1991]: stimulatory
Gαs , inhibitory Gαi , Gαq and Gα12[Chen and Manning, 2001; Cabrera-Vera et al., 2003].
Overall the structures of the Gα subfamilies are similar (Fig. C.1), including a Ras domain and
an alpha helical (AH) domain. The Ras domain is present in all members of the G-protein
superfamily and can perform hydrolysis of GTP to GDP during deactivation of the Gα subunit,
for example [Johnston and Siderovski, 2007]. In addition, the domain includes an interaction
site for GPCRs as well as regions that can interact with the βγ dimer. Moreover, the Ras domain
can also undergo lipidation. Except for Gαt , all Gα proteins are able to reversibly bind a
palmitate to their N-terminal helix. Besides palmitoylation, Gαi can also permanently bind a
myristoyl moiety to the N-terminus that appears to be crucial for the function of the subunit
[Cabrera-Vera et al., 2003; Preininger et al., 2003, 2012; Dessauer et al., 1998].
The AH domain is unique to the Gα subfamilies, which is composed of six α helices and
interacts with the Ras domain when GTP or GDP is present. However, this interaction between
the AH and Ras domain is weakened when a nucleotide is absent in Gα’s active site [Dror et al.,
2015; Louet et al., 2012; Schröter et al., 2015]. The high structural similarity among members
of the Gα subfamilies is illustrated by aligning the X-ray structures of stimulatory Gαs and
inhibitory Gαi1, resulting in a root mean square deviation (RMSD) of only 1.07 Å between the
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Cα atoms of the two structures (Fig. C.1) [Kaya et al., 2014; Sunahara et al., 1997b]. Hence,
from a comparison of the structures it is difﬁcult to conclude what the origin is of their inverse
action, i.e., how the structure can be related to a stimulatory respectively an inhibitory effect.
An example of a protein in which both Gαi and Gαs are important for regulation is adenylyl
cyclase (AC). Ten isoforms of AC are known of which nine are membrane-bound (AC1-9)
and one is soluble (sAC) [Sunahara and Taussig, 2002]. These different types of AC are found
throughout the body in different concentrations. AC5, for instance, is present in high quantities
in the brain, the spinal cord and the heart, and is associated to congestive heart failure and
pain perception [Pierre et al., 2009; Sadana and Dessauer, 2008]. G proteins have the ability to
either stimulate (Gs) or inhibit (Gi ) adenylyl cyclases’ conversion of adenosine triphosphate
(ATP) to cyclic adenosine monophosphate (cAMP) and pyrophosphate [Robinson et al., 1968].
ACs consist of two membrane-bound regions, each built from six trans-membrane domains,
and a catalytic region in the cytosol that includes two pseudo-symmetric domains, C1 and C2
[Hurley, 1999]. GTP-bound Gαs is known to bind to the C2 domain for which the interaction
site is known from X-ray structures of Gαs interacting with AC [Tesmer et al., 1999]. Such data
is absent for the case of Gαi . In the absence of direct experimental information, a putative
interaction site of GTP-bound Gαi has been suggested in analogy to the known structure of the
complex of Gαs and AC (Gαs :AC) as the pseudo-symmetric site on the C1 domain. However,
how the interaction of Gαi on the C1 domain should induce inhibition is not obvious (Fig. C.2)
[Dessauer et al., 1998]. Furthermore, since with this hypothesis the interaction sites of Gαi1
and Gαs are highly similar in addition to their structures, it is unclear how the α subunits can
differentiate the two binding sites on AC and what the cause is of the stimulatory versus the
inhibitory effect induced by the subunits.
A factor that could play an important role in differentiating the action of Gαi and Gαs is the
difference in lipidation of both subunits. Although the X-ray structures in the Protein Data
Base (PDB) [Berman et al., 2000] of the active inhibitory and stimulatory Gα subunits tightly
align, the N-terminus, which is not resolved for Gαi or Gαs , is not myristoylated during the
expression process of Gαi as lipidation can hinder crystallisation [Preininger et al., 2003].
Hence, it is not clear to what extent the missing N-terminal myristoyl moiety affects the Gαi
structure of the remaining protein while the bound myristoyl group has been known to be
crucial for Gαi ’s conformation and function as the ability to interact with AC5 is abolished
upon removal of the myristate [Dessauer et al., 1998; Preininger et al., 2003; Taussig et al.,
1993]. Classical molecular dynamics (MD) simulations of myristoylated Gαi1:GTP (Gα
myr
i1 )
show that myristoylation can have a signiﬁcant effect on the conformation of the subunit
[van Keulen and Rothlisberger, 2016]. The ﬁndings suggest the possibility of an alternative
novel interaction mode and open up new possibilities for selective interactions with AC. This
is because the found structural changes in the classical MD simulations of active Gαmyri1 [van
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Keulen and Rothlisberger, 2016] suggest that the subunit will not be able to interact with C1 in a
similar way as Gαs interacts with C2. In addition, MD simulations of active non-myristoylated
Gαi1 interacting with AC5’s C1 domain suggest that this complex is highly unstable [Lavery].
Here, we investigate the interaction betweenGαmyri1 andAC, using classicalMD simulations. To
this end, the initial structure of Gαmyri1 was taken from reference van Keulen and Rothlisberger
[2016]. Gαmyri1 can inhibit only particular isoforms of AC: AC1, AC5, AC6 [Sunahara et al., 1996].
In this study AC5 is used because X-ray structures of AC’s catalytic domains are composed
of isoforms AC2 and AC5. Ca. 16 AC structures can be found in the PDB with different
resolutions and/or crystallisation conditions. All available structures have been co-crystallised
with a Gαs subunit and correspond therefore to activated conformations at various levels of
activation, depending on the nature of bound cofactors (e.g. cofactor-free complex of AC,
substrate-bound AC complex).
When AC5 becomes active, roughly three conformational options are possible: a complex
of Gαs and AC5 (Gαs :AC5), Gαs in complex with AC5 with bound ATP (Gαs :AC5:ATP), or a com-
plex of Gαs andAC5bound to the reaction products cAMPandpyrophosphate (Gαs :AC5:cAMP).
Currently, it is not known which one of these forms is most likely to interact with Gαmyri1 , or
if Gαmyri1 can inhibit all of them. In this study, the structure of the AC5 protein was taken
from a crystal structure of the cofactor-free Gαs :AC5 complex. This AC5 conformation was
used as it can be viewed as the ﬁrst and the least-stable active conformation among the three
forms, which increases the possibility of observing conformational changes on the time scales
that can be reached via classical MD. The AC5 structure was employed to build a Gαmyri1 :AC5
complex and to explore if the binding of Gαmyri1 is able to reverse the active conformation
initially induced by Gαs . In order to verify which changes are due to the interaction of AC5
with Gαmyri1 and which alterations are a result of the removal of Gαs , a second simulation of
AC5, with the Gαs subunit removed, was performed on the same time scale as the Gα
myr
i1 :AC5
complex.
Hence, in this study the impact of the presence of myristoylated Gαi on the function of
AC5 is explored via investigating the conformational features of the Gαmyri1 :AC5 and the free
AC5 complex (a system that only includes AC’s catalytic region in solution) in comparison
with the Gαs :AC structure. This Gα
myr
i1 :AC5 complex has been obtained via docking the
Gαmyri1 structure on to the C1 domain of AC5. Already the initial docking results conﬁrm
the possible importance of the myristoyl-induced structural changes of Gαmyri1 as a new
interaction mode for Gαmyri1 could be identiﬁed. The comparison of the performed classical
MD simulation (2.5 μs) of the Gαmyri1 :AC5 complex and the free AC5 system suggest two
possible ways of AC inhibition. First, active Gαmyri1 seems to inhibit AC’s conversion of ATP
to cAMP by preventing active-site formation as the Gαi1 subunit perturbs the conformation
of the active site on the C1/C2 interface. Second, the effect of Gαmyri1 on the AC structure
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leads to a closed conformation of the Gαs binding site on C2, decreasing the probability of
Gαs association and thus of a counter-balancing re-stimulation of the AC5 activity. Taken
together, the observed events lead to a suggestion for a putative Gαmyri1 inhibition mechanism
of AC5 (Fig. 5.7) in which lipidation is crucial for Gαmyri1 ’s function and its protein-protein
interactions. This gives a possible indication that lipidation could play a signiﬁcant role in
regulating G protein function and thus signalling in G protein mediated pathways [Dessauer
et al., 1998; Preininger et al., 2003; Taussig et al., 1993].
5.3 Methods
5.3.1 Initial Structures
The PDB structure 1AZS, composed of the catalytic domains of the ATP-free Gαs :AC complex,
was used as a template, including 1AZS’s C1 and C2 domain, for the initial AC5 structure of the
Rattus norvegicus (UniprotKB Q04400) [Tesmer et al., 1999; Eswar et al., 2006; Martí-Renom
et al., 2000]. The missing loop in the C2 domain was modelled using a snippet of the PDB
structure 1J8M [Montoya et al., 2000]. The structure of the Rattus norvegicus Gαmyri1 subunit
(UniprotKB P10824) interacting with GTP and Mg2+ was taken from reference van Keulen and
Rothlisberger [2016] (Fig. C.3 and Fig. C.4).
5.3.2 Docking of Gαi1 with AC5
The HADDOCK web server [De Vries et al., 2010] was used for docking ten conformations of the
myristoylated Gαi1:GTP complex with the catalytic domains of AC5 of Rattus norvegicus. The
active region of Gαi1 was deﬁned in HADDOCK as a large part of the AH domain (112-167), the
switch I domain (175-189) and the switch II domain (200-220), allowing for a large unbiased
region on the Gαmyri1 protein surface to be taken into account during docking. The active
region of AC5’s C1 domain was deﬁned as the α1 helix (479-490) and the C-terminal region of
the α3 helix (554-561) because experimentally it has been found that Gαmyri1 :GTP is unable to
interact with C2 and its main interactions with AC are with the C1 domain [Dessauer et al.,
1998]. Passive residues, residues that could take part in protein-protein interaction, were
deﬁned as residues around the active residues that are on the protein surface and within a
radius of 6.5 Å of any active residue [De Vries et al., 2010]. Ten Gαmyri1 snapshots were used for
docking with a time interval between each snapshot of 0.5 ns. These snapshots were taken
at the end of the Gαmyri1 classical MD trajectory (around 1.9 μs) discussed in reference van
Keulen and Rothlisberger [2016].
The initial Gαmyri1 :AC5 complex for the classical MD simulations was selected based on (1)
the absence of overlap between the C2 domain and Gαmyri1 :GTP, (2) no overlap with the GTP
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binding region and the interaction with C1 and (3) presence of similar complexes in the top-ten
docking results of the docking calculations performed for all ten Gαmyri1 :GTP snapshots. The
ﬁrst property of the selection criteria is important since Gαmyri1 :GTP is unable interact with
C2 [Dessauer et al., 1998]. The second criterium has been deﬁned since GTP is located in the
active site of Gαmyri1 in the classical MD simulations, but was not incorporated in the docking
procedure because this is not possible in HADDOCK. Therefore, no overlap between the GTP
binding site and the C1 domain should be present in the docking result as otherwise the GTP
molecule will not be able to ﬁt in Gαmyri1 ’s active site. The last criterium is the presence of
similar Gαmyri1 :AC complexes of the selected complex in all top-ten docking results which
increases the probability that complexation of the two proteins is not conformation speciﬁc,
but is robust as similar complexes can be obtained using different conformations of Gαmyri1 .
5.3.3 Classical Molecular Dynamics Simulations
The Gαmyri1 :AC5 complex together with the two Mg
2+ ions and GTP was used to simulate the
protein complex for 2.5 μs at 310 K and 1 bar using a Nosé-Hoover thermostat and an isotropic
Parrinello-Rahman barostat. Additionally, about 68 000 water molecules and 150 mM KCl are
present in the simulated system. The force ﬁelds used for the protein and the water molecules
are AMBER99SB [Hornak et al., 2006] and TIP3P [Jorgensen et al., 1983], which were employed
by Gromacs 4.6.6 [Bekker et al., 1993; Hess et al., 2008] to perform the runs. For GTP, the force
ﬁeld generated by Meagher et al. was used [Meagher et al., 2003]. The adjusted force ﬁeld
parameters for K+ and Cl− were taken from Joung et al. [Joung and Cheatham III, 2008]. The
Mg2+ parameters originated from Allnér et al. [Allnér et al., 2012] and the parameter set for
the myristoyl group was taken from reference van Keulen and Rothlisberger [2016].
Electrostatic interactions were calculated with the Ewald particle mesh method with a real
space cutoff of 12 Å. Bonds involving hydrogen atoms were constrained using the LINCS
algorithm [Hess, 2008]. The time integration step was set to 2 fs.
The free AC5 system was also simulated with the same setup as the Gαmyri1 :AC5 complex. The
system was solvated in 30 000 water molecules and 150 mM KCl concentration. The initial
location of Mg2+ in the active site of the enzyme was the same as in the Gαmyri1 :AC5 complex
system.
5.3.4 Structure Superpositions and Images
Multiprot [Shatsky et al., 2004] and VMD [Humphrey et al., 1996] were used to align protein
structures. Uniprot [Consortium, 2014] was used to align protein sequences. Images were
prepared with VMD [Humphrey et al., 1996].
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5.4 Results and Discussion
5.4.1 Classical Molecular Dynamics Simulations of Gαmyri1 :AC5 Complex
Gαmyri1 ’s proposed interaction site in the initial Gα
myr
i1 :AC5 structure (see Supporting Results
and Discussion Section in Appendix C) appears to affect the conformation of C1 in a different
way than Gαs stabilises the C2 domain (Fig. C.2 and Fig. C.4). Unlike Gαs , Gα
myr
i1 is not
located between the helices of AC5’s catalytic domain, but appears to clamp the C1 domain
into its inactive conformation. Gαmyri1 is positioned around AC5’s α3, interacting with α1, α2,
and α3 via its switch I, II and III domain together with the C-terminal domain of αB (Fig. C.4).
Since C1’s α1 helix appears to decrease its distance with respect to the C2 domain when an
ATP analog is present in the active site (Fig. C.3c, d), the interactions between C1 and Gαmyri1
in the initial Gαmyri1 :AC5 complex could suggest that Gα
myr
i1 is able to inhibit ATP’s conversion
by preventing AC5’s α1 to rearrange upon ATP binding due to Gαmyri1 ’s interaction with C1’s
α1.
The stability of the docked complex and the effect of Gαmyri1 association was veriﬁed via
investigating the conformational changes in the complex through classical MD simulations
on the μs time scale. The X-ray structure used for the initial conformation of AC5, was co-
crystallised with Gαs but is not interacting with substrate or products from the ATP conversion
reaction (see Section 5.2). Consequently, this conformation of AC5 could be viewed as a
structure that is present before ATP association, but is already in an active form, due to
its interactions with Gαs . Because of the crystallisation circumstances used to obtain the
selected AC5 structure, the found conformational changes in the catalytic region of AC5 in the
Gαmyri1 :AC5 complex are compared to the conformation found in the classical MD trajectory
of the free AC5 system and the Gαs :AC X-ray structure in order to verify which structural
alterations are due to the presence of Gαmyri1 and which changes are on the other hand the
result of the absence of Gαs .
In order to closer mimic a protein system with which ATP or a product such as pyrophosphate
would be able to interact, a Mg2+ ion was added to the active site of the Gαmyri1 :AC5 and the
free AC5 system. Throughout the MD simulations of free AC5 and Gαmyri1 :AC5, the Mg
2+ ion
remained stable in the active site of AC5. Results on the stability of this Mg2+ ion in AC5’s
active site can be found in the Supporting Results and Discussion Section in Appendix C.
Protein-Protein Interface of the Gαmyri1 :AC5 Complex
The Initial Gαmyri1 Conformation is Very Stable over the Entire Course of the Classical MD
Trajectory Since the starting structure of the Gαmyri1 :AC5 complex is unrelaxed, the confor-
mation of the Gαmyri1 subunit and the Gα
myr
i1 /AC5 interface have been investigated during
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the MD trajectory to study the stability of the Gαmyri1 :AC5 complex and the effect of the AC5
interaction on the Gαmyri1 structure. In fact, the structure of Gα
myr
i1 only changes minimally by
a slight adjustment in the orientation of the alpha helical domain (Fig. 5.1b and Fig. C.7). A
striking feature of the interface between Gαmyri1 and C1 is the fact that the switch regions, I,
II and III, remain involved in AC5 binding, as well as the region on the alpha helical domain
that rearranged upon myristoyl binding (Fig. 5.1a, b) [van Keulen and Rothlisberger, 2016].
Gαmyri1 is stabilised on AC5 via the C1 domain without major interactions with C2 (Fig. 5.1c).
The relative orientation of Gαmyri1 with respect to the C1 domain stabilises after ∼ 400 ns (Fig.
C.7). This slight orientational repositioning is probably a consequence of the relocation of C2’s
β7-β8 loop, which could be due to the removal of the Gαs subunit from the C2 domain in the
initial complex because this β7-β8 loop displacement is present in Gαmyri1 :AC5 as well as free
a b
c
switch II
switch I
alpha helical  
region
Figure 5.1: Gαmyri1 ’s interactions with AC5 are stable over the course of the classical MD trajectory. (a)
Aligned structures of the docked model (cyan) and the Gαmyri1 :AC5 complex after ∼ 1.7 μs (orange and
red). The structures were aligned on the C1 domain, residues 456 to 644, as this domain’s RMSD is low
over the course of the simulation (Fig. 5.3). (b) Aligned structures of the docked model (cyan) and the
Gαmyri1 :AC5 complex after ∼ 1.7 μs (orange and red). The structures were aligned on the Gα
myr
i1 subunit
(residues 34 to 334) in order to show the change in the conformation of Gαmyri1 . (c) Number of hydrogen
bonds between Gαmyri1 and C1 and Gα
myr
i1 and C2 that are present during the classical MD trajectory.
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AC5 (Fig. 5.2).
Besides the orientation of Gαmyri1 , also minor alterations can be observed in Gα
myr
i1 ’s active
site. The Mg2+ ion, near the GTP binding site (Fig. C.8), is moderately altered compared to the
free Gαmyri1 system [van Keulen and Rothlisberger, 2016]. In the Gα
myr
i1 :AC5 both of Asp200’s
oxygens, OD1 andOD2, are able to interact withMg2+, while in freeGαmyri1 only one of Asp200’s
oxygens is interacting with the Mg2+ ion [van Keulen and Rothlisberger, 2016]. The interaction
between Mg2+ and Asp200’s second oxygen in Gαmyri1 :AC5, OD2, can be temporarily perturbed
by a water molecule, which leads to sudden jumps in the Mg2+ and Asp200OD2 distance (Fig.
C.8).
Structural Impact on AC5’s Active Site
Gαmyri1 ’s Interactions with C1 Impact the Entrance of the ATP Binding Site The active site
of AC5 is located on the interface between C1 and C2. Structural changes of both domains
upon Gαmyri1 binding can potentially inﬂuence the protein’s activity. When comparing the root
mean square deviation of the two domains with respect to AC’5 initial conformation, it is clear
that in the free AC5 as well as in the Gαmyri1 :AC5 complex the C2 domain experiences more
changes than C1 (Fig. 5.3). In the X-ray structure, used as a template to construct the initial
AC5 structure, the C2 domain is interacting with a Gαs subunit. The removal of Gαs from the
C2 domain could affect the RMSD of the domain in the Gαmyri1 :AC5 and free AC5 systems as
a b
??
??
C2 C1
Figure 5.2: Change of location of C2’s β7-β8 loop occurs in both Gαmyri1 :AC5 and free AC5 systems. (a)
Graph of the distances between the α carbon of Gly1246 (green dot in image b) and the α carbons of
Ala483 (red dot in image b) and Asn630 (orange dot in image b). (b) β7-β8 loop’s relocation in the free
AC5 system (purple), the Gαmyri1 :AC5 complex (cyan) and PDB structure 1AZS (yellow). The location of
the residues used in image a are assigned according to the Gαmyri1 :AC5 structure.
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the initial structure of AC5 is inﬂuenced by the presence of Gαs .
During classical MD the ﬁrst alteration to C2’s initial structure that can be observed in both
Gαmyri1 :AC5 and free AC5 is the relocation of the β7-β8 loop, positioned on the cytosolic side
(Fig. 5.2). The location of C2’s β7-β8 loop is important for the active conformation of the active
site on the C1/C2 interface (Fig. 5.2 and Fig. C.3). Loop relocation and the accompanying
movement of the two domains appear to have a deactivating effect on the active site (Fig. 5.2
and Fig. C.3b). For instance, a residue that is known to be part of the active site, Lys1245,
located in the β7-β8 loop, is unable to maintain its orientation towards the ATP binding site
(Fig. C.9). A reason for this conformational change in the Gαmyri1 :AC5 and free AC5 simulations
could be the absence of Gαs at the C2 domain that destabilises β7-β8’s location. The presence
of Gαmyri1 appears to increase the stability of the β7-β8 loop relocation compared to the free
AC5 system (Fig. 5.2).
An alteration that also occurs around AC5’s active site in the Gαmyri1 :AC5 system is the decrease
in distance between C2’s α4 helix and C1’s β2-β3 loop (Fig. 5.4, Fig. C.4). This change in the
C1/C2 interface could make the positioning of ATP in the active site less favourable because
ATP’s adenine moiety, which is positioned between C2’s α4 helix and C1’s β2-β3 loop when
ATP interacts with AC5 (Fig. C.3d), is unlikely to ﬁt between the C1/C2 interface due to the
diminished distance between the C1 and C2 regions compared to the initial AC5 structure.
Although the free AC5 system also undergoes a change in this region, theα4 helix of C2 remains
closer to the X-ray location than in the Gαmyri1 :AC5 complex (Fig. 5.4).
Figure 5.3: Signiﬁcant difference between RMSD values of free AC5 and Gαmyri1 :AC5 for the C2 domain.
Root mean square deviations of the backbone of the C1 and the C2 domain. In the RMSD calculation
the residues between 463 to 644 were taken into account for the C1 domain and the residues between
1065 to 1135 and 1145 to 1257 were used for the C2 domain.
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In summary, the conformational changes at the C1/C2 interface of Gαmyri1 :AC5 seem to affect
AC5’s active site by interfering with ATP binding. In fact, the new position of the β7-β8 loop
can even block the active site entrance, which could prevent ATP entry. The relocation of C2’s
β7-β8 loop, present in the Gαmyri1 :AC5 and the free AC5 systems, could be due to the removal
of Gαs , which interacts with the C2 domain in the template X-ray structure. The interaction
between Gαs and AC5 seems to stabilise the position of β7-β8 at the C1/C2 interface, close
to C1’s α1. As C2’s β7-β8 is part of the active site, the position of β7-β8 could be viewed as a
stimulation feature that can be switched on by Gαs or switched off by the absence of Gαs (free
AC5) or by the presence of Gαmyri1 , which stabilises the relocation of the β7-β8 loop even more
(Fig. 5.2).
Gαmyri1 ’s Interactions with C1 Impact ATP’s Binding Site around the AdenineMoiety of ATP
While the RMSD of free AC5 and Gαmyri1 :AC5 compared to the initial AC5 structure (obtained
via the Gαs :AC X-ray structure) appear similar for C1, the C2 domain of Gα
myr
i1 :AC5 diverges
more from the initial structure than free AC5 (Fig. 5.3). One of the major differences between
the C2 domain of the free AC5 system and the Gαmyri1 :AC5 complex lies on the membrane side
of the proteins. In the case of free AC5, C2’s β4-β5 loop is interacting with the C1 domain,
a b
Figure 5.4: Rearrangements of AC5’s active site differ between the Gαmyri1 :AC5 complex and free AC5
system. (a) Graph of the distances between the α carbon of Gly518 (red dot in image b) and the
α carbons of Asn1202 (green dot in image b) and Asn1205 (yellow dot in image b). The respective
distances in PDB structure 1CJK of Gly518-Asn1202 (Gly439-Asn1022 in PDB 1CJK) and Gly518-Asn1205
(Gly439-Asn1025 in PDB 1CJK) are 11 Å and 8.5 Å. (b) Detail of AC’s active site of the free AC5 system
(purple), the Gαmyri1 :AC5 complex (cyan) and PDB structure 1CJK (orange). The location of the residues
used in image a are assigned according to the Gαmyri1 :AC5 structure. In the active site the location of
the Mg2+ are shown for the three structures as well as the position of the ATP analog from the fully
activated AC5 structure (PDB code 1CJK).
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while in the Gαmyri1 :AC5 complex, the loop does no longer interact with the C1 domain, leading
to an unfavourable ATP binding site at the C1/C2 interface (Fig. 5.5a, b, c). A weakening of
the ATP binding site at the C1/C2 interface is also apparent from C1’s interactions with the C2
domain near the active site region (Fig. C.9). Asp1198, for example, which is important for
stabilising ATP’s adenine moiety in the Gαs :AC complex, reorients as the residue is part of the
β4-β5 loop. Due to Asp1198’s change in location, Lys1124, which is interacting with Asp1198,
alters its orientation as well. Lys1124 also inﬂuences the stability of the active site in Gαs :AC
as the residue stabilises ATP in a similar fashion as Asp1198 (Fig. C.9).
a b
c d
β4 β5
α2
Figure 5.5: Conformational changes on membrane side of AC5 show C2’s loop dissociation, which only
occurs in Gαmyri1 :AC5. (a) Graph of the distances between the α2 helix of C1 and the β4-β5 loop of C2
in the Gαmyri1 :AC5 structure (see image b) (b) AC5’s membrane side of the free AC5 system (purple), the
Gαmyri1 :AC5 complex (cyan) and PDB structure 1AZS (yellow) in which the α2 helix of C1 and the β4-β5
loop of C2 are highlighted. In the Gαmyri1 :AC5 complex the location of the residues used in the angle
calculation of image d are represented by a green (Ala488), pink (Leu495) and orange (Phe499) dot. (c)
Graph of the distances between the α2 helix of C1 and the β4-β5 loop in the AC5 system (see image b).
(d) Angle between three helical turns, including Cα atoms of Ala488, Leu495 and Phe499, in which the
kinking of the α2 helix of C1 takes place (see image b).
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Although C1’s RMSD is low (Fig. 5.3 and Fig. C.7), a signiﬁcant change in conformation can be
observed close to the Gαmyri1 /C1 interface where a kink in α2 occurs, which is less pronounced
in free AC5 (Fig. 5.5d). However, overall, the C2 domain seems to be affected most by the
absence of Gαs and the presence of the inhibitory Gα. This observation is in line with the
hypothesis that Gαmyri1 is able to constrain C1’s conformation via its tight interactions with this
domain, leading to a perturbation and destabilisation of the active site on the C1/C2 interface
(Fig. 5.5 and Fig. C.8). This change of the C1/C2 interface prevents the catalytic domains to
sample the conformation in which ATP could be positioned in the active site due to a decrease
in distance between C2’s α4 helix and C1’s β2-β3 loop and a relocation of C2’s β4-β5 and
β7-β8 loops (Fig. 5.2, Fig. 5.4 and Fig. 5.5), which play important roles in the construction of
the active site.
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Figure 5.6: Conformational changes around the Gs binding site on C2 show distinct events of closure in
the Gαmyri1 :AC5. (a) Graph of the distance between the α2 and the α3 helix of C2 including Cα atoms
of Asn1091 and Phe1171, of free AC5 and Gαmyri1 :AC5. A detailed representation of the Gs binding site
is shown in image c. (b) the Gs binding site of the free AC5 system (purple), the Gα
myr
i1 :AC5 complex
(cyan) and PDB structure 1AZS (yellow) in which the Gs subunit is also shown. (c) Detail of the Gs
binding site of Gαmyri1 :AC5 in which residues that are involved in the closing of the binding site are
shown.
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Presence of Gαmyri1 Induces Closure of Gαs ’s Interaction Site on AC5’s C2Domain Besides
the direct conformational changes in AC5’s active site another mechanism that could induce
inhibition is decreasing the probability of Gαs binding to the C2 domain. In free AC5 as
well as in Gαmyri1 :AC5, the Gαs site seems to become less favourable for Gαs binding since
the distance between α2 and α3, α2-α3, is signiﬁcantly decreased with respect to the X-ray
structure of the Gαs :AC5 complex (Fig. 5.6a, b). In the free AC5 system α2-α3 changes from
around 16 Å (initial distance between the Cα carbons of Asn221 and Phe1171) to an average
distance of ∼11 Å (Fig. 5.6a,b). In the Gαmyri1 :AC5 simulations, the distance between the two
residues can decrease even more severely to a distance of∼ 7 Å (Fig. 5.6a,b), leading to a closed
Gαs binding site conformation. Important residues that stabilise this closed conformation of
the Gαs binding site in Gα
myr
i1 :AC5 are AC5’s: Glu1083, Leu1088, Ala1090, Phe1171, Asn1172
and Asn1173 (Fig. 5.6d). Hence, due to the interaction with Gαmyri1 , the catalytic domains of
AC5 appear to deactivate AC5’s catalytic ability via deformation of the active site as well as to
sample closed Gαs binding site conformations.
5.4.2 Possible Mechanism of Gαmyri1 Inhibition
The simulations of Gαmyri1 :AC5 in comparison with free AC5 and the Gαs :AC X-ray structure
demonstrate that the ﬁrst step in decreasing AC5’s activity is the relocation of the β7-β8
loop (Fig. 5.7, step one). In fact, the β7-β8 loop seems to have an important role for the
stimulatory response since the presence of Gαs leads to the stabilisation of the loop, forming
ATP’s binding site (Fig. 5.7, starting conformation of AC in left panel) [Tesmer et al., 1999].
This loop conformation is lost as soon as Gαs is reduced as observed for both free AC5 and
Gαmyri1 :AC5. In step two of ﬁgure 5.7 the Gα
myr
i1 :AC5 complex undergoes a rearrangement in
the C2 domain (absent in free AC5), which leads to a further perturbation of AC5’s active site
and a destabilisation of the C1/C2 interface. The classical molecular dynamics simulations
also show that in the presence of Gαmyri1 , there appears to be a decrease in probability for
Gαs association (Fig. 5.7, step 3 and Fig. 5.6). Through these rearrangements Gα
myr
i1 could
deactivate AC5 as well as decrease the probability of reactivation via Gαs .
5.5 Conclusions
The results of this study suggest that Gαmyri1 deactivates adenylyl cyclase type 5 via constraining
C1’s active site region. Inhibition and stimulation of AC5 appear to follow different pathways.
While Gαs binds between the helices of C2, increasing the stability of the C1:C2 dimer, Gα
myr
i1
is able to clamp the helices of the C1 domain, promoting an inactive conformation of AC5’s
catalytic domains and a possible decrease in afﬁnity for Gαs on the C2 domain. Structurally,
Gαs and non-myristoylated Gαi1 are very similar, however, when myristoylation has taken
place on the N-terminus of Gαi1, the conformation of the subunit changes drastically, leading
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Figure 5.7: Graphical representation of proposed AC5 inhibition mechanism by Gαmyri1 with the upper
row showing the cytosolic side of AC5 and the lower row depicting AC5 from the membrane side. The
change that takes place in step (1) compared to the initial close-to-active AC5 conformation, is the
relocation of the C2 β7-β8 loop away from its active position. This alteration takes place near AC5’s
active site (red star), which is also affected by this event. Conformational change (2) involves the loss of
interaction between C1’s α2 and the C2 β4-β5 loop, weakening the active site. The ﬁnal rearrangement
(3) includes the closer packing of C2’s Gαs interaction site, which appears to result in a less favourable
C2 conformation for the interaction with Gαs .
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to a structure that differentiates itself from the active Gαs and that enables the protein to
function in an inhibitory fashion as is shown via the presented classical MD simulations.
Hence, in line with experimental studies, myristoylation appears to be crucial for Gi ’s function
and demonstrates how important even relatively small changes to a protein structure can be
for its function.
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6 Conclusions and Outlook
T
he ﬁrst step that takes place in the GPCR signal transduction pathway is the transfer
of an extracellular signal to the intracellular side. In this thesis this signal transduction
across themembranewas explored aswell as further transmission of the signal to other
proteins in the cytosol, Gαi and AC. The study of the GPCR rhodopsin at body temperature
showed that the protein environment of the active site plays a signiﬁcant role in biasing the
chromophore into its active conﬁguration after photon exposure. Besides the shape of the
active site, also the rearrangements in the hydrogen bond network and the presence of water
molecules in the active site appear to be crucial for signal propagation from the chromophore
to the protein environment. Because water molecules are not covalently bound to the protein,
they increase the mobility of the active site and can therefore enhance the adaptability as well
as assist structural rearrangements required during photo activation. Rhodopsin’s activation
mechanism demonstrates the importance of the conformation of the active site, but also
reﬂects the sensitivity of the protein to temperature as different photo activation pathways
have been experimentally observed at low and room temperature. Protein crystallisation
procedures can inﬂuence rhodopsin’s conformation as well and can signiﬁcantly alter the state
of the GPCR or the presence of water molecules in the protein.
The presented simulations emphasise that when a protein is sensitive to temperature ﬂuctua-
tions this should be taken into account when investigating reaction pathways using structures
obtained via X-ray crystallisation. However, the neutral Schiff base rhodopsin state, obtained
via QM/MM MD at body temperature, does not reach a fully adapted rhodopsin conformation
yet at the end of the QM/MM MD trajectory. This is because QM/MM MD simulations of
the system can only reach the picosecond time scale while the relaxation of the active site
and the rest of the protein will take place on the nanosecond time scale. Therefore, QM/MM
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MD simulations are not suitable to study the effect of the active site on the other regions of
the protein. The development of a neutral all-trans-retinal force-ﬁeld parameter set could
facilitate the switch from QM/MM MD to classical MD, which would allow the protein system
to relax on the microsecond time scale. Such MD simulations of the neutral all-trans retinal in
rhodopsin would provide the opportunity to study the further relaxation of the active site, the
propagation of the change in retinal structure to other regions of the protein and the role of
water molecules during rhodopsin activation to the meta II form. Another approach that could
be used is multiple time-step QM/MM:MM MD, currently implemented by Rothlisberger’s
laboratory, in which fast components of the forces are calculated via force-ﬁeld based MD
and the difference in force between the QM forces and the MM forces is integrated with a
long time step. In this way ﬁrst-principle MD simulations can be performed in which the
time step can be increased to a similar level as MM MD. The application of this approach
to the deprotonated Schiff base conformation could provide a detailed description of the
further relaxation of the active site around the Schiff base, which might not be possible with
the direct application of classical MD after QM/MM MD. In order to go to very long time scales,
enhanced sampling techniques could be employed to attempt to sample conformations of the
fully activated rhodopsin system in which the ionic lock between Arg135 and Glu247 is broken.
The second step of the GPCR signal transduction pathway that was covered in this thesis is
the activation of the inhibitory Gα subunit. Although N-terminal myristoylation of Gαi is
commonly excluded from the crystallisation process, the classical MD simulations suggest
that the addition of the lipid to the protein structure has an impact over a large region of
the protein surface. Besides the formation of a hydrophobic pocket in the Ras domain, also
other regions of the subunit are altered, which play an essential role in the protein’s function.
Hence, the performed simulations suggest that nature uses N-terminal myristoylation to
induce speciﬁcity and to regulate the function of closely related G proteins. The presence or
absence of a small post-translational modiﬁcation could be viewed as a minimal effort to tune
the same building blocks for diverse (even inverse) functions in the cell.
The study of G-protein AC regulation, the third study included in this thesis, was part of a
sub group in the Human Brain Project in which several European laboratories, specialised in
systems biology, Brownian dynamics, classical MD and QM/MM MD, collaborated to obtain a
better understanding of the rewarding-memory cascade or reinforcement learning. A pathway
in the brain that, due to previous encounters, can associate an external stimulus to a reward or
a reward-producing response [Nair et al., 2015]. The systems biology model of the pathway
includes a biochemical network that starts with GPCR stimulation and ends with protein
kinase A activation [Nair et al., 2015]. The presence of a Gαmyri1 :AC5:Gαs complex – of which
its formation is unclear as it has never been reported in experimental studies [Dessauer et al.,
1998] – or solely Gαmyri1 :AC5 and Gαs :AC5 complexes has a signiﬁcant effect on AC regulation
in the modelled pathway. In order to obtain a better understanding of Gαmyri1 ’s inhibitory
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effect on AC, a classical MD study of the Gαmyri1 :AC5 complex in comparison with the free
AC5 system was performed. According to the MD simulations, the interface between AC5’s
C1 and C2 domain appears to be the main region that is affected by the presence of the Gα
subunits (Gαmyri1 as well as Gαs). Gαs can stabilise C2’s β7-β8 loop via its interactions with
the C2 domain, which assists the formation of the ATP binding site. On the other hand, Gαmyri1
stabilises C2’s β7-β8 loop in a location that seems to interfere with ATP binding. In addition,
Gαmyri1 ’s complexation to AC5 leads to a loop relocation in the C2 domain, increasing the
perturbation of the active site. The presence of Gαmyri1 also appears to disfavour possible
Gαs binding to the C2 domain, suggesting a double mechanism of inhibition via the ATP
binding site and the Gαs binding site. Moreover, the simulations of Gα
myr
i1 :AC5 and free AC5
indicate that despite the high structural similarity of the Gαs and non-myristoylated Gαi1
X-ray structures, Gαmyri1 and Gαs appear to act on two different sites on AC’s catalytic domains.
The mechanistic insights obtained via the investigation of soluble Gαmyri1 and AC’s interaction
with Gα subunits could provide a new perspective on Gα subunit regulation. Before this study
was conducted, the stimulatory and inhibitory Gα subunits appeared to be structurally very
similar according to the X-ray structures of active Gαs and non-myristoylated Gαi . However,
due to the adjustments in Gαi ’s conformation after N-myristoylation, the subunits Gα
myr
i
and Gαs show distinct structural differences, that seem to be essential for differentiating their
action. In combination with experimental studies, the simulation results also suggest the
possibility of the presence of different Gαi conformations in the active (GTP bound) state that
are either soluble when the myristoyl moiety is in the protein’s hydrophobic pocket or can
interact with the membrane, which leads to a relocation of the myristoyl group away from
the hydrophobic pocket and towards the membrane. Hence, the inhibition via Gαi subunits
could be more complicated than previously assumed as at least two conformations of the Gα
subunit can be present on the intracellular side.
The better understanding of the possible interactions between Gαmyri1 and AC5 and the in-
hibitory effect of Gαmyri1 on AC5 obtained in this thesis, helped to identify new key regions
of the enzyme that are essential for activation or inhibition and suggested a new view on
G-protein induced conformational changes of AC5. This new perspective on Gα subunit
regulation impacts besides our understanding of signal transduction also drug development
that targets the GPCR signal transduction pathway as the structural difference between Gαi
and Gαs could open up new avenues for enhancing/reducing AC’s interaction with Gαi or
Gαs .
Although these ﬁrst simulations of Gαmyri1 , AC5 and Gα
myr
i1 :AC5 suggest many interesting new
perspectives, these ﬁndings should also be veriﬁed via experimental studies. One approach to
test the exact location of the myristoyl moiety could be to mutate the hydrophobic binding site
in such a way that the myristoyl moiety is not able to ﬁt in the pocket anymore, for instance,
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via the mutation of Met53 and Phe196 into bulky residues. Because it is known that non-
myristoylated Gαi1 is unable to bind to AC’s C1, the interaction between C1 and Gα
myr
i1 with
the mutated hydrophobic pocket could be tested to investigate if the binding of the myristoyl
moiety in the hydrophobic pocket directly affects the interaction with C1. Another experiment
that could be considered to study the Gαmyri1 /AC5 interface is a FRET experiment between
Gαmyri1 and AC5 for which a donor and acceptor group are attached to the alpha helical domain
of Gαmyri1 and the C1 domain of AC5.
Besides experimental studies also several additional simulations can be conducted to improve
the understanding of Gα regulation. In this thesis the free AC5 system and the Gαmyri1 :AC5
complex were investigated starting from an AC template of substrate-free Gαs :AC. However,
many alternative states of AC still remain to be tested as, for example, the stability of the
Gαmyri1 :AC5:Gαs complex. Currently, the results of Gα
myr
i1 :AC5 and free AC5 suggest that Gα
myr
i1
can act as a preventer of ATP and Gαs association. If this is the case, the AC conformation that
is initially interacting with an analog of ATP and Gαs could be affected less by the presence of
Gαmyri1 because ATP induces a conformation of C1 that appears to be less favourable for Gα
myr
i1
association. Therefore, complexes of Gαmyri1 :AC5 and Gα
myr
i1 :AC5:Gαs with PDB code 1CJK
(Gαs :AC bound to an ATP analog) as AC5 template and Gα
myr
i1 :AC5 and Gα
myr
i1 :AC5:Gαs with
PDB code 3C15 (Gαs :AC bound to pyrophosphate) as AC5 template have also to be included in
followup studies to further validate the proposed inhibition mechanism. Via the simulation of
these different systems it could be investigated how both Gα subunits inﬂuence each other’s
interaction with AC5 and thus modify AC5’s function. In addition, these simulations could
show the effect of different AC5 conformations on the stability of the Gα interactions with the
enzyme. Overall, the results could reveal the inﬂuence of Gα subunits on AC5, depending on
different states of AC5 activation, the possibility of Gαmyri1 :AC5:Gαs formation as well as lead
to a better understanding of which AC5 conformations can be inhibited by Gαmyri1 .
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Appendix A. How Rhodopsin Tunes the Equilibrium between Protonated and
Deprotonated Forms of the Retinal Chromophore
Figure A.1: Rhodopsin dimer system setup. (a) Rhodopsin dimer system in which water is depicted in
orange, the phosphor atoms in the lipids are shown in tan and the protein dimer is represented in cyan
with the retinal moiety in dark blue. (b) Root mean square deviation of the backbone of both rhodopsin
monomers including residue 2 to 322. The structure used as a reference structure for the RMSD was
the dark state dimer structure obtained from combining both 1U19 and 1GZM structures. Monomer 2
was used to perform the cis-trans isomerisation on.
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Figure A.2: QM region that is used in the thermodynamic integration simulations. To the ﬁnal carbons,
before the cut with the protein environment, monovalent pseudo potentials were applied.
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Figure A.3: Alignment of the retinal and Lys296 moieties of the batho conformation from the QM/MM
MD simulation in pink and the batho X-ray structure in cyan (carbon), blue (nitrogen) and red (oxygen)
(PDB code 2G87). The structure of the retinal and Lyr296 are represented without hydrogens for the
QM/MM MD simulations. (a) and (b) show two different perspectives from the PSB and the β-ionone
ring. The alignment of the retinal moiety and the protonated Schiff base of both batho structures (from
the QM/MM simulations and the X-ray structure) results in a RMSD of 0.36 Å. The RMSD between
QM/MM batho and dark state structures is 0.57 Å when the retinal and the protonated Schiff base are
aligned.
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Figure A.4: Alignment of the retinal and Lys296 moieties of the lumi conformation from the QM/MM
MD simulation in yellow and the lumi X-ray structure in cyan (carbon), blue (nitrogen) and red (oxygen)
(PDB code 2HPY). The structure of the retinal, Lys296 and Glu113 are represented without hydrogens
for the QM/MM MD simulations, but for the water molecules the hydrogens are depicted. (a) and
(b) show two different perspectives from the PSB and the β-ionone ring. The alignment of the retinal
moiety and the protonated Schiff base of both lumi structures (from the QM/MM simulations and
the X-ray structure) results in a RMSD of 0.51 Å. The RMSD between QM/MM lumi and dark state
structures is 0.70 Å when the retinal and the protonated Schiff base are aligned. (c) provides a zoom of
the indirect hydrogen bond between Glu113 and PSB in the X-ray and the QM/MM structure.
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Figure A.5: Excitation energies generated via ZINDO/S calculations of the dark state and several other
intermediate states of rhodopsin present after cis-trans isomerisation.
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Figure A.6: Correlation proﬁles of bathorhodopsin, lumirhodopsin and pre-metarhodopsin I.
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Table A.1: Mean and standard deviations of features that are included in the causality proﬁles of batho,
lumi and pre-meta I. The BLA and distances are depicted in Ångstrom, the dihedral angles are shown in
degrees. The values of the features are depicted when the feature is part of the intermediate’s causality
scheme, otherwise the mean and standard deviations are not applicable. The mean and standard
deviations for all features are shown for the reference state, the dark conformation.
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Figure A.7: Graphs of distances of bonds and hydrogen bonds in the unconstrained deprotonated lumi
conﬁguration, after performing TI on the lumi system. The distances in the graphs are visualised via
coloured highlights in a schematic representation of the active site in the lumi state. The coloured
regions corresponds to the colour code of the distances in the graphs.
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Lys296
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Figure A.8: Graphs of distances of bonds and hydrogen bonds in the unconstrained protonated dark
state before TI and the deprotonated dark conﬁguration, after performing TI on the dark system. The
distances in the graphs are visualised via coloured highlights in a schematic representation of the active
site in the dark state. The coloured regions correspond to the colour code of the distances in the graphs.
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Figure A.9: Average force on constraint in Hartree/Bohr for every constraint window. For every window
the standard deviation is shown as well.
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Figure A.10: Colour assignment of the covalent bond and hydrogen bonds that were used to monitor
the change in environment of PBS upon deprotonation in the lumi state (Fig. A.11).
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Figure A.11: Graphs of distances of bonds and hydrogen bonds at different distances (1.44 Å, 1.34 Å, 1.24
Å, 1.14 Å, 1.04 Å, 1.00 Å) of the constraint between H1(WAT1) and O1(Glu113) during the TI calculation
in the lumi state.
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Figure A.12: Colour assignment of the covalent bond and hydrogen bonds that were used to monitor
the change in environment of PBS upon deprotonation in the dark state (Fig. A.13).
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Figure A.13: Graphs of distances of bonds and hydrogen bonds at different distances (1.47 Å, 1.37 Å,
1.27 Å, 1.17 Å, 1.07 Å, 1.00 Å) of the constraint between H(PSB) and O1(Glu113) during the TI calculation
in the dark state.
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Table A.2: pKa calculations of Glu113 in different rhodopsin intermediates. In addition, the pKa values
for Asp83 and Glu122 are shown as reference values since these residues are believed to be protonated
all throughout the activation [Fahmy et al., 1993]. pKa calculations were performed with an external
dielectric of 80, a salinity of 0.15 M and different internal dielectrics. The calculated shift is the total
difference between the full (all) and the minimal (no Gly90, Thr94, WAT1, WAT2) model system, called
no G90, T94, waters. Each time a molecule or residue is removed, the charges of the group are set to
zero, but the radii are maintained. The full model includes rhodopsin without the chromophore and all
water molecules present in the active site.
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Figure B.1: Alignment of the Cα atoms of an active conformation of Gαnoni1 :GTPγS (cyan) and
Gαnons :GTPγS (orange) taken from the PDB codes 1GIA and 1CJK. The root mean square deviation
between both structures is 1.07 Å. GTPγS is a GTP analogue, which is not reactive in the active site of
the subunit.
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Figure B.2: Two perspectives of the initial homology model that was used to start the classical MD
simulation. The template for the cyan region was PDB entry 4PAQ, for the orange area the PDB structure
1AS3 was used and the blue part was modelled after PDB entry 2K5U. The myristoyl moiety is depicted
in yellow.
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Figure B.3: Alignment of the Cα atoms of ARF1:GTP (PDB code 2KSQ) and Gαnoni1 :GDP (PDB code
1BOF) with an RMSD of 1.44 Å. The region on which ARF1:GTP is aligned with Gαnoni1 :GDP is shown in
pink (residue 17-127) while the other regions are depicted in yellow. Gαnoni1 :GDP is represented in cyan.
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Figure B.4: Myristoyl’s atom names, atom types from the AMBER99SB force ﬁeld and charges used for
the generation of the moiety’s topology.
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Figure B.5: Root mean square deviation of the backbone of several regions of the Gαmyri1 :GTP complex.
(a) Representation of the RMSD of the backbone of the protein in four regions: the switch II region
(residues 206 to 220), the β2-β3 region (residues 187 to 199), the αB helix (residues 97 to 111) and
the protein itself (residues 35 to 91, residues 121 to 178, residues 221 to 231, residues 242 to 279 and
residues 296 to 327) for which the part of the protein that was not modelled was included and the αB
helix was excluded together with highly ﬂexible loops. (b) Representation of the regions that were used
for the calculations of the RMSD. The colours of the regions overlap with the colours used in image a.
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Figure B.6: Alignment of the Cα atoms of an X-ray of Gαnoni1 (PDB code 1GIA), interacting with Mg
2+
and GTPγS, in mauve with the structure of the Gαnoni1 :GTP complex at ∼1 μs of classical MD in green.
(a) Orientation of the structural alignments in which the switch I and switch II regions can be viewed.
Besides the protein, also the location of theGTP, GTPγS andMg2+ are shown for both conformations. (b)
Representation of the structural alignment in which the orientation of the β2-β3 region can be viewed.
Besides the protein, also the location of the GTP, GTPγS and Mg2+ are shown for both conformations.
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Figure B.7: Alignment of the Cα atoms of the initial conformation of the Gαmyri1 model (yellow) with the
conformation of Gαmyri1 in the equilibrated conformation (cyan) at ∼ 1.8 μs of classical MD. Besides the
protein, also the location of the myristoyl group, GTP and Mg2+ are shown for both conformations.
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Figure B.8: Representation of the number of water molecules within 3 Å of the side chain of Trp211
during the classical MD simulation of Gαmyri1 :GTP.
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Figure B.9: Comparison of the orientation of Phe336 and Gαs ’s equivalent Phe376 in different states
of activation. (a) Aligned structures of Gαmyri1 :GTP in cyan (after about 1.8 μs of classical MD),
Gαnoni1 :GTPγS in blue (PDB code 1GIA) and Gs in purple. Gs is complexed to a GPCR, β2 adren-
ergic receptor, in yellow (PDB code 3SN6) in which Phe139’s orientation is shown. The myristoyl moiety
is shown in green. (b) Top view of the myristoyl binding pocket in which a clear shift of α5 helix can be
observed for the Gs:GPCR complex. The colour scheme is the same as for image a. (c) Top view of the
myristoyl binding pocket in which can be observed that the GPCR’s Phe139 interacts with Gs’s Phe376.
The colour scheme is the same as for image a.
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Figure B.10: Details of GTP binding in Gαi1. (a) Distances between Mg2+ and two interacting ligands,
Ser47 and Asp200, in the Gαmyri1 :GTP complex. (b) Distances between Mg
2+ and two interacting
oxygen atoms from the GTP molecule in the Gαmyri1 :GTP complex. (c) Zoom of the structure of the
simulated Gαmyri1 :GTP complex in which the GTP molecule and the Mg
2+ are shown with relevant
interacting residues. Characteristic hydrogen bonds are described by the orange lines. (d) Zoom on
the structure of the Gαnoni1 :GTPγS complex (PDB code 1GIA) [Liu et al., 2009] in which the GTPγS
molecule and the Mg2+ are shown with characteristic interacting residues: Ser47, Arg178, Thr181,
Asp200, Gln204. Important hydrogen bonds between moieties are described by the orange lines. (e)
Zoom on the structure of the Gαnoni1 :GDP:AlF
−
4 complex (PDB code 1GFI) [Liu et al., 2009] in which
the GDP molecule, the AlF−4 ion and the Mg
2+ ion are shown with relevant interacting residues: Ser47,
Arg178, Thr181, Asp200, Gln204. Important hydrogen bonds are described by the orange lines.
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Figure B.11: View of the Gαs :AC5 complex (PDB code 1CJK) from the cytosolic side. The Gαs subunit is
depicted in grey, while the C1 domain is represented in blue and the C2 domain is shown in red. The
location of the Gαi1 structure is described by the cyan star.
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Figure B.12: Root mean square deviation of the backbone of the N-terminus of Gαmyri1 :GTP over the
entire classical MD trajectory.
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B.1 SupportingMethods
One of the reasons for using ARF1 as a template for regions of Gαmyri1 is that both, Gα
myr
i1
and ARF1, contain a Ras domain. In addition, both proteins contain an N-terminal myristoyl
group and are structurally very similar (Fig. 4.1), which is also shown via a root mean square
deviation of 1.4 Å between ARF1:GTP and Gαnoni1 :GDP (Fig. B.3). Like Gα
myr
i1 , ARF1 is also
able to switch between its active and inactive state via GDP/GTP exchange for which NMR
structures are available for both cases [Liu et al., 2009, 2010]. When GDP is interacting with
an ARF1 protein, the protein is inactive and its conformation is an equilibrium between a
solvated and a transiently membrane-bound state [Behnia and Munro, 2005]. In its solvated
state, ARF1’s myristoyl group is able to bury itself into an apolar binding site on the protein,
while the N-terminal helix becomes unstructured but remains close to the protein [Liu et al.,
2009]. Once GDP is exchanged for GTP in ARF1’s nucleotide binding site, the protein will
become active and is prone to bind to the cell membrane [Liu et al., 2010]. In the active state,
the N-terminal helix maintains its structure and the myristoyl group is able to interact with
the cell membrane as it has been removed from the protein binding pocket. Comparing the
solvated ARF1:GDP and membrane-bound ARF1:GTP conformation, it becomes apparent
that the switch II and the β2-β3 domains rearrange the most upon GDP/GTP exchange (Fig.
4.1). The domains have to adjust as an area is formed in which the myristoyl is able to
dock. Therefore, the template of the ARF1:GDP complex was used to model this region of the
soluble Gαmyri1 :GTP complex. Even when the N-terminus is cut off and the myristoyl is absent,
Δ17ARF1:GDP, the ARF1 complex is still able to form a hydrophobic pocket, which is similar
to the myristoylated ARF1:GDP complex [Seidel et al., 2004]. Although the ARF1:GDP and
Δ17ARF1:GDP structures are globally similar in their conformation, signiﬁcant changes were
observed by Seidel et al. around: the nucleotide binding site, the interswitch toggle region
and the C-terminus [Seidel et al., 2004]. These are all regions that are in direct or indirect
contact with the myristoyl moiety in the myristoylated ARF1:GDP complex. The formation of
the hydrophobic pocket even in the Δ17ARF1:GDP complex could be due to the fact that ARF1
only contains a Ras domain. Therefore, the switch I region is connecting α1 and β3 directly,
hence, when GTP is exchanged for GDP switch I is free to move and will adjust to a stable
conformation inducing a large rearrangement in the ARF1 conformation (Fig. 4.1). In Gαmyri1 ’s
conformation an alpha helical (AH) domain is present between α1 and the switch I region,
which could signiﬁcantly alter the possible conformational rearrangements that the protein
can under go due to GDP/GTP exchange (Fig. 4.3).
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B.2 Supporting Results and Discussion
B.2.1 Myristoyl Binding Site
The observed upward movement of Phe336 in the myristoylated structure of Gαmyri1 , due to a
change in the residue’s rotamer conformation, is neither present in the Gαmyrnon :GTPγS nor in
the inactive Gαnoni1 :GDP complex (Fig. 4.4a). Phe336’s change of orientation is caused by the
myristoyl group that is interacting with the apolar pocket at Phe336’s initial position. The only
X-ray structure in which similar behaviour of Phe336 has been observed is a Gs structure that
is in the nucleotide free state and is interacting with a GPCR, the β2 adrenergic receptor. This
Gs structure is on its way to the active conformation, but is captured in an intermediate state
between active and inactive. The phenylalanine residue in Gs , Phe376 (UniprotKB P04896),
that is equivalent to Gαi1’s Phe336, moves away from the hydrophobic binding pocket because
of its interactions with the present GPCR (Fig. B.9) [Rasmussen et al., 2011]. The β2 adrenergic
receptor is known to be able to interact with the Gs as well as the Gi1 protein [Kilts et al., 2000].
The effect of the GPCR on Gs ’s conformation could therefore be similar to the effect the GPCR
would have on the Gi structure [Coleman et al., 1994]. Although similar reorientation for
both the Gs :GPCR and the Gα
myr
i1 :GTP complex can be observed, the α5 helix has moved and
rotated towards the GPCR in the Gs:GPCR complex (Fig. B.9), which is not the case in the
Gαmyri1 :GTP structure as Phe336 reorients due to the presence of the myristoyl not because of
a movement of the α5 helix. Hence, interesting similarities and differences can be observed
between the aligned structures in ﬁgure B.8, which underline the importance of Phe336 in the
activation process of G proteins.
Besides Phe336, the conformation of β2-β3 is also modiﬁed due to the presence of the myris-
toyl group (Fig. 4.4b). In ﬁgure 4.4 (a, b), the outward movement and shift of β2-β3 in the
simulated Gαmyri1 :GTP complex is depicted through an alignment with the Gα
non
i1 :GDP (and
Gαnoni1 :GTPγS) structures. Residues, such as Phe191 and Phe189 that are part of β2-β3 have to
change their position due to the steric pressure induced by the myristoyl moiety (Fig. 4.6a, b).
Because of this rearrangement in β2-β3 and the presence of the lipid, Phe191 and Phe336 are
not able to interact with each other anymore like in the Gαnoni1 :GDP complex (Fig. 4.6b). The
absence of direct interactions between Phe191 and Phe336 has been associated to an active
state of the Gαi1 subunit [Kaya et al., 2014]. All these rearrangements in the myristoyl binding
pocket are necessary to make space for the myristoyl moiety and prevent interactions between
β2-β3 and α5 (Fig. 4.6a). The shift of β2-β3 with respect to the rest of the protein results in the
addition of two residue units to the switch II region (Fig. 4.4b, c). Hence, in the Gαmyri1 :GTP
complex, the last hydrogen bond of β2-β3 between Asp200 and Val185 aligns with residues
Gly202 and Gly183 in the Gαi1:GDP complex.
The location of the myristoyl group in the simulated Gαmyri1 :GTP complex stabilises in a similar
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hydrophobic binding pocket as in ARF1:GDP. However, Preininger et al. suggests another
location, between α3 and the switch II region, for the myristoyl moiety on active Gαmyri1
[Preininger et al., 2012]. This hypothesis is mainly based on two ﬁndings: a decrease in the
solubility of Trp211 and a ﬂuorescence quenching experiment to locate the N-terminus in the
GTP-bound form.
Interestingly, the experimental data in combination with the newly obtained classical MD
simulations can also be interpreted in a different way. Due to the conformational changes
induced by the myristoyl group upon activation, the site around Trp211 becomes less solvent
exposed in the simulation (Fig. B.8). The simulation also shows that due to the decrease in
solvent accessibility, the initial space between α3 and the switch II region in Gαnoni1 :GTPγS is
blocked by switch II (Fig. 4.3). This conformational change of switch II would signiﬁcantly
increase the difﬁculty of binding themyristoylmoiety betweenα3 and switch II. The quenching
experiment performed on active Gαmyri1 by Preininger et al. suggests that during Gα
myr
i1 ’s
activation process the N-terminus decreases its distance with respect to the switch II region.
Nonetheless, the region around switch II in which the N-terminus could be located, still covers
a large region [Preininger et al., 2012] and leaves possibility open for other myristoyl binding
sites, such as the hydrophobic binding pocket.
B.2.2 N-Terminus
In the initial structure of the classical MD simulations the X-ray structure of Gαnoni1 :GDP (PDB
code 1AS3) was used as a template for the N-terminus. This X-ray structure was employed
because no GTPγS bound Gαnoni1 structures contain the N-terminal region. The crystallisation
conditions for 1AS3 include the presence of a SO−4 ion, which could have an effect on the
conformation of the N-terminus. However, experiments [Preininger et al., 2003] have shown
that the conformation of the N-terminal region is mainly unstructured and ﬂexible without
the attachment of the myristoyl moiety, which would be similar to the X-ray structure of 1AS3
as in this system the myristoyl is not present. Therefore, the N-terminus of 1AS3 could be
affected by the SO−4 ion, but the experiments performed by Preininger et al. [Preininger et al.,
2003] suggest that the non-myristoylated N-terminal region will lose its structural features
upon solvation. When the myristoyl group is bound, the N-terminus becomes closely packed
to the protein [Preininger et al., 2003]. In order for the N-terminus to decrease its distance with
respect to the rest of the protein, the N-terminus has to change its orientation signiﬁcantly
compared to the heterotrimer conformation.
Hence, although the SO−4 ion might affect the conformation of the X-ray structure, the N-
terminus is bound to change its conformation signiﬁcantly in the classical MD simulations
as in the simulated system the myristoyl group is present. In the performed simulation
the initially guessed N-terminal conformation indeed changes its shape signiﬁcantly upon
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solvation (Fig. B.12), stabilising in a closely packed conformation on the protein (Fig. 4.3). At
the beginning of the simulation, the myristoyl group is also located in a different position then
its ﬁnal location in the hydrophobic pocket which shows that it can sample other regions of
the protein besides its ﬁnal location (Fig. B.2).
B.2.3 GTP Binding Site
As a result of the slight shift of the β2-β3 residues, Asp200 which is located in this strand
is able to interact with the Mg2+ ion in the Gαmyri1 :GTP conformation (Fig. B.10). When
comparing Gαnoni1 :GTPγS (PDB code 1GIA) to Gα
myr
i1 :GTP, the Mg
2+ ion interactions thus
change from Ser47, Thr181, GTP and two water molecules, to Ser47, Asp200, GTP and two
water molecules (Fig. B.10a, c). The water molecules that are interacting with the Mg2+
ion undergo water exchange during the classical MD trajectory. The triphosphate region
of GTP is not only stabilised via Mg2+ interactions but also through other protein residues.
These interactions change from the backbone of Glu43, Ser44, Lys46, Ser47, Thr48 in the
Gαnoni1 :GTPγS conformation to the backbone of Glu43, Ser44, Lys46, Ser47, Thr48, Arg178 and
Lys180 in the Gαmyri1 :GTP complex. The newly formed interaction between GTP and Arg178,
also known as the arginine ﬁnger, in the Gαmyri1 :GTP complex is believed to be crucial for
GTP hydrolysis [Ligeti et al., 2012]. The overall change of ligands coordinating to Mg2+ and
GTP that occurs when moving from the Gαmyri1 :GTPγS to the Gα
myr
i1 :GTP structure, increases
the polarity of the nucleotide binding site in the active myristoylated state, that is consistent
with the ﬂuorescence experiments of Preininger et al. in which the nucleotide binding site of
myristoylated and non-myristoylated Gαi1:GTPγS are compared [Preininger et al., 2012].
It is also interesting to compare the simulation results with an X-ray structure of the Gαnoni1
subunit that represents an intermediate state of Gαi1:GTP during hydrolysis (PDB code 1GFI)
(Fig. B.10e) [Coleman et al., 1994]. This intermediate conformation, however, has also been
crystallised without the N-terminus and the myristoyl moiety. Also in this conformation, the
Mg2+ ion interactions remain different from the one observed for the Gαmyri1 :GTP complex.
The solvated Gαmyri1 subunit (Fig. B.10c) and the Gα
non
i1 :GDP:AlF
−
4 complex do share the same
interaction between Mg2+ and Ser47 and Arg178’s interactions with GTP or GDP:AlF−4 (Fig.
B.10e). However, the substitution of Thr181 by water and the exchange of a water molecule for
Asp200 when going from the GDP:AlF−4 complex to GTP are the same differences as the ones
observed between the Gαmyri1 :GTP and Gα
non
i1 :GTPγS complexes. Another difference between
the two complexes is the presence of a water molecule in the Gαnoni1 :GDP:AlF
−
4 complex located
between AlF−4 , Gln204 and Thr181, which is absent in Gα
myr
i1 :GTP. This water molecule in
the Gαnoni1 :GDP:AlF
−
4 complex that is proposed to be deprotonated in order to become the
attacking base during GTP hydrolysis, is located in the position of Lys180 in the Gαmyri1 :GTP
conformation. Hence, in the case of the Gαmyri1 :GTP complex, a conformational change
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and/or an additional protein interaction appears to be necessary in order to facilitate GTP
hydrolysis. Even though a water molecule is present for GTP hydrolysis in the Gαnoni1 :GDP:AlF
−
4
conformation, an initial deprotonation step of the water molecule that would generate the
attacking base seems unfavourable since the two hydrogens of the water molecule point
towards Gln204 and the backbone of Thr181, which are not common proton acceptors. In
conclusion, the interswitch toggle that inﬂuences the conformation of the switch II region
also affects the GTP binding site signiﬁcantly and leads to altered Mg2+ interactions impacting
GTP hydrolysis.
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Figure C.1: Similarities in sequence and structure of Gαi and Gαs subunits. (a) Sequence alignment of
human Gαi1, Gαi2, Gαi3, which shows a 84% sequence identity between the subunits. (b) Structural
alignment of GTP-analogue-bound Gαi1 (PDB code 1AZT) in cyan and GTP-analogue-bound Gαs (PDB
code 1AS0) in grey.
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Figure C.2: View of the Gαs :AC5 complex (PDB code 1CJK) from the cytosolic side. The Gαs subunit is
depicted in grey, while the C1 domain is represented in blue and the C2 domain is shown in red. The
location of the Gαi1 structure is described by the cyan star.
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Figure C.3: Gαmyri1 :GTP interacting with AC type 5 shows a different type of interaction mode with
AC5 than Gαs . (a) Representation of the docked Gα
myr
i1 : AC5 complex of Rattus norvegicus with the
location of Gαs depicted as well to show the difference in association between the two Gα subunits.
Gαs is depicted in gray, Gα
myr
i1 in cyan, the C1 domain in blue and the C2 domain in red. The location of
the GTP molecules in both Gα subunits is represented by the red pentagons. (b) View from the cytosolic
side on the docked Gαmyri1 :AC5 complex, showing the position of the ATP molecule in the catalytic C1
domain in green. The color scheme is the same as in (a). (c, d) The difference in active AC conformation
is shown, depending on AC’s interaction partners (e.g. analogue of the substrate ATP, the inhibitor
Ca2+, substrate free). The alignment of the initial Gαmyri1 :AC5 complex with three AC:Gαs complexes
demonstrates that the initial AC5 structure used in this study, the substrate-free state, is different from
the fully active AC conformation (yellow) to which an ATP analogue is bound. The yellow structure
is a complex of AC:Gαs with an ATP analogue and forskolin (PDB code 1CJK). The ATP analogue is
depicted in yellow as well with oxygen atoms in red, phosphor in tan and carbon in cyan. This structure
is an active conformation of the AC catalytic domain. The blue (PDB code 3MAA) [Mou et al., 2009]
is suggested to be an inactive AC:Gαs complex and interacts with methylpiperazinoforskolin (FKP)
together with an ATP analogue and a Ca2+ ion. The red structure (PDB code 1AZS) is an Gαs :AC complex
that only interacts with FKP in the catalytic domain and is more similar to the 3MAA structure than
the fully active 1CJK structure around AC’s active site. (e) Alignment of the Gαnoni1 :RGS4 complex (PDB
code 1AGR) and the myristoylated Gαi1:GTP complex. In case of the non-myristoylated Gαi1:RGS4
structure (Gαnoni1 :RGS4), Gα
non
i1 is shown in red and RGS4 is shown in orange. The myristoylated Gαi1
complex is depicted in cyan. The location of Thr182, Glu207 and Lys210 are shown for both complexes
as these residues are important for the interaction between RGS4 and Gαi1 [Tesmer et al., 1997]. The
Gαnoni1 :RGS4 residues are labeled in red and the Gα
myr
i1 :GTP residues are labeled in blue.
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Figure C.4: View of the docked Gαmyri1 :AC5 complex from the cytosolic side. The Gα
myr
i1 subunit is
depicted in cyan, while the C1 domain is represented in blue and the C2 domain is shown in red. The
location of the Gαs structure is described by the grey star and the GTP molecule is represented by the
red pentagon.
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Figure C.5: Distances between the Mg2+ ion and residues in the active site of AC. (a) Distances between
Mg2+ and residues in the active site of the Gαmyri1 :AC5 system. (b) Distances between Mg
2+ and residues
in the active site of the free AC5 system.
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Figure C.6: Mg2+ ion in the active site of AC of the Gαmyri1 :AC5 complex is located in the same interaction
position as in ATP or pyrophosphate bound X-ray structures of Gαs :AC complexes. (a) Alignment of the
Gαmyri1 :AC5 complex (cyan), the AC system (purple) and activated AC (PDB code 1CJK) in orange, which
is interacting with ATP, showing the active site of AC at the C1/C2 interface. The residue names are
following the Rattus norvegicus numbering for AC5. (b) Alignment of the Gαmyri1 :AC5 complex (cyan),
the AC system (purple) and AC associated to pyrophosphate, PPi, (PDB code 3C15) in blue showing
the active site of AC at the C1/C2 interface. The residue names are following the Rattus norvegicus
numbering for AC5.
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Figure C.7: Root mean square deviations of the backbone of the C1:C2 dimer. Additionally also the
RMSD of the Gαmyri1 subunit in the Gα
myr
i1 :AC5 is shown, together with the RMSD of the combination
of Gαmyri1 and the C1 domain. In the RMSD calculation the residues between 463 to 644 were taken
into account for the C1 domain, residues between 1065 to 1135 and 1145 to 1257 were used for the C2
domain and residues 34 to 334 were included for the Gαmyri1 subunit.
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Figure C.8: Graph of the distances between the Mg2+ ion in the active site of Gαmyri1 . Distances are
shown between the Mg2+ ion and its environment, including GTP and the Gαmyri1 residues that are
coordinating to Mg2+: Ser47, Asp200.
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Figure C.9: Changes in the location of important residues in the active site of AC. (a) Detail of the active
site of AC in the Gαmyri1 :AC5 complex, showing the residues that are used in the distance calculations for
image b and d. Additionally, the position of the Mg2+ ion is shown in pink. (b) Graph of the distances in
the Gαmyri1 :AC5 system between the Cα carbon of Asp475, which is positioned close to the ATP binding
site, and other important residues for ATP conversion: Lys1124, Asp1198, Arg1209 and Lys1245. (c)
Detail of the active site of AC in the Gαs :AC complex in which an analogue of ATP is bound (PDB code
1CJK), showing the equivalent residues of the residues in AC5 that are used in the distance calculations
for image b and d. (d) Graph of the distances in the AC system between the Cα carbon of Asp475, which
is positioned close to the ATP binding site, and other important residues for ATP conversion: Lys1124,
Asp1198, Arg1209 and Lys1245.
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C.1 Supporting Results and Discussion
C.1.1 Docking of Gαmyri1 to AC5
Gαmyri1 :AC5 Complex Suggests a Tighter BindingMode of Gα
myr
i1 on AC Compared to Gαs
Figure C.3a and C.3b depict the conformation of the initial Gαmyri1 :AC5 structure, used in the
classical MD simulation. In order to show the difference in orientation between Gαmyri1 on
C1 and Gαs on C2, Gαs ’s location (as observed in the crystal structure) is also depicted in
the ﬁgure. The selected complex from the docking results is characterised by high surface
overlap with the C1 domain and a non-existing overlap with the C2 domain (Fig. C.4), which
is consistent with the experimental data of Dessauer et al. [Dessauer et al., 1998]. Gαmyri1
also covers the experimentally proposed pseudo-symmetric Gαi1:AC binding site on the C1
domain of AC5, the cleft formed by helices α2 and α3 [Dessauer et al., 1998] (Fig. C.4). Yet,
unlike the suggested experimental mode of interaction, Gαmyri1 does not bind within theα2-α3
cleft, but clamps around the helices, forming a tight mode of interaction with AC5 (Fig. C.2
and Fig. C.4).
An additional validation of the proposed model of AC5 and Gαmyri1 is the comparison of active
Gαmyri1 and the complex of non-myristoylated Gαi1 (Gα
non
i1 ) and RGS4 as it has been suggested
that the Gαmyri1 :AC complex is insensitive to RGS4, a regulator of G-protein signalling (Fig.
C.3e) [Markus et al., 2013]. When comparing the Gαmyri1 /AC and the Gα
non
i1 /RGS4 interface
(PDB code 1AGR) [Tesmer et al., 1997], it is clear that residues in the switch II and switch I
region of Gαmyri1 , such as Thr182 and Glu210, that are important for RGS4 binding, are shifted
compared to Gαnoni1 in the RGS4 complex (Fig. C.3,e). Since AC5’s C1 domain is interacting
with and therefore restraining the conformation of Gαmyri1 :GTP, the solvated Gα
myr
i1 appears to
be incompatible with RGS4 binding due to the shift in the switch I and switch II region. This
shift could be a reason for Gαmyri1 ’s insensitivity to RGS4 when complexed to AC.
C.1.2 Addition of Mg2+ to AC’s Active Site Produces a Conformation Close to ATP
or Pyrophosphate Bound Sites
The initial location of the Mg2+ ion was chosen close to the known Mg2+ sites to study whether
the ion would migrate to one of the locations known via X-ray crystallography. Indeed a
relocation of the Mg2+ ion occurs in both systems (free AC and the Gαmyri1 :AC complex) into
the site in which a Mg2+ ion is present in the ATP analogue and the pyrophosphate bound form
(Fig. C.5 and Fig. C.6). This conformation of AC was deemed appropriate for the simulations
as it represents one of the active conformations Gαmyri1 could be able to deactivate.
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